CONSOLIDATED SCHEDULE OF INVESTMENTS € in Thousands, £ in Thousands |
9 Months Ended |
12 Months Ended |
|
|
|
Sep. 30, 2026
USD ($)
shares
|
Dec. 31, 2025
USD ($)
shares
|
Sep. 30, 2026
EUR (€)
shares
|
Sep. 30, 2026
GBP (£)
shares
|
Dec. 31, 2025
EUR (€)
shares
|
Dec. 31, 2025
GBP (£)
shares
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
208.45%
|
[1] |
0.00%
|
[2] |
208.45%
|
[1] |
208.45%
|
[1] |
0.00%
|
[2] |
0.00%
|
[2] |
| Investment, basis spread, variable rate |
|
7.00%
|
|
6.75%
|
|
7.00%
|
|
7.00%
|
|
6.75%
|
|
6.75%
|
|
| Investment cost |
|
$ 4,865,670,000
|
[3] |
$ 4,467,968,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 4,845,903,000
|
|
$ 4,466,647,000
|
|
|
|
|
|
|
|
|
|
| Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
199.85%
|
[1] |
193.11%
|
[2] |
199.85%
|
[1] |
199.85%
|
[1] |
193.11%
|
[2] |
193.11%
|
[2] |
| Investment cost |
|
$ 4,644,453,000
|
[3] |
$ 4,263,950,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 4,645,977,000
|
|
$ 4,279,412,000
|
|
|
|
|
|
|
|
|
|
| Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
6.32%
|
[1] |
6.27%
|
[2] |
6.32%
|
[1] |
6.32%
|
[1] |
6.27%
|
[2] |
6.27%
|
[2] |
| Investment cost |
|
$ 182,457,000
|
[3] |
$ 165,928,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 146,834,000
|
|
$ 139,010,000
|
|
|
|
|
|
|
|
|
|
| Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
1.99%
|
[1] |
1.86%
|
[2] |
1.99%
|
[1] |
1.99%
|
[1] |
1.86%
|
[2] |
1.86%
|
[2] |
| Investment cost |
|
$ 33,431,000
|
[3] |
$ 33,450,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 46,290,000
|
|
$ 41,162,000
|
|
|
|
|
|
|
|
|
|
| Investments In Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
208.16%
|
[1] |
201.24%
|
[2] |
208.16%
|
[1] |
208.16%
|
[1] |
201.24%
|
[2] |
201.24%
|
[2] |
| Investment cost |
|
$ 4,860,341,000
|
[3] |
$ 4,463,328,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 4,839,101,000
|
|
$ 4,459,584,000
|
|
|
|
|
|
|
|
|
|
| Investment Funds & Vehicles Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.29%
|
[1] |
0.32%
|
[2] |
0.29%
|
[1] |
0.29%
|
[1] |
0.32%
|
[2] |
0.32%
|
[2] |
| Investment cost |
|
$ 5,329,000
|
[3] |
$ 4,640,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 6,802,000
|
|
$ 7,063,000
|
|
|
|
|
|
|
|
|
|
| Investments before cash & cash equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
[2] |
|
|
201.56%
|
|
|
|
|
|
201.56%
|
|
201.56%
|
|
| Investment cost |
[4] |
|
|
$ 4,467,968,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 4,466,647,000
|
|
|
|
|
|
|
|
|
|
| Investments, Cash & Cash Equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.00%
|
[1] |
0.46%
|
[2] |
0.00%
|
[1] |
0.00%
|
[1] |
0.46%
|
[2] |
0.46%
|
[2] |
| Investment cost |
|
$ 68,000
|
[3] |
$ 10,250,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 68,000
|
|
$ 10,250,000
|
|
|
|
|
|
|
|
|
|
| Investments after cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
208.45%
|
[1] |
202.02%
|
[2] |
208.45%
|
[1] |
208.45%
|
[1] |
202.02%
|
[2] |
202.02%
|
[2] |
| Investment cost |
|
$ 4,865,738,000
|
[3] |
$ 4,478,218,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 4,845,971,000
|
|
$ 4,476,897,000
|
|
|
|
|
|
|
|
|
|
| Application Software | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
47.90%
|
[1] |
46.44%
|
[2],[5] |
47.90%
|
[1] |
47.90%
|
[1] |
46.44%
|
[2],[5] |
46.44%
|
[2],[5] |
| Investment cost |
|
$ 1,114,552,000
|
[3] |
$ 1,025,012,000
|
[4],[5] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,113,632,000
|
|
$ 1,029,089,000
|
[5] |
|
|
|
|
|
|
|
|
| Application Software | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.32%
|
[1] |
0.48%
|
[2],[5] |
0.32%
|
[1] |
0.32%
|
[1] |
0.48%
|
[2],[5] |
0.48%
|
[2],[5] |
| Investment cost |
|
$ 22,627,000
|
[3] |
$ 15,342,000
|
[4],[5] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 7,438,000
|
|
$ 10,599,000
|
[5] |
|
|
|
|
|
|
|
|
| Application Software | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.15%
|
[1] |
0.25%
|
[2],[5] |
0.15%
|
[1] |
0.15%
|
[1] |
0.25%
|
[2],[5] |
0.25%
|
[2],[5] |
| Investment cost |
|
$ 7,196,000
|
[3] |
$ 7,404,000
|
[4],[5] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,599,000
|
|
$ 5,458,000
|
[5] |
|
|
|
|
|
|
|
|
| Biotechnology Tools | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
2.94%
|
[1] |
0.89%
|
[2] |
2.94%
|
[1] |
2.94%
|
[1] |
0.89%
|
[2] |
0.89%
|
[2] |
| Investment cost |
|
$ 68,560,000
|
[3] |
$ 19,683,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 68,296,000
|
|
$ 19,683,000
|
|
|
|
|
|
|
|
|
|
| Biotechnology Tools | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.31%
|
[1] |
0.04%
|
[2] |
0.31%
|
[1] |
0.31%
|
[1] |
0.04%
|
[2] |
0.04%
|
[2] |
| Investment cost |
|
$ 1,500,000
|
[3] |
$ 1,500,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 7,098,000
|
|
$ 841,000
|
|
|
|
|
|
|
|
|
|
| Biotechnology Tools | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.17%
|
[1] |
0.12%
|
[2] |
0.17%
|
[1] |
0.17%
|
[1] |
0.12%
|
[2] |
0.12%
|
[2] |
| Investment cost |
|
$ 1,637,000
|
[3] |
$ 2,098,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 4,039,000
|
|
$ 2,640,000
|
|
|
|
|
|
|
|
|
|
| Communications & Networking | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
1.45%
|
[1] |
1.19%
|
[2] |
1.45%
|
[1] |
1.45%
|
[1] |
1.19%
|
[2] |
1.19%
|
[2] |
| Investment cost |
|
$ 39,107,000
|
[3] |
$ 28,536,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 33,633,000
|
|
$ 26,263,000
|
|
|
|
|
|
|
|
|
|
| Communications & Networking | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[1] |
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[2] |
| Investment cost |
|
$ 285,000
|
[3] |
$ 242,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 19,000
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Consumer & Business Products | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
1.68%
|
[1] |
0.34%
|
[2] |
1.68%
|
[1] |
1.68%
|
[1] |
0.34%
|
[2] |
0.34%
|
[2] |
| Investment cost |
|
$ 38,924,000
|
[3] |
$ 7,472,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 39,048,000
|
|
$ 7,583,000
|
|
|
|
|
|
|
|
|
|
| Consumer & Business Products | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.01%
|
[1] |
0.02%
|
[2] |
0.01%
|
[1] |
0.01%
|
[1] |
0.02%
|
[2] |
0.02%
|
[2] |
| Investment cost |
|
$ 1,675,000
|
[3] |
$ 1,675,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 315,000
|
|
$ 514,000
|
|
|
|
|
|
|
|
|
|
| Consumer & Business Products | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.09%
|
[1] |
0.03%
|
[2] |
0.09%
|
[1] |
0.09%
|
[1] |
0.03%
|
[2] |
0.03%
|
[2] |
| Investment cost |
|
$ 245,000
|
[3] |
$ 245,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,024,000
|
|
$ 713,000
|
|
|
|
|
|
|
|
|
|
| Consumer & Business Services | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
15.30%
|
[1] |
19.37%
|
[2] |
15.30%
|
[1] |
15.30%
|
[1] |
19.37%
|
[2] |
19.37%
|
[2] |
| Investment cost |
|
$ 363,843,000
|
[3] |
$ 427,993,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 355,771,000
|
|
$ 429,146,000
|
|
|
|
|
|
|
|
|
|
| Consumer & Business Services | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.19%
|
[1] |
0.23%
|
[2] |
0.19%
|
[1] |
0.19%
|
[1] |
0.23%
|
[2] |
0.23%
|
[2] |
| Investment cost |
|
$ 25,474,000
|
[3] |
$ 25,474,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 4,333,000
|
|
$ 5,155,000
|
|
|
|
|
|
|
|
|
|
| Consumer & Business Services | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.31%
|
[1] |
0.32%
|
[2] |
0.31%
|
[1] |
0.31%
|
[1] |
0.32%
|
[2] |
0.32%
|
[2] |
| Investment cost |
|
$ 4,245,000
|
[3] |
$ 4,793,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 7,122,000
|
|
$ 7,166,000
|
|
|
|
|
|
|
|
|
|
| Cybersecurity | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
8.34%
|
[1],[6] |
7.06%
|
[2],[7] |
8.34%
|
[1],[6] |
8.34%
|
[1],[6] |
7.06%
|
[2],[7] |
7.06%
|
[2],[7] |
| Investment cost |
|
$ 205,235,000
|
[3],[6] |
$ 156,709,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 193,782,000
|
[6] |
$ 156,549,000
|
[7] |
|
|
|
|
|
|
|
|
| Cybersecurity | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.21%
|
[1],[6] |
0.23%
|
[2],[7] |
0.21%
|
[1],[6] |
0.21%
|
[1],[6] |
0.23%
|
[2],[7] |
0.23%
|
[2],[7] |
| Investment cost |
|
$ 1,300,000
|
[3],[6] |
$ 1,300,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 4,927,000
|
[6] |
$ 5,063,000
|
[7] |
|
|
|
|
|
|
|
|
| Cybersecurity | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.07%
|
[1],[6] |
0.09%
|
[2],[7] |
0.07%
|
[1],[6] |
0.07%
|
[1],[6] |
0.09%
|
[2],[7] |
0.09%
|
[2],[7] |
| Investment cost |
|
$ 1,191,000
|
[3],[6] |
$ 2,731,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,594,000
|
[6] |
$ 1,956,000
|
[7] |
|
|
|
|
|
|
|
|
| Cybersecurity | Investment Funds & Vehicles Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.02%
|
[1],[6] |
0.02%
|
[2],[7] |
0.02%
|
[1],[6] |
0.02%
|
[1],[6] |
0.02%
|
[2],[7] |
0.02%
|
[2],[7] |
| Investment cost |
|
$ 385,000
|
[3],[6] |
$ 385,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 365,000
|
[6] |
$ 364,000
|
[7] |
|
|
|
|
|
|
|
|
| Defense Technologies | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
12.94%
|
[1] |
6.23%
|
[2] |
12.94%
|
[1] |
12.94%
|
[1] |
6.23%
|
[2] |
6.23%
|
[2] |
| Investment cost |
|
$ 292,189,000
|
[3] |
$ 137,509,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 300,720,000
|
|
$ 138,080,000
|
|
|
|
|
|
|
|
|
|
| Defense Technologies | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.32%
|
[1] |
0.06%
|
[2] |
0.32%
|
[1] |
0.32%
|
[1] |
0.06%
|
[2] |
0.06%
|
[2] |
| Investment cost |
|
$ 6,500,000
|
[3] |
$ 2,250,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 7,487,000
|
|
$ 1,284,000
|
|
|
|
|
|
|
|
|
|
| Defense Technologies | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
[1] |
0.16%
|
|
|
|
0.16%
|
|
0.16%
|
|
|
|
|
|
| Investment cost |
[3] |
$ 2,883,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,814,000
|
|
|
|
|
|
|
|
|
|
|
|
| Diversified Financial Services | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
1.99%
|
[1] |
1.73%
|
[2] |
1.99%
|
[1] |
1.99%
|
[1] |
1.73%
|
[2] |
1.73%
|
[2] |
| Investment cost |
|
$ 46,357,000
|
[3] |
$ 38,255,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 46,357,000
|
|
$ 38,255,000
|
|
|
|
|
|
|
|
|
|
| Diversified Financial Services | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
2.83%
|
[1] |
3.05%
|
[2] |
2.83%
|
[1] |
2.83%
|
[1] |
3.05%
|
[2] |
3.05%
|
[2] |
| Investment cost |
|
$ 45,639,000
|
[3] |
$ 44,894,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 65,721,000
|
|
$ 67,641,000
|
|
|
|
|
|
|
|
|
|
| Diversified Financial Services | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
[2] |
|
|
0.05%
|
|
|
|
|
|
0.05%
|
|
0.05%
|
|
| Investment cost |
[4] |
|
|
$ 726,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 1,094,000
|
|
|
|
|
|
|
|
|
|
| Drug Discovery & Development | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
42.52%
|
[1] |
45.05%
|
[2] |
42.52%
|
[1] |
42.52%
|
[1] |
45.05%
|
[2] |
45.05%
|
[2] |
| Investment cost |
|
$ 972,336,000
|
[3] |
$ 987,270,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 988,403,000
|
|
$ 998,317,000
|
|
|
|
|
|
|
|
|
|
| Drug Discovery & Development | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.81%
|
[1] |
0.98%
|
[2] |
0.81%
|
[1] |
0.81%
|
[1] |
0.98%
|
[2] |
0.98%
|
[2] |
| Investment cost |
|
$ 31,409,000
|
[3] |
$ 29,128,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 18,781,000
|
|
$ 21,774,000
|
|
|
|
|
|
|
|
|
|
| Drug Discovery & Development | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.33%
|
[1] |
0.58%
|
[2] |
0.33%
|
[1] |
0.33%
|
[1] |
0.58%
|
[2] |
0.58%
|
[2] |
| Investment cost |
|
$ 5,350,000
|
[3] |
$ 5,965,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 7,696,000
|
|
$ 12,922,000
|
|
|
|
|
|
|
|
|
|
| Drug Discovery & Development | Investment Funds & Vehicles Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.28%
|
[1] |
0.30%
|
[2] |
0.28%
|
[1] |
0.28%
|
[1] |
0.30%
|
[2] |
0.30%
|
[2] |
| Investment cost |
|
$ 4,944,000
|
[3] |
$ 4,255,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 6,437,000
|
|
$ 6,699,000
|
|
|
|
|
|
|
|
|
|
| Electronics & Computer Hardware | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
2.83%
|
[1] |
2.96%
|
[2] |
2.83%
|
[1] |
2.83%
|
[1] |
2.96%
|
[2] |
2.96%
|
[2] |
| Investment cost |
|
$ 65,694,000
|
[3] |
$ 65,186,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 65,831,000
|
|
$ 65,543,000
|
|
|
|
|
|
|
|
|
|
| Electronics & Computer Hardware | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.05%
|
[1] |
0.04%
|
[2] |
0.05%
|
[1] |
0.05%
|
[1] |
0.04%
|
[2] |
0.04%
|
[2] |
| Investment cost |
|
$ 2,150,000
|
[3] |
$ 2,150,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,189,000
|
|
$ 972,000
|
|
|
|
|
|
|
|
|
|
| Electronics & Computer Hardware | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.04%
|
[1] |
0.02%
|
[2] |
0.04%
|
[1] |
0.04%
|
[1] |
0.02%
|
[2] |
0.02%
|
[2] |
| Investment cost |
|
$ 692,000
|
[3] |
$ 692,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 927,000
|
|
$ 477,000
|
|
|
|
|
|
|
|
|
|
| Energy Technologies | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
2.53%
|
[1],[6] |
1.36%
|
[2],[7] |
2.53%
|
[1],[6] |
2.53%
|
[1],[6] |
1.36%
|
[2],[7] |
1.36%
|
[2],[7] |
| Investment cost |
|
$ 59,041,000
|
[3],[6] |
$ 30,296,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 58,768,000
|
[6] |
$ 30,201,000
|
[7] |
|
|
|
|
|
|
|
|
| Energy Technologies | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.02%
|
[1],[6] |
0.01%
|
[2],[7] |
0.02%
|
[1],[6] |
0.02%
|
[1],[6] |
0.01%
|
[2],[7] |
0.01%
|
[2],[7] |
| Investment cost |
|
$ 1,045,000
|
[3],[6] |
$ 559,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 539,000
|
[6] |
$ 145,000
|
[7] |
|
|
|
|
|
|
|
|
| Financial Technologies | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
1.05%
|
[1],[6] |
0.31%
|
[2],[7] |
1.05%
|
[1],[6] |
1.05%
|
[1],[6] |
0.31%
|
[2],[7] |
0.31%
|
[2],[7] |
| Investment cost |
|
$ 24,294,000
|
[3],[6] |
$ 6,889,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 24,400,000
|
[6] |
$ 6,889,000
|
[7] |
|
|
|
|
|
|
|
|
| Financial Technologies | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.06%
|
[1],[6] |
0.05%
|
[2],[7] |
0.06%
|
[1],[6] |
0.06%
|
[1],[6] |
0.05%
|
[2],[7] |
0.05%
|
[2],[7] |
| Investment cost |
|
$ 1,899,000
|
[3],[6] |
$ 1,499,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,287,000
|
[6] |
$ 1,178,000
|
[7] |
|
|
|
|
|
|
|
|
| Financial Technologies | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.04%
|
[1],[6] |
0.04%
|
[2],[7] |
0.04%
|
[1],[6] |
0.04%
|
[1],[6] |
0.04%
|
[2],[7] |
0.04%
|
[2],[7] |
| Investment cost |
|
$ 331,000
|
[3],[6] |
$ 247,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 889,000
|
[6] |
$ 904,000
|
[7] |
|
|
|
|
|
|
|
|
| Healthcare Services, Other | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
38.60%
|
[1] |
34.51%
|
[2] |
38.60%
|
[1] |
38.60%
|
[1] |
34.51%
|
[2] |
34.51%
|
[2] |
| Investment cost |
|
$ 899,003,000
|
[3] |
$ 768,517,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 897,337,000
|
|
$ 764,794,000
|
|
|
|
|
|
|
|
|
|
| Healthcare Services, Other | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.45%
|
[1] |
0.44%
|
[2] |
0.45%
|
[1] |
0.45%
|
[1] |
0.44%
|
[2] |
0.44%
|
[2] |
| Investment cost |
|
$ 9,197,000
|
[3] |
$ 9,331,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 10,387,000
|
|
$ 9,845,000
|
|
|
|
|
|
|
|
|
|
| Healthcare Services, Other | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.08%
|
[1] |
0.08%
|
[2] |
0.08%
|
[1] |
0.08%
|
[1] |
0.08%
|
[2] |
0.08%
|
[2] |
| Investment cost |
|
$ 1,478,000
|
[3] |
$ 1,384,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,754,000
|
|
$ 1,682,000
|
|
|
|
|
|
|
|
|
|
| Manufacturing Technology | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
1.67%
|
[1] |
0.90%
|
[2] |
1.67%
|
[1] |
1.67%
|
[1] |
0.90%
|
[2] |
0.90%
|
[2] |
| Investment cost |
|
$ 36,543,000
|
[3] |
$ 20,088,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 38,752,000
|
|
$ 19,941,000
|
|
|
|
|
|
|
|
|
|
| Manufacturing Technology | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.03%
|
[1] |
0.01%
|
[2] |
0.03%
|
[1] |
0.03%
|
[1] |
0.01%
|
[2] |
0.01%
|
[2] |
| Investment cost |
|
$ 1,139,000
|
[3] |
$ 1,102,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 598,000
|
|
$ 249,000
|
|
|
|
|
|
|
|
|
|
| Medical Devices & Equipment | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
4.93%
|
[1] |
3.37%
|
[2] |
4.93%
|
[1] |
4.93%
|
[1] |
3.37%
|
[2] |
3.37%
|
[2] |
| Investment cost |
|
$ 113,615,000
|
[3] |
$ 74,875,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 114,662,000
|
|
$ 74,771,000
|
|
|
|
|
|
|
|
|
|
| Medical Devices & Equipment | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.11%
|
[1] |
0.08%
|
[2] |
0.11%
|
[1] |
0.11%
|
[1] |
0.08%
|
[2] |
0.08%
|
[2] |
| Investment cost |
|
$ 1,250,000
|
[3] |
$ 1,250,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,442,000
|
|
$ 1,727,000
|
|
|
|
|
|
|
|
|
|
| Medical Devices & Equipment | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.07%
|
[1] |
0.03%
|
[2] |
0.07%
|
[1] |
0.07%
|
[1] |
0.03%
|
[2] |
0.03%
|
[2] |
| Investment cost |
|
$ 1,176,000
|
[3] |
$ 916,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,570,000
|
|
$ 759,000
|
|
|
|
|
|
|
|
|
|
| Space Technologies | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
1.95%
|
[1] |
1.98%
|
[2] |
1.95%
|
[1] |
1.95%
|
[1] |
1.98%
|
[2] |
1.98%
|
[2] |
| Investment cost |
|
$ 44,566,000
|
[3] |
$ 43,693,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 45,263,000
|
|
$ 43,792,000
|
|
|
|
|
|
|
|
|
|
| Space Technologies | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.37%
|
[1] |
0.06%
|
[2] |
0.37%
|
[1] |
0.37%
|
[1] |
0.06%
|
[2] |
0.06%
|
[2] |
| Investment cost |
|
$ 5,746,000
|
[3] |
$ 1,406,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 8,552,000
|
|
$ 1,256,000
|
|
|
|
|
|
|
|
|
|
| Space Technologies | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.34%
|
[1] |
0.12%
|
[2] |
0.34%
|
[1] |
0.34%
|
[1] |
0.12%
|
[2] |
0.12%
|
[2] |
| Investment cost |
|
$ 1,520,000
|
[3] |
$ 1,438,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 7,927,000
|
|
$ 2,768,000
|
|
|
|
|
|
|
|
|
|
| Sustainable and Renewable Technology | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.32%
|
[1] |
0.21%
|
[2] |
0.32%
|
[1] |
0.32%
|
[1] |
0.21%
|
[2] |
0.21%
|
[2] |
| Investment cost |
|
$ 7,240,000
|
[3] |
$ 4,736,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 7,332,000
|
|
$ 4,736,000
|
|
|
|
|
|
|
|
|
|
| Sustainable and Renewable Technology | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.02%
|
[1] |
0.02%
|
[2] |
0.02%
|
[1] |
0.02%
|
[1] |
0.02%
|
[2] |
0.02%
|
[2] |
| Investment cost |
|
$ 10,153,000
|
[3] |
$ 10,153,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 466,000
|
|
$ 503,000
|
|
|
|
|
|
|
|
|
|
| Sustainable and Renewable Technology | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.01%
|
[1] |
0.01%
|
[2] |
0.01%
|
[1] |
0.01%
|
[1] |
0.01%
|
[2] |
0.01%
|
[2] |
| Investment cost |
|
$ 304,000
|
[3] |
$ 232,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 202,000
|
|
$ 174,000
|
|
|
|
|
|
|
|
|
|
| System Software | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
5.19%
|
[1] |
13.62%
|
[2],[5] |
5.19%
|
[1] |
5.19%
|
[1] |
13.62%
|
[2],[5] |
13.62%
|
[2],[5] |
| Investment cost |
|
$ 120,135,000
|
[3] |
$ 297,602,000
|
[4],[5] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 120,657,000
|
|
$ 301,816,000
|
[5] |
|
|
|
|
|
|
|
|
| System Software | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.01%
|
[1] |
0.24%
|
[2],[5] |
0.01%
|
[1] |
0.01%
|
[1] |
0.24%
|
[2],[5] |
0.24%
|
[2],[5] |
| Investment cost |
|
$ 4,549,000
|
[3] |
$ 7,187,000
|
[4],[5] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 150,000
|
|
$ 5,253,000
|
[5] |
|
|
|
|
|
|
|
|
| System Software | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.04%
|
[1] |
0.07%
|
[2],[5] |
0.04%
|
[1] |
0.04%
|
[1] |
0.07%
|
[2],[5] |
0.07%
|
[2],[5] |
| Investment cost |
|
$ 980,000
|
[3] |
$ 905,000
|
[4],[5] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,017,000
|
|
$ 1,544,000
|
[5] |
|
|
|
|
|
|
|
|
| Drug Delivery | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[1] |
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[2] |
| Investment cost |
|
$ 3,638,000
|
[3] |
$ 3,638,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 14,000
|
|
$ 14,000
|
|
|
|
|
|
|
|
|
|
| Information Services | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.16%
|
[1] |
0.14%
|
[2] |
0.16%
|
[1] |
0.16%
|
[1] |
0.14%
|
[2] |
0.14%
|
[2] |
| Investment cost |
|
$ 3,825,000
|
[3] |
$ 3,825,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,759,000
|
|
$ 3,200,000
|
|
|
|
|
|
|
|
|
|
| Information Services | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[1] |
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[2] |
| Investment cost |
|
$ 356,000
|
[3] |
$ 413,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Semiconductors | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.01%
|
[1] |
0.00%
|
[2] |
0.01%
|
[1] |
0.01%
|
[1] |
0.00%
|
[2] |
0.00%
|
[2] |
| Investment cost |
|
$ 167,000
|
[3] |
$ 167,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 240,000
|
|
$ 109,000
|
|
|
|
|
|
|
|
|
|
| Semiconductors | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[1] |
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[2] |
| Investment cost |
|
$ 92,000
|
[3] |
$ 92,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 89,000
|
|
$ 49,000
|
|
|
|
|
|
|
|
|
|
| Media/Content/Info | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[1] |
0.00%
|
[1] |
0.00%
|
[2] |
0.00%
|
[2] |
| Investment cost |
|
$ 67,000
|
[3] |
$ 67,000
|
[4] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 44,000
|
|
$ 32,000
|
|
|
|
|
|
|
|
|
|
| Healthcare Technology & Digital Health | Debt Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
5.74%
|
[1],[6] |
5.59%
|
[2] |
5.74%
|
[1],[6] |
5.74%
|
[1],[6] |
5.59%
|
[2] |
5.59%
|
[2] |
| Investment cost |
|
$ 133,219,000
|
[3],[6] |
$ 123,629,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 133,333,000
|
[6] |
$ 123,964,000
|
[7] |
|
|
|
|
|
|
|
|
| Healthcare Technology & Digital Health | Equity Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.10%
|
[1],[6] |
0.09%
|
[2],[7] |
0.10%
|
[1],[6] |
0.10%
|
[1],[6] |
0.09%
|
[2],[7] |
0.09%
|
[2],[7] |
| Investment cost |
|
$ 3,759,000
|
[3],[6] |
$ 3,759,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,248,000
|
[6] |
$ 2,082,000
|
[7] |
|
|
|
|
|
|
|
|
| Healthcare Technology & Digital Health | Warrant investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment owned, percent of net assets |
|
0.04%
|
[1],[6] |
0.02%
|
[2],[7] |
0.04%
|
[1],[6] |
0.04%
|
[1],[6] |
0.02%
|
[2],[7] |
0.02%
|
[2],[7] |
| Investment cost |
|
$ 1,219,000
|
[3],[6] |
$ 1,199,000
|
[4],[7] |
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 827,000
|
[6] |
430,000
|
[7] |
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total SeatGeek, Inc |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
103,890,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
105,935,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
105,935,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Total Gibraltar Acquisition, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
38,805,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
38,255,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 38,255,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Altimmune, Inc., Senior Secured, Maturity Date June 2029, Prime + 2.45%, Floor rate 9.70%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[9],[10] |
|
|
2029-06
|
|
|
|
|
|
2029-06
|
|
2029-06
|
|
| Investment, basis spread, variable rate |
[8],[9],[10],[11] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
2.45%
|
|
| Investment, interest rate, floor |
[8],[9],[10],[11] |
|
|
9.70%
|
|
|
|
|
|
9.70%
|
|
9.70%
|
|
| Investment exit fee |
[8],[9],[10],[11] |
|
|
6.25%
|
|
|
|
|
|
6.25%
|
|
6.25%
|
|
| Principal amount |
[8],[9],[10] |
|
|
$ 17,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[10] |
|
|
17,437,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[10] |
|
|
$ 17,403,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 9.90%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[12] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
2027-07
|
|
| Investment, basis spread, variable rate |
[11],[12] |
|
|
1.90%
|
|
|
|
|
|
1.90%
|
|
1.90%
|
|
| Investment, interest rate, floor |
[11],[12] |
|
|
9.90%
|
|
|
|
|
|
9.90%
|
|
9.90%
|
|
| Investment exit fee |
[11],[12] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
7.50%
|
|
| Principal amount |
[12] |
|
|
$ 46,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[12] |
|
|
48,117,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[12] |
|
|
$ 47,862,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date August 2029, Prime + 1.05%, Floor rate 9.55%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[13] |
|
|
2029-08
|
|
|
|
|
|
2029-08
|
|
2029-08
|
|
| Investment, basis spread, variable rate |
[8],[11],[13] |
|
|
1.05%
|
|
|
|
|
|
1.05%
|
|
1.05%
|
|
| Investment, interest rate, floor |
[8],[11],[13] |
|
|
9.55%
|
|
|
|
|
|
9.55%
|
|
9.55%
|
|
| Investment exit fee |
[8],[11],[13] |
|
|
5.95%
|
|
|
|
|
|
5.95%
|
|
5.95%
|
|
| Principal amount |
[8],[13] |
|
|
$ 36,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[13] |
|
|
35,899,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[13] |
|
|
$ 35,899,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investment Healthcare Technology & Digital Health and Modern Life, Inc., Senior Secured, Maturity Date February 2029, Prime + 2.75%, Floor rate 10.25%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[7],[12] |
|
|
2029-02
|
|
|
|
|
|
2029-02
|
|
2029-02
|
|
| Investment, basis spread, variable rate |
[7],[11],[12] |
|
|
2.75%
|
|
|
|
|
|
2.75%
|
|
2.75%
|
|
| Investment, interest rate, floor |
[7],[11],[12] |
|
|
10.25%
|
|
|
|
|
|
10.25%
|
|
10.25%
|
|
| Investment exit fee |
[7],[11],[12] |
|
|
5.00%
|
|
|
|
|
|
5.00%
|
|
5.00%
|
|
| Principal amount |
[7],[12] |
|
|
$ 20,238,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[12] |
|
|
20,281,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[12] |
|
|
$ 20,281,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[12],[14],[15] |
|
|
2028-05
|
|
|
|
|
|
2028-05
|
|
2028-05
|
|
| Investment, basis spread, variable rate |
[5],[11],[12],[14],[15] |
|
|
8.14%
|
|
|
|
|
|
8.14%
|
|
8.14%
|
|
| Investment, interest rate, floor |
[5],[11],[12],[14],[15] |
|
|
9.14%
|
|
|
|
|
|
9.14%
|
|
9.14%
|
|
| Principal amount |
[5],[12],[14],[15] |
|
|
$ 20,163,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[12],[14],[15] |
|
|
19,919,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[12],[14],[15] |
|
|
$ 20,163,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and AlphaSense, Inc., Senior Secured, Maturity Date June 2029, 3-month SOFR + 6.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[16] |
|
|
2029-06
|
|
|
|
|
|
2029-06
|
|
2029-06
|
|
| Investment, basis spread, variable rate |
[5],[11],[16] |
|
|
6.25%
|
|
|
|
|
|
6.25%
|
|
6.25%
|
|
| Investment, interest rate, floor |
[5],[11],[16] |
|
|
8.25%
|
|
|
|
|
|
8.25%
|
|
8.25%
|
|
| Principal amount |
[5],[16] |
|
|
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[16] |
|
|
19,849,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[16] |
|
|
19,916,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Annex Cloud |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[5] |
|
|
10,683,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
10,684,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 6,269,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Annex Cloud Senior Secured, Maturity Date June 2028, PIK Interest 3-month SOFR + 5.73%, Floor rate 6.73% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[15],[17] |
|
|
2028-06
|
|
|
|
|
|
2028-06
|
|
2028-06
|
|
| Investment, basis spread, variable rate |
[5],[11],[15],[17] |
|
|
5.73%
|
|
|
|
|
|
5.73%
|
|
5.73%
|
|
| Investment, interest rate, floor |
[5],[11],[15],[17] |
|
|
6.73%
|
|
|
|
|
|
6.73%
|
|
6.73%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[15],[17] |
|
|
5.73%
|
|
|
|
|
|
5.73%
|
|
5.73%
|
|
| Principal amount |
[5],[15],[17] |
|
|
$ 1,716,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[15],[17] |
|
|
1,717,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[15],[17] |
|
|
$ 687,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Annex Cloud, Senior Secured, Maturity Date December 2025, PIK Interest 3-month SOFR + 9.99%, Floor rate 10.99% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[15],[17],[18] |
|
|
2025-12
|
|
|
|
|
|
2025-12
|
|
2025-12
|
|
| Investment, basis spread, variable rate |
[5],[11],[15],[17],[18] |
|
|
9.99%
|
|
|
|
|
|
9.99%
|
|
9.99%
|
|
| Investment, interest rate, floor |
[5],[11],[15],[17],[18] |
|
|
10.99%
|
|
|
|
|
|
10.99%
|
|
10.99%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[15],[17],[18] |
|
|
9.99%
|
|
|
|
|
|
9.99%
|
|
9.99%
|
|
| Principal amount |
[5],[15],[17],[18] |
|
|
$ 3,325,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[15],[17],[18] |
|
|
3,325,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[15],[17],[18] |
|
|
$ 3,325,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Annex Cloud, Senior Secured, Maturity Date June 2028, PIK Interest 3-month SOFR + 9.99%, Floor rate 10.99% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[12],[15],[17] |
|
|
2028-06
|
|
|
|
|
|
2028-06
|
|
2028-06
|
|
| Investment, basis spread, variable rate |
[5],[11],[12],[15],[17] |
|
|
9.99%
|
|
|
|
|
|
9.99%
|
|
9.99%
|
|
| Investment, interest rate, floor |
[5],[11],[12],[15],[17] |
|
|
10.99%
|
|
|
|
|
|
10.99%
|
|
10.99%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[12],[15],[17] |
|
|
9.99%
|
|
|
|
|
|
9.99%
|
|
9.99%
|
|
| Principal amount |
[5],[12],[15],[17] |
|
|
$ 5,642,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[12],[15],[17] |
|
|
5,642,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[12],[15],[17] |
|
|
$ 2,257,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Babel Street, Senior Secured, December 2027, 3-month SOFR + 8.01%, Floor rate 9.01% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[14],[15] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
2027-12
|
|
| Investment, basis spread, variable rate |
[5],[8],[11],[14],[15] |
|
|
8.01%
|
|
|
|
|
|
8.01%
|
|
8.01%
|
|
| Investment, interest rate, floor |
[5],[8],[11],[14],[15] |
|
|
9.01%
|
|
|
|
|
|
9.01%
|
|
9.01%
|
|
| Principal amount |
[5],[8],[14],[15] |
|
|
$ 65,937,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[14],[15] |
|
|
65,038,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[14],[15] |
|
|
$ 64,738,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Behavox Limited, Senior Secured, Maturity Date September 2027, Prime - 0.55%, Floor rate 7.45%, PIK Interest 3.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[9],[14],[16],[19],[20] |
|
|
2027-09
|
|
|
|
|
|
2027-09
|
|
2027-09
|
|
| Investment, basis spread, variable rate |
[5],[9],[11],[14],[16],[19],[20] |
|
|
(0.55%)
|
|
|
|
|
|
(0.55%)
|
|
(0.55%)
|
|
| Investment, interest rate, floor |
[5],[9],[11],[14],[16],[19],[20] |
|
|
7.45%
|
|
|
|
|
|
7.45%
|
|
7.45%
|
|
| Investment, interest rate, paid in kind |
[5],[9],[11],[14],[16],[19],[20] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Investment exit fee |
[5],[9],[11],[14],[16],[19],[20] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount |
[5],[9],[14],[16],[19],[20] |
|
|
$ 19,444,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[14],[16],[19],[20] |
|
|
19,596,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[14],[16],[19],[20] |
|
|
$ 19,598,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Brain Corporation, Senior Secured, September 2028, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.50%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[12],[19] |
|
|
2028-09
|
|
|
|
|
|
2028-09
|
|
2028-09
|
|
| Investment, basis spread, variable rate |
[5],[11],[12],[19] |
|
|
1.35%
|
|
|
|
|
|
1.35%
|
|
1.35%
|
|
| Investment, interest rate, floor |
[5],[11],[12],[19] |
|
|
9.85%
|
|
|
|
|
|
9.85%
|
|
9.85%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[12],[19] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Investment exit fee |
[5],[11],[12],[19] |
|
|
3.95%
|
|
|
|
|
|
3.95%
|
|
3.95%
|
|
| Principal amount |
[5],[12],[19] |
|
|
$ 32,830,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[12],[19] |
|
|
32,865,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[12],[19] |
|
|
$ 33,410,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Carbyne, Inc., Senior Secured, February 2029, Prime + 3.50%, Floor rate 10.00%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14] |
|
|
2029-02
|
|
|
|
|
|
2029-02
|
|
2029-02
|
|
| Investment, basis spread, variable rate |
[5],[11],[14] |
|
|
3.50%
|
|
|
|
|
|
3.50%
|
|
3.50%
|
|
| Investment, interest rate, floor |
[5],[11],[14] |
|
|
10.00%
|
|
|
|
|
|
10.00%
|
|
10.00%
|
|
| Investment exit fee |
[5],[11],[14] |
|
|
3.50%
|
|
|
|
|
|
3.50%
|
|
3.50%
|
|
| Principal amount |
[5],[14] |
|
|
$ 7,450,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14] |
|
|
7,430,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14] |
|
|
$ 7,711,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Ceros, Inc., Senior Secured, June 2027, 3-month SOFR + 8.99%, Floor rate 9.89% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[15] |
|
|
2027-06
|
|
|
|
|
|
2027-06
|
|
2027-06
|
|
| Investment, basis spread, variable rate |
[5],[11],[15] |
|
|
8.99%
|
|
|
|
|
|
8.99%
|
|
8.99%
|
|
| Investment, interest rate, floor |
[5],[11],[15] |
|
|
9.89%
|
|
|
|
|
|
9.89%
|
|
9.89%
|
|
| Principal amount |
[5],[15] |
|
|
$ 22,656,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[15] |
|
|
22,543,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[15] |
|
|
$ 22,506,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Chainalysis, Inc., Senior Secured, June 2029, Prime + 2.95%, Floor rate 10.45% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5] |
|
|
2029-06
|
|
|
|
|
|
2029-06
|
|
2029-06
|
|
| Investment, basis spread, variable rate |
[5],[11] |
|
|
2.95%
|
|
|
|
|
|
2.95%
|
|
2.95%
|
|
| Investment, interest rate, floor |
[5],[11] |
|
|
10.45%
|
|
|
|
|
|
10.45%
|
|
10.45%
|
|
| Principal amount |
[5] |
|
|
$ 36,412,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
35,954,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 36,143,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Dashlane, Inc., Senior Secured, December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 6.28% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[12],[16],[19],[21] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
2027-12
|
|
| Investment, basis spread, variable rate |
[5],[11],[12],[16],[19],[21] |
|
|
3.05%
|
|
|
|
|
|
3.05%
|
|
3.05%
|
|
| Investment, interest rate, floor |
[5],[11],[12],[16],[19],[21] |
|
|
11.55%
|
|
|
|
|
|
11.55%
|
|
11.55%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[12],[16],[19],[21] |
|
|
1.10%
|
|
|
|
|
|
1.10%
|
|
1.10%
|
|
| Investment exit fee |
[5],[11],[12],[16],[19],[21] |
|
|
6.28%
|
|
|
|
|
|
6.28%
|
|
6.28%
|
|
| Principal amount |
[5],[12],[16],[19],[21] |
|
|
$ 45,986,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[12],[16],[19],[21] |
|
|
46,789,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[12],[16],[19],[21] |
|
|
$ 48,034,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Dispatch Technologies, Inc., Senior Secured, April 2028, 3-month SOFR + 7.86%, Floor rate 8.61% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[15] |
|
|
2028-04
|
|
|
|
|
|
2028-04
|
|
2028-04
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[15] |
|
|
7.86%
|
|
|
|
|
|
7.86%
|
|
7.86%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[15] |
|
|
8.61%
|
|
|
|
|
|
8.61%
|
|
8.61%
|
|
| Principal amount |
[5],[14],[15] |
|
|
$ 8,751,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[15] |
|
|
8,634,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[15] |
|
|
$ 8,524,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Distributed Creation Inc., Senior Secured, April 2029, Prime + 3.00%, Floor rate 10.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[16] |
|
|
2029-04
|
|
|
|
|
|
2029-04
|
|
2029-04
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[16] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[16] |
|
|
10.25%
|
|
|
|
|
|
10.25%
|
|
10.25%
|
|
| Investment exit fee |
[5],[11],[14],[16] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
4.50%
|
|
| Principal amount |
[5],[14],[16] |
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[16] |
|
|
24,825,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[16] |
|
|
$ 25,024,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and DocPlanner., Senior Secured, January 2030, Prime + 2.75%, Floor rate 9.75%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[9],[14],[20] |
|
|
2030-01
|
|
|
|
|
|
2030-01
|
|
2030-01
|
|
| Investment, basis spread, variable rate |
[5],[9],[11],[14],[20] |
|
|
2.75%
|
|
|
|
|
|
2.75%
|
|
2.75%
|
|
| Investment, interest rate, floor |
[5],[9],[11],[14],[20] |
|
|
9.75%
|
|
|
|
|
|
9.75%
|
|
9.75%
|
|
| Investment exit fee |
[5],[9],[11],[14],[20] |
|
|
4.25%
|
|
|
|
|
|
4.25%
|
|
4.25%
|
|
| Principal amount | € |
[5],[9],[14],[20] |
|
|
|
|
|
|
|
|
€ 68,200
|
|
|
|
| Investment cost |
[4],[5],[9],[14],[20] |
|
|
$ 69,857,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[14],[20] |
|
|
$ 80,519,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Earnix, Inc., Senior Secured, June 2029, Prime - 1.15%, Floor rate 5.35%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[16],[19] |
|
|
2029-06
|
|
|
|
|
|
2029-06
|
|
2029-06
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[16],[19] |
|
|
(1.15%)
|
|
|
|
|
|
(1.15%)
|
|
(1.15%)
|
|
| Investment, interest rate, floor |
[5],[11],[14],[16],[19] |
|
|
5.35%
|
|
|
|
|
|
5.35%
|
|
5.35%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[14],[16],[19] |
|
|
4.45%
|
|
|
|
|
|
4.45%
|
|
4.45%
|
|
| Principal amount |
[5],[14],[16],[19] |
|
|
$ 20,049,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[16],[19] |
|
|
19,790,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[16],[19] |
|
|
$ 20,126,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Funnel Holding AB (publ)., Senior Secured, October 2029, Prime + 0.60%, Floor rate 7.10%, Cap rate 8.60%, PIK Interest 3.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[9],[14],[19],[20],[21] |
|
|
2029-10
|
|
|
|
|
|
2029-10
|
|
2029-10
|
|
| Investment, basis spread, variable rate |
[5],[9],[11],[14],[19],[20],[21] |
|
|
0.60%
|
|
|
|
|
|
0.60%
|
|
0.60%
|
|
| Investment, interest rate, floor |
[5],[9],[11],[14],[19],[20],[21] |
|
|
7.10%
|
|
|
|
|
|
7.10%
|
|
7.10%
|
|
| Investment, interest rate, cap |
[5],[9],[11],[14],[19],[20],[21] |
|
|
8.60%
|
|
|
|
|
|
8.60%
|
|
8.60%
|
|
| Investment, interest rate, paid in kind |
[5],[9],[11],[14],[19],[20],[21] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Investment exit fee |
[5],[9],[11],[14],[19],[20],[21] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Principal amount |
[5],[9],[14],[19],[20],[21] |
|
|
$ 18,433,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[14],[19],[20],[21] |
|
|
18,196,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[14],[19],[20],[21] |
|
|
$ 18,196,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Khoros, LLC, Senior Secured, May 2030, FIXED 10.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5] |
|
|
2030-05
|
|
|
|
|
|
2030-05
|
|
2030-05
|
|
| Investment, interest rate, paid in cash |
[5],[11] |
|
|
10.00%
|
|
|
|
|
|
10.00%
|
|
10.00%
|
|
| Principal amount |
[5] |
|
|
$ 11,704,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
11,704,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 11,399,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and LinenMaster, LLC, Senior Secured, August 2029, 1-month SOFR + 8.28%, Floor rate 9.28% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[15] |
|
|
2029-08
|
|
|
|
|
|
2029-08
|
|
2029-08
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[15] |
|
|
8.28%
|
|
|
|
|
|
8.28%
|
|
8.28%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[15] |
|
|
9.28%
|
|
|
|
|
|
9.28%
|
|
9.28%
|
|
| Principal amount |
[5],[14],[15] |
|
|
$ 11,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[15] |
|
|
11,179,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[15] |
|
|
$ 11,096,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Loftware, Inc., Senior Secured, March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[15] |
|
|
2028-03
|
|
|
|
|
|
2028-03
|
|
2028-03
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[15] |
|
|
7.88%
|
|
|
|
|
|
7.88%
|
|
7.88%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[15] |
|
|
8.88%
|
|
|
|
|
|
8.88%
|
|
8.88%
|
|
| Principal amount |
[5],[14],[15] |
|
|
$ 29,660,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[15] |
|
|
29,247,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[15] |
|
|
$ 29,660,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and LogicSource., Senior Secured, July 2027, 3-month SOFR + 8.93%, Floor rate 9.93% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[15] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
2027-07
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[15] |
|
|
8.93%
|
|
|
|
|
|
8.93%
|
|
8.93%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[15] |
|
|
9.93%
|
|
|
|
|
|
9.93%
|
|
9.93%
|
|
| Principal amount |
[5],[14],[15] |
|
|
$ 11,113,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[15] |
|
|
11,020,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[15] |
|
|
$ 11,113,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Mango Technologies, Inc., Senior Secured, August 2030, Prime + 2.25%, Floor rate 8.25%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14] |
|
|
2030-08
|
|
|
|
|
|
2030-08
|
|
2030-08
|
|
| Investment, basis spread, variable rate |
[5],[11],[14] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Investment, interest rate, floor |
[5],[11],[14] |
|
|
8.25%
|
|
|
|
|
|
8.25%
|
|
8.25%
|
|
| Investment exit fee |
[5],[11],[14] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Principal amount |
[5],[14] |
|
|
$ 16,750,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14] |
|
|
16,528,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14] |
|
|
$ 16,528,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Marigold Group, Inc., Senior Secured, April 2028, 6-month SOFR + 4.75%, Floor rate 5.75%, PIK Interest 5.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[12],[19],[21] |
|
|
2028-04
|
|
|
|
|
|
2028-04
|
|
2028-04
|
|
| Investment, basis spread, variable rate |
[5],[11],[12],[19],[21] |
|
|
4.75%
|
|
|
|
|
|
4.75%
|
|
4.75%
|
|
| Investment, interest rate, floor |
[5],[11],[12],[19],[21] |
|
|
5.75%
|
|
|
|
|
|
5.75%
|
|
5.75%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[12],[19],[21] |
|
|
5.25%
|
|
|
|
|
|
5.25%
|
|
5.25%
|
|
| Principal amount |
[5],[12],[19],[21] |
|
|
$ 44,555,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[12],[19],[21] |
|
|
43,960,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[12],[19],[21] |
|
|
$ 40,736,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Omeda Holdings, LLC., Senior Secured, July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[15],[16] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
2027-07
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[15],[16] |
|
|
8.05%
|
|
|
|
|
|
8.05%
|
|
8.05%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[15],[16] |
|
|
9.05%
|
|
|
|
|
|
9.05%
|
|
9.05%
|
|
| Principal amount |
[5],[14],[15],[16] |
|
|
$ 7,303,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[15],[16] |
|
|
7,207,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[15],[16] |
|
|
$ 7,303,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Pindrop Security, Inc., Senior Secured, June 2029, Prime + 3.50%, Floor rate 10.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[14] |
|
|
2029-06
|
|
|
|
|
|
2029-06
|
|
2029-06
|
|
| Investment, basis spread, variable rate |
[5],[8],[11],[14] |
|
|
3.50%
|
|
|
|
|
|
3.50%
|
|
3.50%
|
|
| Investment, interest rate, floor |
[5],[8],[11],[14] |
|
|
10.00%
|
|
|
|
|
|
10.00%
|
|
10.00%
|
|
| Investment exit fee |
[5],[8],[11],[14] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Principal amount |
[5],[8],[14] |
|
|
$ 31,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[14] |
|
|
30,759,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[14] |
|
|
$ 31,338,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Proven Optics, LLC, Senior Secured, December 2030, 3-month SOFR + 7.30%, Floor rate 8.30% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[15] |
|
|
2030-12
|
|
|
|
|
|
2030-12
|
|
2030-12
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[15] |
|
|
7.30%
|
|
|
|
|
|
7.30%
|
|
7.30%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[15] |
|
|
8.30%
|
|
|
|
|
|
8.30%
|
|
8.30%
|
|
| Principal amount |
[5],[14],[15] |
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[15] |
|
|
14,726,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[15] |
|
|
$ 14,726,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Remodel Health Holdco, LLC, Senior Secured, December 2028, Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[10] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
2028-12
|
|
| Investment, basis spread, variable rate |
[5],[8],[10],[11] |
|
|
2.35%
|
|
|
|
|
|
2.35%
|
|
2.35%
|
|
| Investment, interest rate, floor |
[5],[8],[10],[11] |
|
|
10.35%
|
|
|
|
|
|
10.35%
|
|
10.35%
|
|
| Investment exit fee |
[5],[8],[10],[11] |
|
|
6.50%
|
|
|
|
|
|
6.50%
|
|
6.50%
|
|
| Principal amount |
[5],[8],[10] |
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10] |
|
|
25,126,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10] |
|
|
$ 25,334,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Reveleer, Senior Secured, February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[10],[19] |
|
|
2027-02
|
|
|
|
|
|
2027-02
|
|
2027-02
|
|
| Investment, basis spread, variable rate |
[5],[8],[10],[11],[19] |
|
|
0.65%
|
|
|
|
|
|
0.65%
|
|
0.65%
|
|
| Investment, interest rate, floor |
[5],[8],[10],[11],[19] |
|
|
9.15%
|
|
|
|
|
|
9.15%
|
|
9.15%
|
|
| Investment, interest rate, paid in kind |
[5],[8],[10],[11],[19] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Investment exit fee |
[5],[8],[10],[11],[19] |
|
|
5.05%
|
|
|
|
|
|
5.05%
|
|
5.05%
|
|
| Principal amount |
[5],[8],[10],[19] |
|
|
$ 50,052,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10],[19] |
|
|
51,052,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10],[19] |
|
|
$ 50,938,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and ShadowDragon, LLC, Senior Secured, December 2026, 3-month SOFR + 8.79%, Floor rate 9.69% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[15] |
|
|
2026-12
|
|
|
|
|
|
2026-12
|
|
2026-12
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[15] |
|
|
8.79%
|
|
|
|
|
|
8.79%
|
|
8.79%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[15] |
|
|
9.69%
|
|
|
|
|
|
9.69%
|
|
9.69%
|
|
| Principal amount |
[5],[14],[15] |
|
|
$ 6,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[15] |
|
|
5,958,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[15] |
|
|
$ 5,958,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Simon Data, Inc., Senior Secured, March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 3.58% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[13],[19] |
|
|
2027-03
|
|
|
|
|
|
2027-03
|
|
2027-03
|
|
| Investment, basis spread, variable rate |
[5],[11],[13],[19] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment, interest rate, floor |
[5],[11],[13],[19] |
|
|
8.75%
|
|
|
|
|
|
8.75%
|
|
8.75%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[13],[19] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
1.95%
|
|
| Investment exit fee |
[5],[11],[13],[19] |
|
|
3.58%
|
|
|
|
|
|
3.58%
|
|
3.58%
|
|
| Principal amount |
[5],[13],[19] |
|
|
$ 11,350,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[13],[19] |
|
|
11,560,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[13],[19] |
|
|
$ 11,343,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Sisense Ltd., Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[9],[19],[20] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
2027-07
|
|
| Investment, basis spread, variable rate |
[5],[9],[11],[19],[20] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
1.50%
|
|
| Investment, interest rate, floor |
[5],[9],[11],[19],[20] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
9.50%
|
|
| Investment, interest rate, paid in kind |
[5],[9],[11],[19],[20] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
1.95%
|
|
| Investment exit fee |
[5],[9],[11],[19],[20] |
|
|
5.95%
|
|
|
|
|
|
5.95%
|
|
5.95%
|
|
| Principal amount |
[5],[9],[19],[20] |
|
|
$ 30,613,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[19],[20] |
|
|
31,624,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[19],[20] |
|
|
$ 31,029,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Smartsheet Inc., Senior Secured, January 2031, 3-month SOFR + 6.50%, Floor rate 7.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14] |
|
|
2031-01
|
|
|
|
|
|
2031-01
|
|
2031-01
|
|
| Investment, basis spread, variable rate |
[5],[11],[14] |
|
|
6.50%
|
|
|
|
|
|
6.50%
|
|
6.50%
|
|
| Investment, interest rate, floor |
[5],[11],[14] |
|
|
7.25%
|
|
|
|
|
|
7.25%
|
|
7.25%
|
|
| Principal amount |
[5],[14] |
|
|
$ 46,785,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14] |
|
|
45,957,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14] |
|
|
$ 46,204,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Snappt, Inc., Senior Secured, April 2029, Prime + 2.35%, Floor rate 8.85%, PIK Interest 1.00%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[10],[19] |
|
|
2029-04
|
|
|
|
|
|
2029-04
|
|
2029-04
|
|
| Investment, basis spread, variable rate |
[5],[8],[10],[11],[19] |
|
|
2.35%
|
|
|
|
|
|
2.35%
|
|
2.35%
|
|
| Investment, interest rate, floor |
[5],[8],[10],[11],[19] |
|
|
8.85%
|
|
|
|
|
|
8.85%
|
|
8.85%
|
|
| Investment, interest rate, paid in kind |
[5],[8],[10],[11],[19] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment exit fee |
[5],[8],[10],[11],[19] |
|
|
4.25%
|
|
|
|
|
|
4.25%
|
|
4.25%
|
|
| Principal amount |
[5],[8],[10],[19] |
|
|
$ 20,139,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10],[19] |
|
|
20,071,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10],[19] |
|
|
$ 19,753,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Suzy, Inc., Senior Secured, August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[10],[19] |
|
|
2027-08
|
|
|
|
|
|
2027-08
|
|
2027-08
|
|
| Investment, basis spread, variable rate |
[5],[8],[10],[11],[19] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
1.75%
|
|
| Investment, interest rate, floor |
[5],[8],[10],[11],[19] |
|
|
10.00%
|
|
|
|
|
|
10.00%
|
|
10.00%
|
|
| Investment, interest rate, paid in kind |
[5],[8],[10],[11],[19] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
1.95%
|
|
| Investment exit fee |
[5],[8],[10],[11],[19] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
3.45%
|
|
| Principal amount |
[5],[8],[10],[19] |
|
|
$ 24,827,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10],[19] |
|
|
24,901,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10],[19] |
|
|
$ 24,378,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and TaxCalc, Senior Secured, November 2029, Daily SONIA + 8.17%, Floor rate 8.67% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[9],[14],[15],[20] |
|
|
2029-11
|
|
|
|
|
|
2029-11
|
|
2029-11
|
|
| Investment, basis spread, variable rate |
[5],[9],[11],[14],[15],[20] |
|
|
8.17%
|
|
|
|
|
|
8.17%
|
|
8.17%
|
|
| Investment, interest rate, floor |
[5],[9],[11],[14],[15],[20] |
|
|
8.67%
|
|
|
|
|
|
8.67%
|
|
8.67%
|
|
| Principal amount | £ |
[5],[9],[14],[15],[20] |
|
|
|
|
|
|
|
|
|
|
£ 8,250
|
|
| Investment cost |
[4],[5],[9],[14],[15],[20] |
|
|
$ 10,557,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[14],[15],[20] |
|
|
10,897,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[5] |
|
|
115,161,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
114,849,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 113,129,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Tipalti Solutions Ltd., Senior Secured, April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[19],[22] |
|
|
2029-04
|
|
|
|
|
|
2029-04
|
|
2029-04
|
|
| Investment, basis spread, variable rate |
[5],[11],[19],[22] |
|
|
0.45%
|
|
|
|
|
|
0.45%
|
|
0.45%
|
|
| Investment, interest rate, floor |
[5],[11],[19],[22] |
|
|
6.45%
|
|
|
|
|
|
6.45%
|
|
6.45%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[19],[22] |
|
|
2.30%
|
|
|
|
|
|
2.30%
|
|
2.30%
|
|
| Principal amount |
[5],[19],[22] |
|
|
$ 72,488,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[19],[22] |
|
|
72,141,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[19],[22] |
|
|
$ 70,507,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Tipalti Solutions Ltd., Senior Secured, April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[19],[22] |
|
|
2029-04
|
|
|
|
|
|
2029-04
|
|
2029-04
|
|
| Investment, basis spread, variable rate |
[5],[11],[19],[22] |
|
|
0.45%
|
|
|
|
|
|
0.45%
|
|
0.45%
|
|
| Investment, interest rate, floor |
[5],[11],[19],[22] |
|
|
6.45%
|
|
|
|
|
|
6.45%
|
|
6.45%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[19],[22] |
|
|
2.30%
|
|
|
|
|
|
2.30%
|
|
2.30%
|
|
| Investment exit fee |
[5],[11],[19],[22] |
|
|
3.75%
|
|
|
|
|
|
3.75%
|
|
3.75%
|
|
| Principal amount |
[5],[19],[22] |
|
|
$ 42,673,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[19],[22] |
|
|
42,708,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[19],[22] |
|
|
$ 42,622,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Ushur, Inc. Senior Secured, June 2028, Prime + 2.20%, Floor rate 9.20%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[10] |
|
|
2028-06
|
|
|
|
|
|
2028-06
|
|
2028-06
|
|
| Investment, basis spread, variable rate |
[5],[8],[10],[11] |
|
|
2.20%
|
|
|
|
|
|
2.20%
|
|
2.20%
|
|
| Investment, interest rate, floor |
[5],[8],[10],[11] |
|
|
9.20%
|
|
|
|
|
|
9.20%
|
|
9.20%
|
|
| Investment exit fee |
[5],[8],[10],[11] |
|
|
3.95%
|
|
|
|
|
|
3.95%
|
|
3.95%
|
|
| Principal amount |
[5],[8],[10] |
|
|
$ 14,400,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10] |
|
|
14,191,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10] |
|
|
$ 14,106,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Zappi, Inc. Senior Secured, December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[9],[12],[14],[15],[20] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
2027-12
|
|
| Investment, basis spread, variable rate |
[5],[9],[11],[12],[14],[15],[20] |
|
|
8.03%
|
|
|
|
|
|
8.03%
|
|
8.03%
|
|
| Investment, interest rate, floor |
[5],[9],[11],[12],[14],[15],[20] |
|
|
9.03%
|
|
|
|
|
|
9.03%
|
|
9.03%
|
|
| Principal amount |
[5],[9],[12],[14],[15],[20] |
|
|
$ 12,600,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[12],[14],[15],[20] |
|
|
12,456,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[12],[14],[15],[20] |
|
|
$ 12,614,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and ZeroEyes, Inc. Senior Secured, May 2030, Prime + 2.00%, Floor rate 9.50%, PIK Interest 2.00%, 1.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[10],[14],[19] |
|
|
2030-05
|
|
|
|
|
|
2030-05
|
|
2030-05
|
|
| Investment, basis spread, variable rate |
[5],[8],[10],[11],[14],[19] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Investment, interest rate, floor |
[5],[8],[10],[11],[14],[19] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
9.50%
|
|
| Investment, interest rate, paid in kind |
[5],[8],[10],[11],[14],[19] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Investment exit fee |
[5],[8],[10],[11],[14],[19] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
1.50%
|
|
| Principal amount |
[5],[8],[10],[14],[19] |
|
|
$ 16,414,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10],[14],[19] |
|
|
16,146,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10],[14],[19] |
|
|
16,218,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and iSpot.tv, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[5] |
|
|
42,421,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
42,265,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 42,412,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and iSpot.tv, Inc., Senior Secured, January 2029, Prime + 1.40%, Floor rate 7.90%, PIK Interest 0.75%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[13],[14],[19] |
|
|
2029-01
|
|
|
|
|
|
2029-01
|
|
2029-01
|
|
| Investment, basis spread, variable rate |
[5],[11],[13],[14],[19] |
|
|
1.40%
|
|
|
|
|
|
1.40%
|
|
1.40%
|
|
| Investment, interest rate, floor |
[5],[11],[13],[14],[19] |
|
|
7.90%
|
|
|
|
|
|
7.90%
|
|
7.90%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[13],[14],[19] |
|
|
0.75%
|
|
|
|
|
|
0.75%
|
|
0.75%
|
|
| Investment exit fee |
[5],[11],[13],[14],[19] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
4.50%
|
|
| Principal amount |
[5],[13],[14],[19] |
|
|
$ 39,139,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[13],[14],[19] |
|
|
38,980,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[13],[14],[19] |
|
|
$ 39,147,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and iSpot.tv, Inc., Senior Secured, January 2029, Prime + 2.25%, Floor rate 8.75%, PIK Interest 1.00%, 5.70% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[19] |
|
|
2029-01
|
|
|
|
|
|
2029-01
|
|
2029-01
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[19] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Investment, interest rate, floor |
[5],[11],[14],[19] |
|
|
8.75%
|
|
|
|
|
|
8.75%
|
|
8.75%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[14],[19] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment exit fee |
[5],[11],[14],[19] |
|
|
5.70%
|
|
|
|
|
|
5.70%
|
|
5.70%
|
|
| Principal amount |
[5],[14],[19] |
|
|
$ 3,282,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[19] |
|
|
3,285,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[19] |
|
|
$ 3,265,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Antheia, Inc., Senior Secured, Maturity Date August 2029, Prime + 2.85%, Floor rate 10.35%, 5.55% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
|
|
2029-08
|
|
|
|
|
|
2029-08
|
|
2029-08
|
|
| Investment, basis spread, variable rate |
[11] |
|
|
2.85%
|
|
|
|
|
|
2.85%
|
|
2.85%
|
|
| Investment, interest rate, floor |
[11] |
|
|
10.35%
|
|
|
|
|
|
10.35%
|
|
10.35%
|
|
| Investment exit fee |
[11] |
|
|
5.55%
|
|
|
|
|
|
5.55%
|
|
5.55%
|
|
| Principal amount |
|
|
|
$ 21,250,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
19,683,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 19,683,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 6.73% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[13],[19],[21] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
2028-12
|
|
| Investment, basis spread, variable rate |
[11],[13],[19],[21] |
|
|
1.80%
|
|
|
|
|
|
1.80%
|
|
1.80%
|
|
| Investment, interest rate, floor |
[11],[13],[19],[21] |
|
|
9.30%
|
|
|
|
|
|
9.30%
|
|
9.30%
|
|
| Investment, interest rate, paid in kind |
[11],[13],[19],[21] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
1.25%
|
|
| Investment exit fee |
[11],[13],[19],[21] |
|
|
6.73%
|
|
|
|
|
|
6.73%
|
|
6.73%
|
|
| Principal amount |
[13],[19],[21] |
|
|
$ 28,271,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[13],[19],[21] |
|
|
28,536,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[13],[19],[21] |
|
|
$ 26,263,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Products Weee! Inc., Senior Secured, April 2028, Prime + 2.25%, Floor rate 9.75%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[14],[16] |
|
|
2028-04
|
|
|
|
|
|
2028-04
|
|
2028-04
|
|
| Investment, basis spread, variable rate |
[11],[14],[16] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Investment, interest rate, floor |
[11],[14],[16] |
|
|
9.75%
|
|
|
|
|
|
9.75%
|
|
9.75%
|
|
| Investment exit fee |
[11],[14],[16] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Principal amount |
[14],[16] |
|
|
$ 7,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[14],[16] |
|
|
7,472,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[14],[16] |
|
|
$ 7,583,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc., Senior Secured, September 2029, Prime + 2.05%, Floor rate 8.55%, PIK Interest 1.00%, 4.70% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[19] |
|
|
2029-09
|
|
|
|
|
|
2029-09
|
|
2029-09
|
|
| Investment, basis spread, variable rate |
[11],[19] |
|
|
2.05%
|
|
|
|
|
|
2.05%
|
|
2.05%
|
|
| Investment, interest rate, floor |
[11],[19] |
|
|
8.55%
|
|
|
|
|
|
8.55%
|
|
8.55%
|
|
| Investment, interest rate, paid in kind |
[11],[19] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment exit fee |
[11],[19] |
|
|
4.70%
|
|
|
|
|
|
4.70%
|
|
4.70%
|
|
| Principal amount |
[19] |
|
|
$ 55,357,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[19] |
|
|
54,713,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[19] |
|
|
$ 54,713,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD, Senior Secured, December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[19],[20] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
2027-12
|
|
| Investment, basis spread, variable rate |
[9],[11],[19],[20] |
|
|
4.70%
|
|
|
|
|
|
4.70%
|
|
4.70%
|
|
| Investment, interest rate, floor |
[9],[11],[19],[20] |
|
|
11.45%
|
|
|
|
|
|
11.45%
|
|
11.45%
|
|
| Investment, interest rate, paid in kind |
[9],[11],[19],[20] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
1.45%
|
|
| Investment exit fee |
[9],[11],[19],[20] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount | £ |
[9],[19],[20] |
|
|
|
|
|
|
|
|
|
|
£ 20,662
|
|
| Investment cost |
[4],[9],[19],[20] |
|
|
$ 28,533,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[19],[20] |
|
|
$ 27,960,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and GoEuro Travel GmbH, Senior Secured, November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[14],[20] |
|
|
2029-11
|
|
|
|
|
|
2029-11
|
|
2029-11
|
|
| Investment, basis spread, variable rate |
[9],[11],[14],[20] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
3.45%
|
|
| Investment, interest rate, floor |
[9],[11],[14],[20] |
|
|
10.45%
|
|
|
|
|
|
10.45%
|
|
10.45%
|
|
| Investment exit fee |
[9],[11],[14],[20] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
4.50%
|
|
| Principal amount |
[9],[14],[20] |
|
|
$ 48,750,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[14],[20] |
|
|
48,750,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[14],[20] |
|
|
$ 49,137,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 12.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[19],[23] |
|
|
2028-05
|
|
|
|
|
|
2028-05
|
|
2028-05
|
|
| Investment, interest rate, paid in kind |
[11],[19],[23] |
|
|
12.00%
|
|
|
|
|
|
12.00%
|
|
12.00%
|
|
| Principal amount |
[19],[23] |
|
|
$ 28,901,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[19],[23] |
|
|
28,901,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[19],[23] |
|
|
$ 30,986,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, October 2028, 1-month SOFR + 3.50%, Floor rate 4.50%, PIK Interest 3.25%, 6.42% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[19],[20] |
|
|
2028-10
|
|
|
|
|
|
2028-10
|
|
2028-10
|
|
| Investment, basis spread, variable rate |
[9],[11],[19],[20] |
|
|
3.50%
|
|
|
|
|
|
3.50%
|
|
3.50%
|
|
| Investment, interest rate, floor |
[9],[11],[19],[20] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
4.50%
|
|
| Investment, interest rate, paid in kind |
[9],[11],[19],[20] |
|
|
3.25%
|
|
|
|
|
|
3.25%
|
|
3.25%
|
|
| Investment exit fee |
[9],[11],[19],[20] |
|
|
6.42%
|
|
|
|
|
|
6.42%
|
|
6.42%
|
|
| Principal amount |
[9],[19],[20] |
|
|
$ 14,270,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[19],[20] |
|
|
14,839,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[19],[20] |
|
|
$ 14,082,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Nerdy Inc., Senior Secured, November 2029, Prime + 3.50%, Floor rate 10.75%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[14] |
|
|
2029-11
|
|
|
|
|
|
2029-11
|
|
2029-11
|
|
| Investment, basis spread, variable rate |
[11],[14] |
|
|
3.50%
|
|
|
|
|
|
3.50%
|
|
3.50%
|
|
| Investment, interest rate, floor |
[11],[14] |
|
|
10.75%
|
|
|
|
|
|
10.75%
|
|
10.75%
|
|
| Investment exit fee |
[11],[14] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
7.50%
|
|
| Principal amount |
[14] |
|
|
$ 14,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[14] |
|
|
13,867,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[14] |
|
|
$ 13,867,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Peek Travel Inc., Senior Secured, October 2028, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[14],[19] |
|
|
2028-10
|
|
|
|
|
|
2028-10
|
|
2028-10
|
|
| Investment, basis spread, variable rate |
[11],[14],[19] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
1.75%
|
|
| Investment, interest rate, floor |
[11],[14],[19] |
|
|
9.25%
|
|
|
|
|
|
9.25%
|
|
9.25%
|
|
| Investment, interest rate, paid in kind |
[11],[14],[19] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment exit fee |
[11],[14],[19] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount |
[14],[19] |
|
|
$ 16,515,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[14],[19] |
|
|
16,280,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[14],[19] |
|
|
$ 16,280,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[12],[20] |
|
|
2026-10
|
|
|
|
|
|
2026-10
|
|
2026-10
|
|
| Investment, basis spread, variable rate |
[9],[11],[12],[20] |
|
|
2.55%
|
|
|
|
|
|
2.55%
|
|
2.55%
|
|
| Investment, interest rate, floor |
[9],[11],[12],[20] |
|
|
11.05%
|
|
|
|
|
|
11.05%
|
|
11.05%
|
|
| Investment exit fee |
[9],[11],[12],[20] |
|
|
2.95%
|
|
|
|
|
|
2.95%
|
|
2.95%
|
|
| Principal amount |
[9],[12],[20] |
|
|
$ 3,035,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[12],[20] |
|
|
3,073,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[12],[20] |
|
|
$ 3,073,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, December 2027, Prime + 4.40%, Floor rate 10.65%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
2027-12
|
|
| Investment, basis spread, variable rate |
[8],[11] |
|
|
4.40%
|
|
|
|
|
|
4.40%
|
|
4.40%
|
|
| Investment, interest rate, floor |
[8],[11] |
|
|
10.65%
|
|
|
|
|
|
10.65%
|
|
10.65%
|
|
| Investment exit fee |
[8],[11] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Principal amount |
[8] |
|
|
$ 15,443,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
15,394,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 15,389,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 9.50%, Floor rate 10.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[12],[19] |
|
|
2026-12
|
|
|
|
|
|
2026-12
|
|
2026-12
|
|
| Investment, basis spread, variable rate |
[8],[11],[12],[19] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
9.50%
|
|
| Investment, interest rate, floor |
[8],[11],[12],[19] |
|
|
10.50%
|
|
|
|
|
|
10.50%
|
|
10.50%
|
|
| Principal amount |
[8],[12],[19] |
|
|
$ 25,809,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[12],[19] |
|
|
25,719,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[12],[19] |
|
|
$ 25,719,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, March 2028, 1-month SOFR + 8.28%, Floor rate 9.28% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[15] |
|
|
2028-03
|
|
|
|
|
|
2028-03
|
|
2028-03
|
|
| Investment, basis spread, variable rate |
[11],[15] |
|
|
8.28%
|
|
|
|
|
|
8.28%
|
|
8.28%
|
|
| Investment, interest rate, floor |
[11],[15] |
|
|
9.28%
|
|
|
|
|
|
9.28%
|
|
9.28%
|
|
| Principal amount |
[15] |
|
|
$ 36,126,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[15] |
|
|
35,850,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[15] |
|
|
$ 35,546,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[13],[19],[22] |
|
|
2026-07
|
|
|
|
|
|
2026-07
|
|
2026-07
|
|
| Investment, basis spread, variable rate |
[11],[13],[19],[22] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Investment, interest rate, floor |
[11],[13],[19],[22] |
|
|
10.75%
|
|
|
|
|
|
10.75%
|
|
10.75%
|
|
| Investment, interest rate, paid in kind |
[11],[13],[19],[22] |
|
|
0.50%
|
|
|
|
|
|
0.50%
|
|
0.50%
|
|
| Investment exit fee |
[11],[13],[19],[22] |
|
|
3.50%
|
|
|
|
|
|
3.50%
|
|
3.50%
|
|
| Principal amount |
[13],[19],[22] |
|
|
$ 78,434,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[13],[19],[22] |
|
|
79,685,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[13],[19],[22] |
|
|
$ 79,685,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[16],[19],[22] |
|
|
2026-05
|
|
|
|
|
|
2026-05
|
|
2026-05
|
|
| Investment, basis spread, variable rate |
[11],[16],[19],[22] |
|
|
7.00%
|
|
|
|
|
|
7.00%
|
|
7.00%
|
|
| Investment, interest rate, floor |
[11],[16],[19],[22] |
|
|
10.50%
|
|
|
|
|
|
10.50%
|
|
10.50%
|
|
| Investment, interest rate, paid in kind |
[11],[16],[19],[22] |
|
|
0.50%
|
|
|
|
|
|
0.50%
|
|
0.50%
|
|
| Investment exit fee |
[11],[16],[19],[22] |
|
|
4.50%
|
|
|
|
|
|
4.50%
|
|
4.50%
|
|
| Principal amount |
[16],[19],[22] |
|
|
$ 25,456,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[16],[19],[22] |
|
|
26,250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[16],[19],[22] |
|
|
$ 26,250,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[12],[19] |
|
|
2027-11
|
|
|
|
|
|
2027-11
|
|
2027-11
|
|
| Investment, basis spread, variable rate |
[11],[12],[19] |
|
|
2.75%
|
|
|
|
|
|
2.75%
|
|
2.75%
|
|
| Investment, interest rate, floor |
[11],[12],[19] |
|
|
9.25%
|
|
|
|
|
|
9.25%
|
|
9.25%
|
|
| Investment, interest rate, paid in kind |
[11],[12],[19] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
1.75%
|
|
| Investment exit fee |
[11],[12],[19] |
|
|
5.50%
|
|
|
|
|
|
5.50%
|
|
5.50%
|
|
| Principal amount |
[12],[19] |
|
|
$ 6,705,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[12],[19] |
|
|
6,913,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[12],[19] |
|
|
$ 6,705,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date January 2027, FIXED 8.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[24] |
|
|
2027-01
|
|
|
|
|
|
2027-01
|
|
2027-01
|
|
| Investment, interest rate, paid in cash |
[11],[24] |
|
|
8.25%
|
|
|
|
|
|
8.25%
|
|
8.25%
|
|
| Principal amount |
[24] |
|
|
$ 8,250,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24] |
|
|
8,250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24] |
|
|
$ 8,091,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc., Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[16],[19] |
|
|
2028-03
|
|
|
|
|
|
2028-03
|
|
2028-03
|
|
| Investment, basis spread, variable rate |
[11],[16],[19] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
2.45%
|
|
| Investment, interest rate, floor |
[11],[16],[19] |
|
|
10.95%
|
|
|
|
|
|
10.95%
|
|
10.95%
|
|
| Investment, interest rate, paid in kind |
[11],[16],[19] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
1.50%
|
|
| Principal amount |
[16],[19] |
|
|
$ 21,238,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[16],[19] |
|
|
20,976,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[16],[19] |
|
|
$ 21,663,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Akeyless Security Ltd. and Senior Secured and Maturity Date August 2028 and Prime + 4.00%, Floor rate 11.00%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[9],[14],[20] |
|
|
2028-08
|
|
|
|
|
|
2028-08
|
|
2028-08
|
|
| Investment, basis spread, variable rate |
[5],[7],[9],[11],[14],[20] |
|
|
4.00%
|
|
|
|
|
|
4.00%
|
|
4.00%
|
|
| Investment, interest rate, floor |
[5],[7],[9],[11],[14],[20] |
|
|
11.00%
|
|
|
|
|
|
11.00%
|
|
11.00%
|
|
| Investment exit fee |
[5],[7],[9],[11],[14],[20] |
|
|
2.95%
|
|
|
|
|
|
2.95%
|
|
2.95%
|
|
| Principal amount |
[5],[7],[9],[14],[20] |
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[9],[14],[20] |
|
|
9,848,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[9],[14],[20] |
|
|
$ 9,848,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Coronet Cyber Security Ltd. and Senior Secured and Maturity Date October 2028 and Prime - 2.95%, Floor rate 3.55%, PIK Interest 5.85% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[19] |
|
|
2028-10
|
|
|
|
|
|
2028-10
|
|
2028-10
|
|
| Investment, basis spread, variable rate |
[5],[7],[11],[19] |
|
|
(2.95%)
|
|
|
|
|
|
(2.95%)
|
|
(2.95%)
|
|
| Investment, interest rate, floor |
[5],[7],[11],[19] |
|
|
3.55%
|
|
|
|
|
|
3.55%
|
|
3.55%
|
|
| Investment, interest rate, paid in kind |
[5],[7],[11],[19] |
|
|
5.85%
|
|
|
|
|
|
5.85%
|
|
5.85%
|
|
| Principal amount |
[5],[7],[19] |
|
|
$ 9,115,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[19] |
|
|
8,999,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[19] |
|
|
$ 8,759,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and DNSFilter, Inc. and Senior Secured and Maturity Date October 2028 and Prime + 2.15%, Floor rate 8.65%, PIK Interest 0.75%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[14],[19],[21] |
|
|
2028-10
|
|
|
|
|
|
2028-10
|
|
2028-10
|
|
| Investment, basis spread, variable rate |
[5],[7],[11],[14],[19],[21] |
|
|
2.15%
|
|
|
|
|
|
2.15%
|
|
2.15%
|
|
| Investment, interest rate, floor |
[5],[7],[11],[14],[19],[21] |
|
|
8.65%
|
|
|
|
|
|
8.65%
|
|
8.65%
|
|
| Investment, interest rate, paid in kind |
[5],[7],[11],[14],[19],[21] |
|
|
0.75%
|
|
|
|
|
|
0.75%
|
|
0.75%
|
|
| Investment exit fee |
[5],[7],[11],[14],[19],[21] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount |
[5],[7],[14],[19],[21] |
|
|
$ 5,009,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[14],[19],[21] |
|
|
4,968,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[14],[19],[21] |
|
|
$ 4,968,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and LogRhythm, Inc. and Senior Secured and Maturity Date July 2029 and 3-month SOFR + 7.50%, Floor rate 8.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7] |
|
|
2029-07
|
|
|
|
|
|
2029-07
|
|
2029-07
|
|
| Investment, basis spread, variable rate |
[5],[7],[11] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
7.50%
|
|
| Investment, interest rate, floor |
[5],[7],[11] |
|
|
8.50%
|
|
|
|
|
|
8.50%
|
|
8.50%
|
|
| Principal amount |
[5],[7] |
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
24,428,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 23,977,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Morphisec Information Security 2014 Ltd. and Senior Secured and Maturity Date October 2027 and Prime + 3.45%, Floor rate 11.70%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[9],[20] |
|
|
2027-10
|
|
|
|
|
|
2027-10
|
|
2027-10
|
|
| Investment, basis spread, variable rate |
[5],[7],[9],[11],[20] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
3.45%
|
|
| Investment, interest rate, floor |
[5],[7],[9],[11],[20] |
|
|
11.70%
|
|
|
|
|
|
11.70%
|
|
11.70%
|
|
| Investment exit fee |
[5],[7],[9],[11],[20] |
|
|
5.95%
|
|
|
|
|
|
5.95%
|
|
5.95%
|
|
| Principal amount |
[5],[7],[9],[20] |
|
|
$ 11,435,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[9],[20] |
|
|
11,574,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[9],[20] |
|
|
$ 11,496,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Semperis Technologies Inc. and Senior Secured and Maturity Date April 2028 and Prime - 0.50%, Floor rate 8.00%, PIK Interest 3.85% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[19],[21] |
|
|
2028-04
|
|
|
|
|
|
2028-04
|
|
2028-04
|
|
| Investment, basis spread, variable rate |
[5],[7],[11],[19],[21] |
|
|
(0.50%)
|
|
|
|
|
|
(0.50%)
|
|
(0.50%)
|
|
| Investment, interest rate, floor |
[5],[7],[11],[19],[21] |
|
|
8.00%
|
|
|
|
|
|
8.00%
|
|
8.00%
|
|
| Investment, interest rate, paid in kind |
[5],[7],[11],[19],[21] |
|
|
3.85%
|
|
|
|
|
|
3.85%
|
|
3.85%
|
|
| Principal amount |
[5],[7],[19],[21] |
|
|
$ 33,815,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[19],[21] |
|
|
33,363,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[19],[21] |
|
|
$ 33,350,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Semperis Technologies Inc. and Senior Secured and Maturity Date April 2028 and Prime - 1.75%, Floor rate 6.75%, PIK Interest 3.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[16],[19],[21] |
|
|
2028-04
|
|
|
|
|
|
2028-04
|
|
2028-04
|
|
| Investment, basis spread, variable rate |
[5],[7],[11],[16],[19],[21] |
|
|
(1.75%)
|
|
|
|
|
|
(1.75%)
|
|
(1.75%)
|
|
| Investment, interest rate, floor |
[5],[7],[11],[16],[19],[21] |
|
|
6.75%
|
|
|
|
|
|
6.75%
|
|
6.75%
|
|
| Investment, interest rate, paid in kind |
[5],[7],[11],[16],[19],[21] |
|
|
3.25%
|
|
|
|
|
|
3.25%
|
|
3.25%
|
|
| Principal amount |
[5],[7],[16],[19],[21] |
|
|
$ 23,511,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[16],[19],[21] |
|
|
23,300,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[16],[19],[21] |
|
|
$ 23,736,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Sumo Logic, Inc. and Senior Secured and Maturity Date May 2030 and 3-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[14] |
|
|
2030-05
|
|
|
|
|
|
2030-05
|
|
2030-05
|
|
| Investment, basis spread, variable rate |
[5],[7],[11],[14] |
|
|
6.50%
|
|
|
|
|
|
6.50%
|
|
6.50%
|
|
| Investment, interest rate, floor |
[5],[7],[11],[14] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
7.50%
|
|
| Principal amount |
[5],[7],[14] |
|
|
$ 23,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[14] |
|
|
22,591,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[14] |
|
|
22,796,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Total Semperis Technologies Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[7] |
|
|
57,326,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7] |
|
|
56,663,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7] |
|
|
$ 57,086,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Zimperium, Inc. and Senior Secured and Maturity Date May 2027 and 6-month SOFR + 8.31%, Floor rate 9.31% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[14],[15] |
|
|
2027-05
|
|
|
|
|
|
2027-05
|
|
2027-05
|
|
| Investment, basis spread, variable rate |
[5],[7],[11],[14],[15] |
|
|
8.31%
|
|
|
|
|
|
8.31%
|
|
8.31%
|
|
| Investment, interest rate, floor |
[5],[7],[11],[14],[15] |
|
|
9.31%
|
|
|
|
|
|
9.31%
|
|
9.31%
|
|
| Principal amount |
[5],[7],[14],[15] |
|
|
$ 17,771,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[14],[15] |
|
|
17,638,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[14],[15] |
|
|
$ 17,619,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Defense Technologies and Saronic Technologies, Inc., Senior Secured, June 2030, Prime + 2.50%, Floor rate 9.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[10],[14] |
|
|
2030-06
|
|
|
|
|
|
2030-06
|
|
2030-06
|
|
| Investment, basis spread, variable rate |
[8],[10],[11],[14] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Investment, interest rate, floor |
[8],[10],[11],[14] |
|
|
9.00%
|
|
|
|
|
|
9.00%
|
|
9.00%
|
|
| Investment exit fee |
[8],[10],[11],[14] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Principal amount |
[8],[10],[14] |
|
|
$ 21,250,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[10],[14] |
|
|
20,974,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[10],[14] |
|
|
$ 21,237,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Defense Technologies and Shield AI, Inc., Senior Secured, February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[13],[19],[22] |
|
|
2029-02
|
|
|
|
|
|
2029-02
|
|
2029-02
|
|
| Investment, basis spread, variable rate |
[11],[13],[19],[22] |
|
|
0.85%
|
|
|
|
|
|
0.85%
|
|
0.85%
|
|
| Investment, interest rate, floor |
[11],[13],[19],[22] |
|
|
6.85%
|
|
|
|
|
|
6.85%
|
|
6.85%
|
|
| Investment, interest rate, cap |
[11],[13],[19],[22] |
|
|
9.60%
|
|
|
|
|
|
9.60%
|
|
9.60%
|
|
| Investment, interest rate, paid in kind |
[11],[13],[19],[22] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Investment exit fee |
[11],[13],[19],[22] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Principal amount |
[13],[19],[22] |
|
|
$ 116,675,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[13],[19],[22] |
|
|
116,535,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[13],[19],[22] |
|
|
$ 116,843,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date July 2029, FIXED 11.95% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[24],[25] |
|
|
2029-07
|
|
|
|
|
|
2029-07
|
|
2029-07
|
|
| Investment, interest rate, paid in cash |
[11],[24],[25] |
|
|
11.95%
|
|
|
|
|
|
11.95%
|
|
11.95%
|
|
| Principal amount |
[24],[25] |
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24],[25] |
|
|
9,843,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[25] |
|
|
$ 9,843,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date July 2029, FIXED 3.45%, PIK Interest 8.05% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[19],[24],[25] |
|
|
2029-07
|
|
|
|
|
|
2029-07
|
|
2029-07
|
|
| Investment, interest rate, paid in kind |
[11],[19],[24],[25] |
|
|
8.05%
|
|
|
|
|
|
8.05%
|
|
8.05%
|
|
| Investment, interest rate, paid in cash |
[11],[19],[24],[25] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
3.45%
|
|
| Principal amount |
[19],[24],[25] |
|
|
$ 28,805,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[19],[24],[25] |
|
|
28,412,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[19],[24],[25] |
|
|
$ 28,412,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc., Senior Secured, Maturity Date April 2026, Prime + 3.10%, Floor rate 11.10%, 8.90% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[16] |
|
|
2026-04
|
|
|
|
|
|
2026-04
|
|
2026-04
|
|
| Investment, basis spread, variable rate |
[11],[16] |
|
|
3.10%
|
|
|
|
|
|
3.10%
|
|
3.10%
|
|
| Investment, interest rate, floor |
[11],[16] |
|
|
11.10%
|
|
|
|
|
|
11.10%
|
|
11.10%
|
|
| Investment exit fee |
[11],[16] |
|
|
8.90%
|
|
|
|
|
|
8.90%
|
|
8.90%
|
|
| Principal amount |
[16] |
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[16] |
|
|
15,246,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[16] |
|
|
$ 15,246,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alector, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.05%, Floor rate 8.05%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[9],[10],[14] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
2028-12
|
|
| Investment, basis spread, variable rate |
[8],[9],[10],[11],[14] |
|
|
1.05%
|
|
|
|
|
|
1.05%
|
|
1.05%
|
|
| Investment, interest rate, floor |
[8],[9],[10],[11],[14] |
|
|
8.05%
|
|
|
|
|
|
8.05%
|
|
8.05%
|
|
| Investment exit fee |
[8],[9],[10],[11],[14] |
|
|
4.75%
|
|
|
|
|
|
4.75%
|
|
4.75%
|
|
| Principal amount |
[8],[9],[10],[14] |
|
|
$ 7,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[10],[14] |
|
|
7,044,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[10],[14] |
|
|
$ 7,055,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Arcus Biosciences, Inc., Senior Secured, Maturity Date September 2030, Prime - 0.05%, Floor rate 8.45%, PIK Interest 2.20%, 9.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[9],[10],[14],[16],[19] |
|
|
2030-09
|
|
|
|
|
|
2030-09
|
|
2030-09
|
|
| Investment, basis spread, variable rate |
[8],[9],[10],[11],[14],[16],[19] |
|
|
(0.05%)
|
|
|
|
|
|
(0.05%)
|
|
(0.05%)
|
|
| Investment, interest rate, floor |
[8],[9],[10],[11],[14],[16],[19] |
|
|
8.45%
|
|
|
|
|
|
8.45%
|
|
8.45%
|
|
| Investment, interest rate, paid in kind |
[8],[9],[10],[11],[14],[16],[19] |
|
|
2.20%
|
|
|
|
|
|
2.20%
|
|
2.20%
|
|
| Investment exit fee |
[8],[9],[10],[11],[14],[16],[19] |
|
|
9.00%
|
|
|
|
|
|
9.00%
|
|
9.00%
|
|
| Principal amount |
[8],[9],[10],[14],[16],[19] |
|
|
$ 75,704,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[10],[14],[16],[19] |
|
|
76,173,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[10],[14],[16],[19] |
|
|
$ 79,788,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Beren Therapeutics P.B.C., Senior Secured, Maturity Date October 2029, Prime + 2.45%, Floor rate 9.95%, 5.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[10] |
|
|
2029-10
|
|
|
|
|
|
2029-10
|
|
2029-10
|
|
| Investment, basis spread, variable rate |
[10],[11] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
2.45%
|
|
| Investment, interest rate, floor |
[10],[11] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
9.95%
|
|
| Investment exit fee |
[10],[11] |
|
|
5.25%
|
|
|
|
|
|
5.25%
|
|
5.25%
|
|
| Principal amount |
[10] |
|
|
$ 8,625,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10] |
|
|
8,471,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10] |
|
|
$ 8,471,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 3.00%, Floor rate 10.50%, PIK Interest 0.25%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[19] |
|
|
2028-10
|
|
|
|
|
|
2028-10
|
|
2028-10
|
|
| Investment, basis spread, variable rate |
[11],[19] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Investment, interest rate, floor |
[11],[19] |
|
|
10.50%
|
|
|
|
|
|
10.50%
|
|
10.50%
|
|
| Investment, interest rate, paid in kind |
[11],[19] |
|
|
0.25%
|
|
|
|
|
|
0.25%
|
|
0.25%
|
|
| Investment exit fee |
[11],[19] |
|
|
5.45%
|
|
|
|
|
|
5.45%
|
|
5.45%
|
|
| Principal amount |
[19] |
|
|
$ 53,633,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[19] |
|
|
54,463,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[19] |
|
|
$ 55,720,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and COMPASS Pathways plc, Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[16],[19],[20] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
2027-07
|
|
| Investment, basis spread, variable rate |
[9],[11],[16],[19],[20] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
1.50%
|
|
| Investment, interest rate, floor |
[9],[11],[16],[19],[20] |
|
|
9.75%
|
|
|
|
|
|
9.75%
|
|
9.75%
|
|
| Investment, interest rate, paid in kind |
[9],[11],[16],[19],[20] |
|
|
1.40%
|
|
|
|
|
|
1.40%
|
|
1.40%
|
|
| Investment exit fee |
[9],[11],[16],[19],[20] |
|
|
4.75%
|
|
|
|
|
|
4.75%
|
|
4.75%
|
|
| Principal amount |
[9],[16],[19],[20] |
|
|
$ 24,840,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[16],[19],[20] |
|
|
25,464,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[16],[19],[20] |
|
|
$ 25,543,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc., Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[12] |
|
|
2026-09
|
|
|
|
|
|
2026-09
|
|
2026-09
|
|
| Investment, basis spread, variable rate |
[11],[12] |
|
|
5.70%
|
|
|
|
|
|
5.70%
|
|
5.70%
|
|
| Investment, interest rate, floor |
[11],[12] |
|
|
8.95%
|
|
|
|
|
|
8.95%
|
|
8.95%
|
|
| Investment exit fee |
[11],[12] |
|
|
7.75%
|
|
|
|
|
|
7.75%
|
|
7.75%
|
|
| Principal amount |
[12] |
|
|
$ 86,925,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[12] |
|
|
92,296,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[12] |
|
|
$ 92,296,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Disc Medicine, Inc., Senior Secured, Maturity Date December 2029, Prime + 1.75%, Floor rate 8.25%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[9],[10],[14] |
|
|
2029-12
|
|
|
|
|
|
2029-12
|
|
2029-12
|
|
| Investment, basis spread, variable rate |
[8],[9],[10],[11],[14] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
1.75%
|
|
| Investment, interest rate, floor |
[8],[9],[10],[11],[14] |
|
|
8.25%
|
|
|
|
|
|
8.25%
|
|
8.25%
|
|
| Investment exit fee |
[8],[9],[10],[11],[14] |
|
|
6.75%
|
|
|
|
|
|
6.75%
|
|
6.75%
|
|
| Principal amount |
[8],[9],[10],[14] |
|
|
$ 22,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[10],[14] |
|
|
22,659,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[10],[14] |
|
|
$ 23,279,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Dyne Therapeutics, Inc., Senior Secured, Maturity Date July 2030, Prime + 2.45%, Floor rate 9.95%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[9],[10] |
|
|
2030-07
|
|
|
|
|
|
2030-07
|
|
2030-07
|
|
| Investment, basis spread, variable rate |
[8],[9],[10],[11] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
2.45%
|
|
| Investment, interest rate, floor |
[8],[9],[10],[11] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
9.95%
|
|
| Investment exit fee |
[8],[9],[10],[11] |
|
|
5.50%
|
|
|
|
|
|
5.50%
|
|
5.50%
|
|
| Principal amount |
[8],[9],[10] |
|
|
$ 100,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[10] |
|
|
99,389,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[10] |
|
|
$ 101,148,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Genetix Biotherapeutics Inc. (p.k.a. bluebird bio, Inc.), Senior Secured, Maturity Date April 2029, Prime + 2.45%, Floor rate 9.45%, 6.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[19] |
|
|
2029-04
|
|
|
|
|
|
2029-04
|
|
2029-04
|
|
| Investment, basis spread, variable rate |
[11],[19] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
2.45%
|
|
| Investment, interest rate, floor |
[11],[19] |
|
|
9.45%
|
|
|
|
|
|
9.45%
|
|
9.45%
|
|
| Investment exit fee |
[11],[19] |
|
|
6.45%
|
|
|
|
|
|
6.45%
|
|
6.45%
|
|
| Principal amount |
[19] |
|
|
$ 67,116,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[19] |
|
|
66,811,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[19] |
|
|
$ 66,664,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date September 2030, Prime + 1.95%, Floor rate 9.45%, PIK Interest 1.00%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[19] |
|
|
2030-09
|
|
|
|
|
|
2030-09
|
|
2030-09
|
|
| Investment, basis spread, variable rate |
[8],[11],[19] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
1.95%
|
|
| Investment, interest rate, floor |
[8],[11],[19] |
|
|
9.45%
|
|
|
|
|
|
9.45%
|
|
9.45%
|
|
| Investment, interest rate, paid in kind |
[8],[11],[19] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment exit fee |
[8],[11],[19] |
|
|
6.25%
|
|
|
|
|
|
6.25%
|
|
6.25%
|
|
| Principal amount |
[8],[19] |
|
|
$ 80,368,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[19] |
|
|
79,892,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[19] |
|
|
$ 79,892,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[9] |
|
|
2027-11
|
|
|
|
|
|
2027-11
|
|
2027-11
|
|
| Investment, basis spread, variable rate |
[8],[9],[11] |
|
|
2.40%
|
|
|
|
|
|
2.40%
|
|
2.40%
|
|
| Investment, interest rate, floor |
[8],[9],[11] |
|
|
8.65%
|
|
|
|
|
|
8.65%
|
|
8.65%
|
|
| Investment exit fee |
[8],[9],[11] |
|
|
6.05%
|
|
|
|
|
|
6.05%
|
|
6.05%
|
|
| Principal amount |
[8],[9] |
|
|
$ 5,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9] |
|
|
5,712,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9] |
|
|
$ 5,833,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and MoonLake Immunotherapeutics, Senior Secured, Maturity Date April 2030, Prime + 1.45%, Floor rate 8.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[20] |
|
|
2030-04
|
|
|
|
|
|
2030-04
|
|
2030-04
|
|
| Investment, basis spread, variable rate |
[9],[11],[20] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
1.45%
|
|
| Investment, interest rate, floor |
[9],[11],[20] |
|
|
8.45%
|
|
|
|
|
|
8.45%
|
|
8.45%
|
|
| Investment exit fee |
[9],[11],[20] |
|
|
6.95%
|
|
|
|
|
|
6.95%
|
|
6.95%
|
|
| Principal amount |
[9],[20] |
|
|
$ 34,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
34,479,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 34,246,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and NorthSea Therapeutics, Convertible Debt, Maturity Date December 2026, FIXED 6.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[20],[23] |
|
|
2026-12
|
|
|
|
|
|
2026-12
|
|
2026-12
|
|
| Investment, interest rate, paid in cash |
[9],[11],[20],[23] |
|
|
6.00%
|
|
|
|
|
|
6.00%
|
|
6.00%
|
|
| Principal amount |
[9],[20],[23] |
|
|
$ 373,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20],[23] |
|
|
373,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20],[23] |
|
|
$ 373,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[19],[22] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
2027-12
|
|
| Investment, basis spread, variable rate |
[11],[19],[22] |
|
|
1.35%
|
|
|
|
|
|
1.35%
|
|
1.35%
|
|
| Investment, interest rate, floor |
[11],[19],[22] |
|
|
9.85%
|
|
|
|
|
|
9.85%
|
|
9.85%
|
|
| Investment, interest rate, cap |
[11],[19],[22] |
|
|
10.35%
|
|
|
|
|
|
10.35%
|
|
10.35%
|
|
| Investment, interest rate, paid in kind |
[11],[19],[22] |
|
|
2.15%
|
|
|
|
|
|
2.15%
|
|
2.15%
|
|
| Investment exit fee |
[11],[19],[22] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Principal amount |
[19],[22] |
|
|
$ 31,904,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[19],[22] |
|
|
32,005,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[19],[22] |
|
|
$ 32,542,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 7.06% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[9],[10],[13],[19],[22],[26] |
|
|
2027-12
|
|
|
|
|
|
2027-12
|
|
2027-12
|
|
| Investment, basis spread, variable rate |
[8],[9],[10],[11],[13],[19],[22],[26] |
|
|
1.35%
|
|
|
|
|
|
1.35%
|
|
1.35%
|
|
| Investment, interest rate, floor |
[8],[9],[10],[11],[13],[19],[22],[26] |
|
|
9.85%
|
|
|
|
|
|
9.85%
|
|
9.85%
|
|
| Investment, interest rate, cap |
[8],[9],[10],[11],[13],[19],[22],[26] |
|
|
10.35%
|
|
|
|
|
|
10.35%
|
|
10.35%
|
|
| Investment, interest rate, paid in kind |
[8],[9],[10],[11],[13],[19],[22],[26] |
|
|
2.15%
|
|
|
|
|
|
2.15%
|
|
2.15%
|
|
| Investment exit fee |
[8],[9],[10],[11],[13],[19],[22],[26] |
|
|
7.06%
|
|
|
|
|
|
7.06%
|
|
7.06%
|
|
| Principal amount |
[8],[9],[10],[13],[19],[22],[26] |
|
|
$ 140,460,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[10],[13],[19],[22],[26] |
|
|
145,207,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[10],[13],[19],[22],[26] |
|
|
$ 147,718,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[12],[13],[19] |
|
|
2027-10
|
|
|
|
|
|
2027-10
|
|
2027-10
|
|
| Investment, basis spread, variable rate |
[9],[11],[12],[13],[19] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
1.75%
|
|
| Investment, interest rate, floor |
[9],[11],[12],[13],[19] |
|
|
7.25%
|
|
|
|
|
|
7.25%
|
|
7.25%
|
|
| Investment, interest rate, cap |
[9],[11],[12],[13],[19] |
|
|
9.00%
|
|
|
|
|
|
9.00%
|
|
9.00%
|
|
| Investment, interest rate, paid in kind |
[9],[11],[12],[13],[19] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
1.50%
|
|
| Investment exit fee |
[9],[11],[12],[13],[19] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount |
[9],[12],[13],[19] |
|
|
$ 32,378,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[12],[13],[19] |
|
|
33,205,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[12],[13],[19] |
|
|
$ 33,280,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Savara, Inc. and Senior Secured and Maturity Date April 2030 and Prime + 1.45%, Floor rate 7.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[9],[10] |
|
|
2030-04
|
|
|
|
|
|
2030-04
|
|
2030-04
|
|
| Investment, basis spread, variable rate |
[8],[9],[10],[11] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
1.45%
|
|
| Investment, interest rate, floor |
[8],[9],[10],[11] |
|
|
7.45%
|
|
|
|
|
|
7.45%
|
|
7.45%
|
|
| Investment exit fee |
[8],[9],[10],[11] |
|
|
6.95%
|
|
|
|
|
|
6.95%
|
|
6.95%
|
|
| Principal amount |
[8],[9],[10] |
|
|
$ 21,450,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[10] |
|
|
21,565,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[10] |
|
|
$ 21,548,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and SynOx Therapeutics Limited, Senior Secured, Maturity Date May 2027, Prime + 1.40%, Floor rate 9.90%, 7.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[16],[20] |
|
|
2027-05
|
|
|
|
|
|
2027-05
|
|
2027-05
|
|
| Investment, basis spread, variable rate |
[9],[11],[16],[20] |
|
|
1.40%
|
|
|
|
|
|
1.40%
|
|
1.40%
|
|
| Investment, interest rate, floor |
[9],[11],[16],[20] |
|
|
9.90%
|
|
|
|
|
|
9.90%
|
|
9.90%
|
|
| Investment exit fee |
[9],[11],[16],[20] |
|
|
7.25%
|
|
|
|
|
|
7.25%
|
|
7.25%
|
|
| Principal amount |
[9],[16],[20] |
|
|
$ 4,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[16],[20] |
|
|
4,635,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[16],[20] |
|
|
4,646,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Total Phathom Pharmaceuticals, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
172,364,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
177,212,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 180,260,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2030, Prime + 1.45%, Floor rate 8.95%, Cap rate 9.45%, 6.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[12],[14] |
|
|
2030-10
|
|
|
|
|
|
2030-10
|
|
2030-10
|
|
| Investment, basis spread, variable rate |
[9],[11],[12],[14] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
1.45%
|
|
| Investment, interest rate, floor |
[9],[11],[12],[14] |
|
|
8.95%
|
|
|
|
|
|
8.95%
|
|
8.95%
|
|
| Investment, interest rate, cap |
[9],[11],[12],[14] |
|
|
9.45%
|
|
|
|
|
|
9.45%
|
|
9.45%
|
|
| Investment exit fee |
[9],[11],[12],[14] |
|
|
6.00%
|
|
|
|
|
|
6.00%
|
|
6.00%
|
|
| Principal amount |
[9],[12],[14] |
|
|
$ 24,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[12],[14] |
|
|
24,366,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[12],[14] |
|
|
$ 24,366,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[12],[13],[16] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
2027-07
|
|
| Investment, basis spread, variable rate |
[11],[12],[13],[16] |
|
|
3.15%
|
|
|
|
|
|
3.15%
|
|
3.15%
|
|
| Investment, interest rate, floor |
[11],[12],[13],[16] |
|
|
10.15%
|
|
|
|
|
|
10.15%
|
|
10.15%
|
|
| Investment exit fee |
[11],[12],[13],[16] |
|
|
3.72%
|
|
|
|
|
|
3.72%
|
|
3.72%
|
|
| Principal amount |
[12],[13],[16] |
|
|
$ 75,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[12],[13],[16] |
|
|
76,459,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[12],[13],[16] |
|
|
$ 76,524,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc., Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[19],[20] |
|
|
2028-01
|
|
|
|
|
|
2028-01
|
|
2028-01
|
|
| Investment, basis spread, variable rate |
[9],[11],[19],[20] |
|
|
0.75%
|
|
|
|
|
|
0.75%
|
|
0.75%
|
|
| Investment, interest rate, floor |
[9],[11],[19],[20] |
|
|
9.25%
|
|
|
|
|
|
9.25%
|
|
9.25%
|
|
| Investment, interest rate, cap |
[9],[11],[19],[20] |
|
|
9.75%
|
|
|
|
|
|
9.75%
|
|
9.75%
|
|
| Investment, interest rate, paid in kind |
[9],[11],[19],[20] |
|
|
1.15%
|
|
|
|
|
|
1.15%
|
|
1.15%
|
|
| Investment exit fee |
[9],[11],[19],[20] |
|
|
5.50%
|
|
|
|
|
|
5.50%
|
|
5.50%
|
|
| Principal amount |
[9],[19],[20] |
|
|
$ 16,111,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[19],[20] |
|
|
16,510,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[19],[20] |
|
|
$ 16,672,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date October 2030, Prime + 2.45%, Floor rate 9.45%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[9],[16],[20] |
|
|
2030-10
|
|
|
|
|
|
2030-10
|
|
2030-10
|
|
| Investment, basis spread, variable rate |
[9],[11],[16],[20] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
2.45%
|
|
| Investment, interest rate, floor |
[9],[11],[16],[20] |
|
|
9.45%
|
|
|
|
|
|
9.45%
|
|
9.45%
|
|
| Investment exit fee |
[9],[11],[16],[20] |
|
|
5.50%
|
|
|
|
|
|
5.50%
|
|
5.50%
|
|
| Principal amount |
[9],[16],[20] |
|
|
$ 27,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[16],[20] |
|
|
27,409,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[16],[20] |
|
|
$ 28,064,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date December 2028, Prime + 3.00%, Floor rate 9.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[10],[16] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
2028-12
|
|
| Investment, basis spread, variable rate |
[8],[10],[11],[16] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Investment, interest rate, floor |
[8],[10],[11],[16] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
9.50%
|
|
| Investment exit fee |
[8],[10],[11],[16] |
|
|
4.00%
|
|
|
|
|
|
4.00%
|
|
4.00%
|
|
| Principal amount |
[8],[10],[16] |
|
|
$ 65,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[10],[16] |
|
|
65,186,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[10],[16] |
|
|
65,543,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Energy Technologies Total Electric Hydrogen Co. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[7] |
|
|
30,384,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7] |
|
|
30,296,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7] |
|
|
$ 30,201,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Energy Technologies and Electric Hydrogen Co., Senior Secured, Maturity Date May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[7],[8],[19],[21] |
|
|
2028-05
|
|
|
|
|
|
2028-05
|
|
2028-05
|
|
| Investment, basis spread, variable rate |
[7],[8],[11],[19],[21] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Investment, interest rate, floor |
[7],[8],[11],[19],[21] |
|
|
10.75%
|
|
|
|
|
|
10.75%
|
|
10.75%
|
|
| Investment, interest rate, paid in kind |
[7],[8],[11],[19],[21] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
1.25%
|
|
| Investment exit fee |
[7],[8],[11],[19],[21] |
|
|
4.25%
|
|
|
|
|
|
4.25%
|
|
4.25%
|
|
| Principal amount |
[7],[8],[19],[21] |
|
|
$ 12,769,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[8],[19],[21] |
|
|
12,718,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[8],[19],[21] |
|
|
$ 12,559,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Energy Technologies and Electric Hydrogen Co., Senior Secured, Maturity Date May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[7],[8],[19],[21] |
|
|
2028-05
|
|
|
|
|
|
2028-05
|
|
2028-05
|
|
| Investment, basis spread, variable rate |
[7],[8],[11],[19],[21] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Investment, interest rate, floor |
[7],[8],[11],[19],[21] |
|
|
10.75%
|
|
|
|
|
|
10.75%
|
|
10.75%
|
|
| Investment, interest rate, paid in kind |
[7],[8],[11],[19],[21] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
1.25%
|
|
| Investment exit fee |
[7],[8],[11],[19],[21] |
|
|
5.95%
|
|
|
|
|
|
5.95%
|
|
5.95%
|
|
| Principal amount |
[7],[8],[19],[21] |
|
|
$ 17,615,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[8],[19],[21] |
|
|
17,578,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[8],[19],[21] |
|
|
$ 17,642,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Financial Technologies and Finix Payments, Inc., Senior Secured, December 2029, Prime + 2.50%, Floor rate 9.25%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[7],[10],[14] |
|
|
2029-12
|
|
|
|
|
|
2029-12
|
|
2029-12
|
|
| Investment, basis spread, variable rate |
[10],[11],[14] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Investment, interest rate, floor |
[10],[11],[14] |
|
|
9.25%
|
|
|
|
|
|
9.25%
|
|
9.25%
|
|
| Investment exit fee |
[10],[11],[14] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount |
[7],[10],[14] |
|
|
$ 7,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[10],[14] |
|
|
6,889,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[10],[14] |
|
|
$ 6,889,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Belong Health, Inc. and Senior Secured and Maturity Date November 2029 and Prime + 2.25%, Floor rate 9.75%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[10] |
|
|
2029-11
|
|
|
|
|
|
2029-11
|
|
2029-11
|
|
| Investment, basis spread, variable rate |
[10],[11] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Investment, interest rate, floor |
[10],[11] |
|
|
9.75%
|
|
|
|
|
|
9.75%
|
|
9.75%
|
|
| Investment exit fee |
[10],[11] |
|
|
5.45%
|
|
|
|
|
|
5.45%
|
|
5.45%
|
|
| Principal amount |
[10] |
|
|
$ 11,250,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10] |
|
|
10,950,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10] |
|
|
$ 10,950,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[12],[13],[16],[19] |
|
|
2026-11
|
|
|
|
|
|
2026-11
|
|
2026-11
|
|
| Investment, basis spread, variable rate |
[11],[12],[13],[16],[19] |
|
|
5.11%
|
|
|
|
|
|
5.11%
|
|
5.11%
|
|
| Investment, interest rate, floor |
[11],[12],[13],[16],[19] |
|
|
6.00%
|
|
|
|
|
|
6.00%
|
|
6.00%
|
|
| Investment, interest rate, paid in kind |
[11],[12],[13],[16],[19] |
|
|
4.45%
|
|
|
|
|
|
4.45%
|
|
4.45%
|
|
| Principal amount |
[12],[13],[16],[19] |
|
|
$ 75,547,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[12],[13],[16],[19] |
|
|
75,265,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[12],[13],[16],[19] |
|
|
$ 73,386,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and ChenMed, LLC, Senior Secured, Maturity Date May 2030, Prime + 2.45%, Floor rate 9.45%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[14],[22] |
|
|
2030-05
|
|
|
|
|
|
2030-05
|
|
2030-05
|
|
| Investment, basis spread, variable rate |
[11],[14],[22] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
2.45%
|
|
| Investment, interest rate, floor |
[11],[14],[22] |
|
|
9.45%
|
|
|
|
|
|
9.45%
|
|
9.45%
|
|
| Investment exit fee |
[11],[14],[22] |
|
|
3.75%
|
|
|
|
|
|
3.75%
|
|
3.75%
|
|
| Principal amount |
[14],[22] |
|
|
$ 130,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[14],[22] |
|
|
128,101,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[14],[22] |
|
|
$ 128,240,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Curana Health Holdings, LLC, Senior Secured, Maturity Date January 2028, Prime + 1.45%, Floor rate 9.20%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[12],[14],[21] |
|
|
2028-01
|
|
|
|
|
|
2028-01
|
|
2028-01
|
|
| Investment, basis spread, variable rate |
[11],[12],[14],[21] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
1.45%
|
|
| Investment, interest rate, floor |
[11],[12],[14],[21] |
|
|
9.20%
|
|
|
|
|
|
9.20%
|
|
9.20%
|
|
| Investment exit fee |
[11],[12],[14],[21] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount |
[12],[14],[21] |
|
|
$ 27,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[12],[14],[21] |
|
|
28,111,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[12],[14],[21] |
|
|
$ 28,412,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Ennoble Care LLC and Senior Secured and Maturity Date February 2030 and Prime + 2.60%, Floor rate 10.35%, 7.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[10] |
|
|
2030-02
|
|
|
|
|
|
2030-02
|
|
2030-02
|
|
| Investment, basis spread, variable rate |
[8],[10],[11] |
|
|
2.60%
|
|
|
|
|
|
2.60%
|
|
2.60%
|
|
| Investment, interest rate, floor |
[8],[10],[11] |
|
|
10.35%
|
|
|
|
|
|
10.35%
|
|
10.35%
|
|
| Investment exit fee |
[8],[10],[11] |
|
|
7.95%
|
|
|
|
|
|
7.95%
|
|
7.95%
|
|
| Principal amount |
[8],[10] |
|
|
$ 13,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[10] |
|
|
13,473,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[10] |
|
|
$ 13,548,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2028, Prime + 5.85%, Floor rate 9.50%, PIK Interest 1.95%, 1.27% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[13],[16],[19] |
|
|
2028-02
|
|
|
|
|
|
2028-02
|
|
2028-02
|
|
| Investment, basis spread, variable rate |
[11],[13],[16],[19] |
|
|
5.85%
|
|
|
|
|
|
5.85%
|
|
5.85%
|
|
| Investment, interest rate, floor |
[11],[13],[16],[19] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
9.50%
|
|
| Investment, interest rate, paid in kind |
[11],[13],[16],[19] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
1.95%
|
|
| Investment exit fee |
[11],[13],[16],[19] |
|
|
1.27%
|
|
|
|
|
|
1.27%
|
|
1.27%
|
|
| Principal amount |
[13],[16],[19] |
|
|
$ 71,943,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[13],[16],[19] |
|
|
72,286,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[13],[16],[19] |
|
|
$ 72,193,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[12] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
2027-07
|
|
| Investment, basis spread, variable rate |
[8],[11],[12] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
1.95%
|
|
| Investment, interest rate, floor |
[8],[11],[12] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
9.95%
|
|
| Investment exit fee |
[8],[11],[12] |
|
|
6.85%
|
|
|
|
|
|
6.85%
|
|
6.85%
|
|
| Principal amount |
[8],[12] |
|
|
$ 73,500,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[12] |
|
|
75,009,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[12] |
|
|
$ 75,007,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 0.75%, Floor rate 8.75%, PIK Interest 2.25%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[14],[19],[22] |
|
|
2029-02
|
|
|
|
|
|
2029-02
|
|
2029-02
|
|
| Investment, basis spread, variable rate |
[11],[14],[19],[22] |
|
|
0.75%
|
|
|
|
|
|
0.75%
|
|
0.75%
|
|
| Investment, interest rate, floor |
[11],[14],[19],[22] |
|
|
8.75%
|
|
|
|
|
|
8.75%
|
|
8.75%
|
|
| Investment, interest rate, paid in kind |
[11],[14],[19],[22] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Investment exit fee |
[11],[14],[19],[22] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Principal amount |
[14],[19],[22] |
|
|
$ 178,230,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[14],[19],[22] |
|
|
178,449,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[14],[19],[22] |
|
|
$ 176,337,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 3.00%, Floor rate 11.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[14],[22] |
|
|
2029-02
|
|
|
|
|
|
2029-02
|
|
2029-02
|
|
| Investment, basis spread, variable rate |
[11],[14],[22] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Investment, interest rate, floor |
[11],[14],[22] |
|
|
11.00%
|
|
|
|
|
|
11.00%
|
|
11.00%
|
|
| Principal amount |
[14],[22] |
|
|
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[14],[22] |
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[14],[22] |
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
183,230,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
183,449,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 181,337,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and NeueHealth, Inc., Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[13],[19] |
|
|
2028-06
|
|
|
|
|
|
2028-06
|
|
2028-06
|
|
| Investment, basis spread, variable rate |
[11],[13],[19] |
|
|
1.15%
|
|
|
|
|
|
1.15%
|
|
1.15%
|
|
| Investment, interest rate, floor |
[11],[13],[19] |
|
|
9.65%
|
|
|
|
|
|
9.65%
|
|
9.65%
|
|
| Investment, interest rate, paid in kind |
[11],[13],[19] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Investment exit fee |
[11],[13],[19] |
|
|
2.50%
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
| Principal amount |
[13],[19] |
|
|
$ 46,393,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[13],[19] |
|
|
44,817,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[13],[19] |
|
|
$ 45,469,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Octave Health Group, Inc. and Senior Secured and Maturity Date October 2029, Prime + 2.70%, Floor rate 9.95%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[10],[14] |
|
|
2029-10
|
|
|
|
|
|
2029-10
|
|
2029-10
|
|
| Investment, basis spread, variable rate |
[10],[11],[14] |
|
|
2.70%
|
|
|
|
|
|
2.70%
|
|
2.70%
|
|
| Investment, interest rate, floor |
[10],[11],[14] |
|
|
9.95%
|
|
|
|
|
|
9.95%
|
|
9.95%
|
|
| Investment exit fee |
[10],[11],[14] |
|
|
5.35%
|
|
|
|
|
|
5.35%
|
|
5.35%
|
|
| Principal amount |
[10],[14] |
|
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10],[14] |
|
|
9,768,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10],[14] |
|
|
$ 9,768,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Tungsten Health Holdings, LLC and Senior Secured and Maturity Date December 2029 and Prime + 1.00%, Floor rate 8.50%, Cap rate 9.00%, PIK Interest 1.25%, 8.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
|
|
2029-12
|
|
|
|
|
|
2029-12
|
|
2029-12
|
|
| Investment, basis spread, variable rate |
[11] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment, interest rate, floor |
[11] |
|
|
8.50%
|
|
|
|
|
|
8.50%
|
|
8.50%
|
|
| Investment, interest rate, cap |
[11] |
|
|
9.00%
|
|
|
|
|
|
9.00%
|
|
9.00%
|
|
| Investment, interest rate, paid in kind |
[11] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
1.25%
|
|
| Investment exit fee |
[11] |
|
|
8.35%
|
|
|
|
|
|
8.35%
|
|
8.35%
|
|
| Principal amount |
|
|
|
$ 10,125,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
10,033,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 10,033,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and WellBe Senior Medical LLC, Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[19] |
|
|
2029-05
|
|
|
|
|
|
2029-05
|
|
2029-05
|
|
| Investment, basis spread, variable rate |
[8],[11],[19] |
|
|
0.75%
|
|
|
|
|
|
0.75%
|
|
0.75%
|
|
| Investment, interest rate, floor |
[8],[11],[19] |
|
|
7.75%
|
|
|
|
|
|
7.75%
|
|
7.75%
|
|
| Investment, interest rate, paid in kind |
[8],[11],[19] |
|
|
2.65%
|
|
|
|
|
|
2.65%
|
|
2.65%
|
|
| Investment exit fee |
[8],[11],[19] |
|
|
6.75%
|
|
|
|
|
|
6.75%
|
|
6.75%
|
|
| Principal amount |
[8],[19] |
|
|
$ 33,050,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[19] |
|
|
33,239,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[19] |
|
|
$ 32,690,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Elation Health, Inc., Senior Secured, April 2029, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.30%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[14],[16],[19],[21] |
|
|
2029-04
|
|
|
|
|
|
2029-04
|
|
2029-04
|
|
| Investment, basis spread, variable rate |
[5],[7],[11],[14],[16],[19],[21] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
1.75%
|
|
| Investment, interest rate, floor |
[5],[7],[11],[14],[16],[19],[21] |
|
|
9.25%
|
|
|
|
|
|
9.25%
|
|
9.25%
|
|
| Investment, interest rate, paid in kind |
[5],[7],[11],[14],[16],[19],[21] |
|
|
1.30%
|
|
|
|
|
|
1.30%
|
|
1.30%
|
|
| Investment exit fee |
[5],[7],[11],[14],[16],[19],[21] |
|
|
3.95%
|
|
|
|
|
|
3.95%
|
|
3.95%
|
|
| Principal amount |
[5],[7],[14],[16],[19],[21] |
|
|
$ 13,575,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[14],[16],[19],[21] |
|
|
13,283,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[14],[16],[19],[21] |
|
|
$ 13,477,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Imagen Technologies, Inc., Senior Secured, November 2028, Prime + 1.55%, Floor rate 9.05%, PIK Interest 1.00%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[10],[14],[19] |
|
|
2028-11
|
|
|
|
|
|
2028-11
|
|
2028-11
|
|
| Investment, basis spread, variable rate |
[5],[7],[10],[11],[14],[19] |
|
|
1.55%
|
|
|
|
|
|
1.55%
|
|
1.55%
|
|
| Investment, interest rate, floor |
[5],[7],[10],[11],[14],[19] |
|
|
9.05%
|
|
|
|
|
|
9.05%
|
|
9.05%
|
|
| Investment, interest rate, paid in kind |
[5],[7],[10],[11],[14],[19] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment exit fee |
[5],[7],[10],[11],[14],[19] |
|
|
3.95%
|
|
|
|
|
|
3.95%
|
|
3.95%
|
|
| Principal amount |
[5],[7],[10],[14],[19] |
|
|
$ 7,501,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[10],[14],[19] |
|
|
7,360,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[10],[14],[19] |
|
|
$ 7,360,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[7],[13],[14],[19] |
|
|
2027-07
|
|
|
|
|
|
2027-07
|
|
2027-07
|
|
| Investment, basis spread, variable rate |
[7],[11],[13],[14],[19] |
|
|
0.70%
|
|
|
|
|
|
0.70%
|
|
0.70%
|
|
| Investment, interest rate, floor |
[7],[11],[13],[14],[19] |
|
|
8.95%
|
|
|
|
|
|
8.95%
|
|
8.95%
|
|
| Investment, interest rate, paid in kind |
[7],[11],[13],[14],[19] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Investment exit fee |
[7],[11],[13],[14],[19] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
3.45%
|
|
| Principal amount |
[7],[13],[14],[19] |
|
|
$ 22,123,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[13],[14],[19] |
|
|
22,297,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[13],[14],[19] |
|
|
$ 22,689,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Streamline Healthcare Solutions, Senior Secured, June 2030, 3-month SOFR + 7.30%, Floor rate 8.30% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[7],[8],[10],[12],[14],[15],[16] |
|
|
2030-06
|
|
|
|
|
|
2030-06
|
|
2030-06
|
|
| Investment, basis spread, variable rate |
[5],[7],[8],[10],[11],[12],[14],[15],[16] |
|
|
7.30%
|
|
|
|
|
|
7.30%
|
|
7.30%
|
|
| Investment, interest rate, floor |
[5],[7],[8],[10],[11],[12],[14],[15],[16] |
|
|
8.30%
|
|
|
|
|
|
8.30%
|
|
8.30%
|
|
| Principal amount |
[5],[7],[8],[10],[12],[14],[15],[16] |
|
|
$ 21,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[8],[10],[12],[14],[15],[16] |
|
|
20,403,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[8],[10],[12],[14],[15],[16] |
|
|
$ 20,443,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Vida Health, Inc., Senior Secured, Maturity Date January 2028, Prime - 2.75%, Floor rate 5.75%, PIK Interest 5.35%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[7],[16],[19] |
|
|
2028-01
|
|
|
|
|
|
2028-01
|
|
2028-01
|
|
| Investment, basis spread, variable rate |
[7],[11],[16],[19] |
|
|
(2.75%)
|
|
|
|
|
|
(2.75%)
|
|
(2.75%)
|
|
| Investment, interest rate, floor |
[7],[11],[16],[19] |
|
|
5.75%
|
|
|
|
|
|
5.75%
|
|
5.75%
|
|
| Investment, interest rate, paid in kind |
[7],[11],[16],[19] |
|
|
5.35%
|
|
|
|
|
|
5.35%
|
|
5.35%
|
|
| Investment exit fee |
[7],[11],[16],[19] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount |
[7],[16],[19] |
|
|
$ 38,798,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[16],[19] |
|
|
40,005,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[16],[19] |
|
|
$ 39,714,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and VulcanForms Inc. and Senior Secured, Maturity Date January 2028, Prime + 4.25%, Floor rate 11.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[16],[21] |
|
|
2028-01
|
|
|
|
|
|
2028-01
|
|
2028-01
|
|
| Investment, basis spread, variable rate |
[11],[16],[21] |
|
|
4.25%
|
|
|
|
|
|
4.25%
|
|
4.25%
|
|
| Investment, interest rate, floor |
[11],[16],[21] |
|
|
11.25%
|
|
|
|
|
|
11.25%
|
|
11.25%
|
|
| Investment exit fee |
[11],[16],[21] |
|
|
4.25%
|
|
|
|
|
|
4.25%
|
|
4.25%
|
|
| Principal amount |
[16],[21] |
|
|
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[16],[21] |
|
|
20,088,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[16],[21] |
|
|
$ 19,941,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Senior Secured, Maturity Date November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[10] |
|
|
2028-11
|
|
|
|
|
|
2028-11
|
|
2028-11
|
|
| Investment, basis spread, variable rate |
[8],[10],[11] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Investment, interest rate, floor |
[8],[10],[11] |
|
|
9.50%
|
|
|
|
|
|
9.50%
|
|
9.50%
|
|
| Investment exit fee |
[8],[10],[11] |
|
|
6.35%
|
|
|
|
|
|
6.35%
|
|
6.35%
|
|
| Principal amount |
[8],[10] |
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[10] |
|
|
15,036,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[10] |
|
|
$ 15,132,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, Maturity Date August 2029, Prime + 2.40%, Floor rate 9.90%, 13.40% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[16] |
|
|
2029-08
|
|
|
|
|
|
2029-08
|
|
2029-08
|
|
| Investment, basis spread, variable rate |
[11],[16] |
|
|
2.40%
|
|
|
|
|
|
2.40%
|
|
2.40%
|
|
| Investment, interest rate, floor |
[11],[16] |
|
|
9.90%
|
|
|
|
|
|
9.90%
|
|
9.90%
|
|
| Investment exit fee |
[11],[16] |
|
|
13.40%
|
|
|
|
|
|
13.40%
|
|
13.40%
|
|
| Principal amount |
[16] |
|
|
$ 30,625,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[16] |
|
|
31,441,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[16] |
|
|
$ 31,252,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Sight Sciences, Inc., Senior Secured, Maturity Date July 2028, Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[10],[13] |
|
|
2028-07
|
|
|
|
|
|
2028-07
|
|
2028-07
|
|
| Investment, basis spread, variable rate |
[10],[11],[13] |
|
|
2.35%
|
|
|
|
|
|
2.35%
|
|
2.35%
|
|
| Investment, interest rate, floor |
[10],[11],[13] |
|
|
10.35%
|
|
|
|
|
|
10.35%
|
|
10.35%
|
|
| Investment exit fee |
[10],[11],[13] |
|
|
5.95%
|
|
|
|
|
|
5.95%
|
|
5.95%
|
|
| Principal amount |
[10],[13] |
|
|
$ 28,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10],[13] |
|
|
28,398,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10],[13] |
|
|
$ 28,387,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Space Technologies and HawkEye 360, Inc. and Senior Secured and Maturity Date December 2028 and Prime + 2.10%, Floor rate 9.35%, PIK Interest 1.50%, 1.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[21] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
2028-12
|
|
| Investment, basis spread, variable rate |
[11],[21] |
|
|
2.10%
|
|
|
|
|
|
2.10%
|
|
2.10%
|
|
| Investment, interest rate, floor |
[11],[21] |
|
|
9.35%
|
|
|
|
|
|
9.35%
|
|
9.35%
|
|
| Investment, interest rate, paid in kind |
[11],[21] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
1.50%
|
|
| Investment exit fee |
[11],[21] |
|
|
1.95%
|
|
|
|
|
|
1.95%
|
|
1.95%
|
|
| Principal amount |
[21] |
|
|
$ 8,013,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[21] |
|
|
7,674,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[21] |
|
|
$ 7,674,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Space Technologies and Loft Orbital Solutions Inc. and Senior Secured and Maturity Date December 2029 and Prime + 1.75%, Floor rate 8.75%, PIK Interest 1.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[14],[19],[21] |
|
|
2029-12
|
|
|
|
|
|
2029-12
|
|
2029-12
|
|
| Investment, basis spread, variable rate |
[11],[14],[19],[21] |
|
|
1.75%
|
|
|
|
|
|
1.75%
|
|
1.75%
|
|
| Investment, interest rate, floor |
[11],[14],[19],[21] |
|
|
8.75%
|
|
|
|
|
|
8.75%
|
|
8.75%
|
|
| Investment, interest rate, paid in kind |
[11],[14],[19],[21] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment exit fee |
[11],[14],[19],[21] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
3.45%
|
|
| Principal amount |
[14],[19],[21] |
|
|
$ 8,820,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[14],[19],[21] |
|
|
8,579,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[14],[19],[21] |
|
|
$ 8,579,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Space Technologies and Stoke Space Technologies, Inc., Senior Secured, Maturity Date May 2029, Prime + 1.00%, Floor rate 7.50%, PIK Interest 2.00%, 5.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[8],[10],[19] |
|
|
2029-05
|
|
|
|
|
|
2029-05
|
|
2029-05
|
|
| Investment, basis spread, variable rate |
[8],[10],[11],[19] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Investment, interest rate, floor |
[8],[10],[11],[19] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
7.50%
|
|
| Investment, interest rate, paid in kind |
[8],[10],[11],[19] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Investment exit fee |
[8],[10],[11],[19] |
|
|
5.25%
|
|
|
|
|
|
5.25%
|
|
5.25%
|
|
| Principal amount |
[8],[10],[19] |
|
|
$ 28,294,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[10],[19] |
|
|
27,440,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[10],[19] |
|
|
$ 27,539,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Tidal Vision Products, Inc. and Senior Secured and Maturity Date October 2028 and Prime + 2.45%, Floor rate 9.70%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[10],[14] |
|
|
2028-10
|
|
|
|
|
|
2028-10
|
|
2028-10
|
|
| Investment, basis spread, variable rate |
[10],[11],[14] |
|
|
2.45%
|
|
|
|
|
|
2.45%
|
|
2.45%
|
|
| Investment, interest rate, floor |
[10],[11],[14] |
|
|
9.70%
|
|
|
|
|
|
9.70%
|
|
9.70%
|
|
| Investment exit fee |
[10],[11],[14] |
|
|
3.45%
|
|
|
|
|
|
3.45%
|
|
3.45%
|
|
| Principal amount |
[10],[14] |
|
|
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10],[14] |
|
|
4,736,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10],[14] |
|
|
$ 4,736,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Armis, Inc. and Senior Secured and Maturity Date March 2028 and Prime + 0.00%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[13],[19],[22] |
|
|
2028-03
|
|
|
|
|
|
2028-03
|
|
2028-03
|
|
| Investment, basis spread, variable rate |
[5],[11],[13],[19],[22] |
|
|
0.00%
|
|
|
|
|
|
0.00%
|
|
0.00%
|
|
| Investment, interest rate, floor |
[5],[11],[13],[19],[22] |
|
|
7.50%
|
|
|
|
|
|
7.50%
|
|
7.50%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[13],[19],[22] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Investment exit fee |
[5],[11],[13],[19],[22] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Principal amount |
[5],[13],[19],[22] |
|
|
$ 51,771,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[13],[19],[22] |
|
|
51,909,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[13],[19],[22] |
|
|
$ 52,896,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Armis, Inc. and Senior Secured and Maturity Date March 2028 and Prime + 1.25%, Floor rate 8.75%, PIK Interest 2.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[16],[19],[22] |
|
|
2028-03
|
|
|
|
|
|
2028-03
|
|
2028-03
|
|
| Investment, basis spread, variable rate |
[5],[11],[16],[19],[22] |
|
|
1.25%
|
|
|
|
|
|
1.25%
|
|
1.25%
|
|
| Investment, interest rate, floor |
[5],[11],[16],[19],[22] |
|
|
8.75%
|
|
|
|
|
|
8.75%
|
|
8.75%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[16],[19],[22] |
|
|
2.00%
|
|
|
|
|
|
2.00%
|
|
2.00%
|
|
| Investment exit fee |
[5],[11],[16],[19],[22] |
|
|
2.25%
|
|
|
|
|
|
2.25%
|
|
2.25%
|
|
| Principal amount |
[5],[16],[19],[22] |
|
|
$ 101,183,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[16],[19],[22] |
|
|
100,789,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[16],[19],[22] |
|
|
$ 102,916,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and CoreView USA, Inc. and Senior Secured and Maturity Date January 2029 and Prime + 2.75%, Floor rate 9.25%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[10],[14] |
|
|
2029-01
|
|
|
|
|
|
2029-01
|
|
2029-01
|
|
| Investment, basis spread, variable rate |
[5],[10],[11],[14] |
|
|
2.75%
|
|
|
|
|
|
2.75%
|
|
2.75%
|
|
| Investment, interest rate, floor |
[5],[10],[11],[14] |
|
|
9.25%
|
|
|
|
|
|
9.25%
|
|
9.25%
|
|
| Investment exit fee |
[5],[10],[11],[14] |
|
|
4.95%
|
|
|
|
|
|
4.95%
|
|
4.95%
|
|
| Principal amount |
[5],[10],[14] |
|
|
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[10],[14] |
|
|
25,045,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[10],[14] |
|
|
$ 24,978,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Harness, Inc. and Senior Secured and Maturity Date March 2029 and Prime - 2.25%, Floor rate 5.25%, Cap rate 6.50%, PIK Interest 6.25%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14],[19],[21] |
|
|
2029-03
|
|
|
|
|
|
2029-03
|
|
2029-03
|
|
| Investment, basis spread, variable rate |
[5],[11],[14],[19],[21] |
|
|
(2.25%)
|
|
|
|
|
|
(2.25%)
|
|
(2.25%)
|
|
| Investment, interest rate, floor |
[5],[11],[14],[19],[21] |
|
|
5.25%
|
|
|
|
|
|
5.25%
|
|
5.25%
|
|
| Investment, interest rate, cap |
[5],[11],[14],[19],[21] |
|
|
6.50%
|
|
|
|
|
|
6.50%
|
|
6.50%
|
|
| Investment, interest rate, paid in kind |
[5],[11],[14],[19],[21] |
|
|
6.25%
|
|
|
|
|
|
6.25%
|
|
6.25%
|
|
| Investment exit fee |
[5],[11],[14],[19],[21] |
|
|
1.00%
|
|
|
|
|
|
1.00%
|
|
1.00%
|
|
| Principal amount |
[5],[14],[19],[21] |
|
|
$ 57,906,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14],[19],[21] |
|
|
57,378,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14],[19],[21] |
|
|
$ 58,967,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and New Relic, Inc. and Senior Secured and Maturity Date November 2030 and 3-month SOFR + 6.75%, Floor rate 7.75% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[14] |
|
|
2030-11
|
|
|
|
|
|
2030-11
|
|
2030-11
|
|
| Investment, basis spread, variable rate |
[5],[11],[14] |
|
|
6.75%
|
|
|
|
|
|
6.75%
|
|
6.75%
|
|
| Investment, interest rate, floor |
[5],[11],[14] |
|
|
7.75%
|
|
|
|
|
|
7.75%
|
|
7.75%
|
|
| Principal amount |
[5],[14] |
|
|
$ 21,890,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[14] |
|
|
21,465,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[14] |
|
|
$ 21,491,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and PayIt, LLC and Senior Secured and Maturity Date December 2028 and Prime + 1.45%, Floor rate 7.95%, PIK Interest 1.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[8],[10],[14],[19],[21] |
|
|
2028-12
|
|
|
|
|
|
2028-12
|
|
2028-12
|
|
| Investment, basis spread, variable rate |
[5],[8],[10],[11],[14],[19],[21] |
|
|
1.45%
|
|
|
|
|
|
1.45%
|
|
1.45%
|
|
| Investment, interest rate, floor |
[5],[8],[10],[11],[14],[19],[21] |
|
|
7.95%
|
|
|
|
|
|
7.95%
|
|
7.95%
|
|
| Investment, interest rate, paid in kind |
[5],[8],[10],[11],[14],[19],[21] |
|
|
1.50%
|
|
|
|
|
|
1.50%
|
|
1.50%
|
|
| Investment exit fee |
[5],[8],[10],[11],[14],[19],[21] |
|
|
5.00%
|
|
|
|
|
|
5.00%
|
|
5.00%
|
|
| Principal amount |
[5],[8],[10],[14],[19],[21] |
|
|
$ 26,271,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10],[14],[19],[21] |
|
|
26,218,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10],[14],[19],[21] |
|
|
$ 25,868,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Scylla DB Ltd. and Senior Secured and Maturity Date July 2029 and Prime + 3.00%, Floor rate 10.50%, 0.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[5],[9],[20] |
|
|
2029-07
|
|
|
|
|
|
2029-07
|
|
2029-07
|
|
| Investment, basis spread, variable rate |
[5],[9],[11],[20] |
|
|
3.00%
|
|
|
|
|
|
3.00%
|
|
3.00%
|
|
| Investment, interest rate, floor |
[5],[9],[11],[20] |
|
|
10.50%
|
|
|
|
|
|
10.50%
|
|
10.50%
|
|
| Investment exit fee |
[5],[9],[11],[20] |
|
|
0.75%
|
|
|
|
|
|
0.75%
|
|
0.75%
|
|
| Principal amount |
[5],[9],[20] |
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
14,798,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
14,700,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Total Armis, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[5] |
|
|
152,954,000
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
152,698,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
155,812,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Alchemer LLC, Senior Secured, May 2028, 1-month SOFR + 7.89%, Floor rate 8.89% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[28],[29] |
2028-05
|
|
|
|
2028-05
|
|
2028-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[29],[30] |
7.89%
|
|
|
|
7.89%
|
|
7.89%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[28],[29],[30] |
8.89%
|
|
|
|
8.89%
|
|
8.89%
|
|
|
|
|
|
| Principal amount |
[27],[28],[29] |
$ 20,003,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[28],[29] |
19,829,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[28],[29] |
$ 19,674,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, AlphaSense, Inc., Senior Secured, June 2029, 1-month SOFR + 6.25% , Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
2029-06
|
|
|
|
2029-06
|
|
2029-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30] |
6.25%
|
|
|
|
6.25%
|
|
6.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30] |
8.25%
|
|
|
|
8.25%
|
|
8.25%
|
|
|
|
|
|
| Principal amount |
|
$ 37,128,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
37,128,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 37,871,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, AlphaSense, Inc., Senior Secured, June 2029, 3-month SOFR + 6.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31] |
2029-06
|
|
|
|
2029-06
|
|
2029-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31] |
6.25%
|
|
|
|
6.25%
|
|
6.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31] |
8.25%
|
|
|
|
8.25%
|
|
8.25%
|
|
|
|
|
|
| Principal amount |
[31] |
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31] |
19,877,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31] |
$ 20,400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Annex Cloud, Senior Secured, September 2026, PIK Interest 3-month SOFR + 9.99%, Floor rate 10.99% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[32],[33],[34] |
2026-09
|
|
|
|
2026-09
|
|
2026-09
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[32],[33],[34] |
9.99%
|
|
|
|
9.99%
|
|
9.99%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[32],[33],[34] |
10.99%
|
|
|
|
10.99%
|
|
10.99%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[32],[33],[34] |
9.99%
|
|
|
|
9.99%
|
|
9.99%
|
|
|
|
|
|
| Principal amount |
[32],[33],[34] |
$ 3,325,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[32],[33],[34] |
3,325,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33],[34] |
$ 3,036,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Babel Street, Senior Secured, December 2027, 3-month SOFR + 8.01%, Floor rate 9.01% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[29],[35] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[29],[30],[35] |
8.01%
|
|
|
|
8.01%
|
|
8.01%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[29],[30],[35] |
9.01%
|
|
|
|
9.01%
|
|
9.01%
|
|
|
|
|
|
| Principal amount |
[28],[29],[35] |
$ 64,845,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[29],[35] |
64,258,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[29],[35] |
$ 63,953,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Brain Corporation, Senior Secured, September 2028, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.50%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[36] |
2028-09
|
|
|
|
2028-09
|
|
2028-09
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[36] |
1.35%
|
|
|
|
1.35%
|
|
1.35%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[36] |
9.85%
|
|
|
|
9.85%
|
|
9.85%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[27],[30],[36] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Investment exit fee |
[27],[30],[36] |
3.95%
|
|
|
|
3.95%
|
|
3.95%
|
|
|
|
|
|
| Principal amount |
[27],[36] |
$ 33,460,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[36] |
33,787,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[36] |
$ 34,012,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Ceros, Inc., Senior Secured, June 2027, 3-month SOFR + 8.99%, Floor rate 9.89% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[29] |
2027-06
|
|
|
|
2027-06
|
|
2027-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[29],[30] |
8.99%
|
|
|
|
8.99%
|
|
8.99%
|
|
|
|
|
|
| Investment, interest rate, floor |
[29],[30] |
9.89%
|
|
|
|
9.89%
|
|
9.89%
|
|
|
|
|
|
| Principal amount |
[29] |
$ 22,656,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[29] |
22,599,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[29] |
$ 22,380,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Chainalysis, Inc., Senior Secured, June 2029, Prime + 2.95%, Floor rate 10.45% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
2029-06
|
|
|
|
2029-06
|
|
2029-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30] |
2.95%
|
|
|
|
2.95%
|
|
2.95%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30] |
10.45%
|
|
|
|
10.45%
|
|
10.45%
|
|
|
|
|
|
| Principal amount |
|
$ 39,413,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
39,040,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 39,891,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Dashlane, Inc., Senior Secured, December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[31],[37] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[31],[37] |
3.05%
|
|
|
|
3.05%
|
|
3.05%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[31],[37] |
11.55%
|
|
|
|
11.55%
|
|
11.55%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[27],[30],[31],[37] |
1.10%
|
|
|
|
1.10%
|
|
1.10%
|
|
|
|
|
|
| Investment exit fee |
[27],[30],[31],[37] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
|
|
| Principal amount |
[27],[31],[37] |
$ 43,369,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[31],[37] |
44,640,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[31],[37] |
$ 45,081,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, DevRev, Inc., Senior Secured, July 2029, Prime + 3.95%, Floor rate 10.70%, Cap rate 14.70%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
2029-07
|
|
|
|
2029-07
|
|
2029-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30] |
3.95%
|
|
|
|
3.95%
|
|
3.95%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30] |
10.70%
|
|
|
|
10.70%
|
|
10.70%
|
|
|
|
|
|
| Investment, interest rate, cap |
[30] |
14.70%
|
|
|
|
14.70%
|
|
14.70%
|
|
|
|
|
|
| Investment exit fee |
[30] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
|
|
| Principal amount |
|
$ 36,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
36,246,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 36,247,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Distributed Creation Inc., Senior Secured, April 2029, Prime + 3.00%, Floor rate 10.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31] |
10.25%
|
|
|
|
10.25%
|
|
10.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[31] |
4.50%
|
|
|
|
4.50%
|
|
4.50%
|
|
|
|
|
|
| Principal amount |
[31] |
$ 40,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31] |
39,948,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31] |
$ 39,878,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, DocPlanner, Senior Secured, January 2030, Prime + 2.75%, Floor rate 9.75%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[39] |
2030-01
|
|
|
|
2030-01
|
|
2030-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[38],[39] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[38],[39] |
9.75%
|
|
|
|
9.75%
|
|
9.75%
|
|
|
|
|
|
| Investment exit fee |
[30],[38],[39] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
|
|
| Principal amount | € |
[38],[39] |
|
|
|
|
€ 68,200
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 70,406,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 77,535,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Earnix, Inc., Senior Secured, June 2029, Prime - 1.15%, Floor rate 5.35%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[31],[36] |
2029-06
|
|
|
|
2029-06
|
|
2029-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[31],[36] |
(1.15%)
|
|
|
|
(1.15%)
|
|
(1.15%)
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[31],[36] |
5.35%
|
|
|
|
5.35%
|
|
5.35%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[31],[36] |
4.45%
|
|
|
|
4.45%
|
|
4.45%
|
|
|
|
|
|
| Principal amount |
[28],[31],[36] |
$ 20,739,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[31],[36] |
20,525,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[31],[36] |
$ 20,946,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Funnel Holding AB (publ), Senior Secured, October 2029, Prime + 0.60%, Floor rate 7.10%, Cap rate 8.60%, PIK Interest 3.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36],[37],[38],[39] |
2029-10
|
|
|
|
2029-10
|
|
2029-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36],[37],[38],[39] |
0.60%
|
|
|
|
0.60%
|
|
0.60%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36],[37],[38],[39] |
7.10%
|
|
|
|
7.10%
|
|
7.10%
|
|
|
|
|
|
| Investment, interest rate, cap |
[28],[30],[36],[37],[38],[39] |
8.60%
|
|
|
|
8.60%
|
|
8.60%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36],[37],[38],[39] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36],[37],[38],[39] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Principal amount |
[28],[36],[37],[38],[39] |
$ 21,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36],[37],[38],[39] |
21,337,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36],[37],[38],[39] |
$ 21,339,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Khoros, LLC, Senior Secured, May 2030 , FIXED 10.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
2030-05
|
|
|
|
2030-05
|
|
2030-05
|
|
|
|
|
|
| Investment, interest rate, paid in cash |
[30] |
10.00%
|
|
|
|
10.00%
|
|
10.00%
|
|
|
|
|
|
| Principal amount |
|
$ 11,469,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
11,469,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 10,941,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, LinenMaster, LLC, Senior Secured, August 2029, 1-month SOFR + 8.28%, Floor rate 9.28% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[29] |
2029-08
|
|
|
|
2029-08
|
|
2029-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[29],[30] |
8.28%
|
|
|
|
8.28%
|
|
8.28%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[29],[30] |
9.28%
|
|
|
|
9.28%
|
|
9.28%
|
|
|
|
|
|
| Principal amount |
[28],[29] |
$ 11,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[29] |
11,234,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[29] |
$ 11,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Loftware, Inc., Senior Secured, March 2028, 3-month SOFR + 7.75%, Floor rate 8.75% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[29] |
2028-03
|
|
|
|
2028-03
|
|
2028-03
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[29],[30] |
7.75%
|
|
|
|
7.75%
|
|
7.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[29],[30] |
8.75%
|
|
|
|
8.75%
|
|
8.75%
|
|
|
|
|
|
| Principal amount |
[28],[29] |
$ 29,511,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[29] |
29,225,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[29] |
$ 29,511,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Mango Technologies, Inc., Senior Secured, August 2030, Prime + 2.25%, Floor rate 8.25%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[40] |
2030-08
|
|
|
|
2030-08
|
|
2030-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[40] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[40] |
8.25%
|
|
|
|
8.25%
|
|
8.25%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[40] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Principal amount |
[28],[40] |
$ 62,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[40] |
61,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[40] |
$ 61,464,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Marigold Group, Inc., Senior Secured, April 2028, 3-month SOFR + 9.50%, Floor rate 10.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[36],[37] |
2028-04
|
|
|
|
2028-04
|
|
2028-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[36],[37] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[36],[37] |
10.50%
|
|
|
|
10.50%
|
|
10.50%
|
|
|
|
|
|
| Principal amount |
[27],[36],[37] |
$ 45,739,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[36],[37] |
45,308,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[36],[37] |
$ 44,520,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Microblink LLC, Senior Secured, August 2027, 3-month SOFR + 7.84%, Floor rate 8.84% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[29] |
2027-08
|
|
|
|
2027-08
|
|
2027-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[29],[30] |
7.84%
|
|
|
|
7.84%
|
|
7.84%
|
|
|
|
|
|
| Investment, interest rate, floor |
[29],[30] |
8.84%
|
|
|
|
8.84%
|
|
8.84%
|
|
|
|
|
|
| Principal amount |
[29] |
$ 5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[29] |
4,929,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[29] |
$ 4,929,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Omeda Holdings, LLC, Senior Secured, July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[29],[31] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[29],[30],[31] |
8.05%
|
|
|
|
8.05%
|
|
8.05%
|
|
|
|
|
|
| Investment, interest rate, floor |
[29],[30],[31] |
9.05%
|
|
|
|
9.05%
|
|
9.05%
|
|
|
|
|
|
| Principal amount |
[29],[31] |
$ 6,602,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[29],[31] |
6,554,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[29],[31] |
$ 6,554,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Pindrop Security, Inc., Senior Secured, June 2029, Prime + 3.50%, Floor rate 10.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[35] |
2029-06
|
|
|
|
2029-06
|
|
2029-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[35] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[35] |
10.00%
|
|
|
|
10.00%
|
|
10.00%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[35] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Principal amount |
[28],[35] |
$ 31,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[35] |
30,921,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35] |
$ 31,813,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Proven Optics, LLC, Senior Secured, December 2030, 3-month SOFR + 7.30%, Floor rate 8.30% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[29] |
2030-12
|
|
|
|
2030-12
|
|
2030-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[29],[30] |
7.30%
|
|
|
|
7.30%
|
|
7.30%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[29],[30] |
8.30%
|
|
|
|
8.30%
|
|
8.30%
|
|
|
|
|
|
| Principal amount |
[28],[29] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[29] |
14,759,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[29] |
$ 14,899,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Remodel Health Holdco, LLC, Senior Secured, December 2028, Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[41] |
2028-12
|
|
|
|
2028-12
|
|
2028-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[41] |
2.35%
|
|
|
|
2.35%
|
|
2.35%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[41] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[41] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
|
|
| Principal amount |
[35],[41] |
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41] |
25,461,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41] |
$ 25,869,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Reveleer, Senior Secured, February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.60% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[36],[41] |
2027-02
|
|
|
|
2027-02
|
|
2027-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[36],[41] |
0.65%
|
|
|
|
0.65%
|
|
0.65%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[36],[41] |
9.15%
|
|
|
|
9.15%
|
|
9.15%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[35],[36],[41] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[36],[41] |
5.60%
|
|
|
|
5.60%
|
|
5.60%
|
|
|
|
|
|
| Principal amount |
[35],[36],[41] |
$ 50,819,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[36],[41] |
52,977,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[41] |
$ 52,977,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Sisense Ltd., Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36],[38],[39] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36],[38],[39] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36],[38],[39] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36],[38],[39] |
1.95%
|
|
|
|
1.95%
|
|
1.95%
|
|
|
|
|
|
| Investment exit fee |
[30],[36],[38],[39] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
|
|
| Principal amount |
[36],[38],[39] |
$ 26,744,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36],[38],[39] |
28,054,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36],[38],[39] |
$ 27,070,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Smartsheet Inc., Senior Secured, January 2031, 3-month SOFR + 5.25%, Floor rate 6.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28] |
2031-01
|
|
|
|
2031-01
|
|
2031-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30] |
5.25%
|
|
|
|
5.25%
|
|
5.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30] |
6.00%
|
|
|
|
6.00%
|
|
6.00%
|
|
|
|
|
|
| Principal amount |
[28] |
$ 46,785,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28] |
46,056,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28] |
$ 47,370,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Snappt, Inc., Senior Secured, April 2029, Prime + 2.35%, Floor rate 8.85%, PIK Interest 1.00%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[36],[41] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[36],[41] |
2.35%
|
|
|
|
2.35%
|
|
2.35%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[36],[41] |
8.85%
|
|
|
|
8.85%
|
|
8.85%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[35],[36],[41] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[36],[41] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
|
|
| Principal amount |
[35],[36],[41] |
$ 22,049,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[36],[41] |
22,155,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[41] |
$ 21,646,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Suzy, Inc., Senior Secured, June 2028, Prime - 2.00%, Floor rate 5.00%, PIK Interest 6.95%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[36],[41] |
2028-06
|
|
|
|
2028-06
|
|
2028-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[36],[41] |
(2.00%)
|
|
|
|
(2.00%)
|
|
(2.00%)
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[36],[41] |
5.00%
|
|
|
|
5.00%
|
|
5.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[35],[36],[41] |
6.95%
|
|
|
|
6.95%
|
|
6.95%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[36],[41] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
|
|
| Principal amount |
[35],[36],[41] |
$ 22,986,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[36],[41] |
23,314,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[41] |
$ 13,209,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Tipalti Solutions Ltd., Senior Secured, April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36],[42] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36],[42] |
0.45%
|
|
|
|
0.45%
|
|
0.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36],[42] |
6.45%
|
|
|
|
6.45%
|
|
6.45%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36],[42] |
2.30%
|
|
|
|
2.30%
|
|
2.30%
|
|
|
|
|
|
| Principal amount |
[28],[36],[42] |
$ 73,767,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36],[42] |
73,488,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36],[42] |
$ 72,775,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Tipalti Solutions Ltd., Senior Secured, April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36],[42] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36],[42] |
0.45%
|
|
|
|
0.45%
|
|
0.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36],[42] |
6.45%
|
|
|
|
6.45%
|
|
6.45%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36],[42] |
2.30%
|
|
|
|
2.30%
|
|
2.30%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36],[42] |
3.75%
|
|
|
|
3.75%
|
|
3.75%
|
|
|
|
|
|
| Principal amount |
[28],[36],[42] |
$ 43,426,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36],[42] |
43,762,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36],[42] |
44,052,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Total AlphaSense, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
57,128,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
57,005,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
58,271,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Total Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
117,193,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
117,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
116,827,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Total iSpot.tv, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
42,670,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
42,922,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 43,147,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Ushur, Inc., Senior Secured, June 2028, Prime + 2.20%, Floor rate 9.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[41] |
2028-06
|
|
|
|
2028-06
|
|
2028-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[41] |
2.20%
|
|
|
|
2.20%
|
|
2.20%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[41] |
9.20%
|
|
|
|
9.20%
|
|
9.20%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[41] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
|
|
| Principal amount |
[35],[41] |
$ 14,150,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41] |
14,200,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41] |
$ 13,949,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Zappi, Inc., Senior Secured, December 2027, 6-month SOFR + 8.03%, Floor rate 9.03% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[28],[29],[38],[39] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[29],[30],[38],[39] |
8.03%
|
|
|
|
8.03%
|
|
8.03%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[28],[29],[30],[38],[39] |
9.03%
|
|
|
|
9.03%
|
|
9.03%
|
|
|
|
|
|
| Principal amount |
[27],[28],[29],[38],[39] |
$ 12,504,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[28],[29],[38],[39] |
12,411,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[28],[29],[38],[39] |
$ 12,449,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, ZeroEyes, Inc., Senior Secured, May 2030, Prime + 2.00%, Floor rate 9.50%, PIK Interest 2.00%, 1.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[36],[41] |
2030-05
|
|
|
|
2030-05
|
|
2030-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[36],[41] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[36],[41] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[35],[36],[41] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[36],[41] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
|
|
| Principal amount |
[35],[36],[41] |
$ 21,182,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[36],[41] |
20,926,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[41] |
$ 20,513,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, iSpot.tv, Inc., Senior Secured, January 2029, Prime + 1.40%, Floor rate 8.15%, PIK Interest 0.75%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36],[40] |
2029-01
|
|
|
|
2029-01
|
|
2029-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36],[40] |
1.40%
|
|
|
|
1.40%
|
|
1.40%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36],[40] |
8.15%
|
|
|
|
8.15%
|
|
8.15%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36],[40] |
0.75%
|
|
|
|
0.75%
|
|
0.75%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36],[40] |
4.50%
|
|
|
|
4.50%
|
|
4.50%
|
|
|
|
|
|
| Principal amount |
[28],[36],[40] |
$ 39,363,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36],[40] |
39,574,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36],[40] |
$ 39,806,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, iSpot.tv, Inc., Senior Secured, January 2029, Prime + 2.25%, Floor rate 9.00%, PIK Interest 1.00%, 5.70% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36] |
2029-01
|
|
|
|
2029-01
|
|
2029-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36] |
5.70%
|
|
|
|
5.70%
|
|
5.70%
|
|
|
|
|
|
| Principal amount |
[28],[36] |
$ 3,307,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36] |
3,348,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36] |
$ 3,341,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, micro1 Inc., Senior Secured, June 2029, Prime + 3.50%, Floor rate 10.25%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[37],[41] |
2029-06
|
|
|
|
2029-06
|
|
2029-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[37],[41] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[37],[41] |
10.25%
|
|
|
|
10.25%
|
|
10.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[37],[41] |
4.00%
|
|
|
|
4.00%
|
|
4.00%
|
|
|
|
|
|
| Principal amount |
[37],[41] |
$ 20,750,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[37],[41] |
20,232,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[37],[41] |
$ 20,232,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Biotechnology Tools, Antheia, Inc., Senior Secured, August 2029, Prime + 2.85%, Floor rate 10.35%, 5.55% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31] |
2029-08
|
|
|
|
2029-08
|
|
2029-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31] |
2.85%
|
|
|
|
2.85%
|
|
2.85%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
|
|
| Investment exit fee |
[30],[31] |
5.55%
|
|
|
|
5.55%
|
|
5.55%
|
|
|
|
|
|
| Principal amount |
[31] |
$ 21,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31] |
20,323,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31] |
$ 20,059,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Biotechnology Tools, NorthStar Medical Technologies, LLC, Senior Secured, October 2030, Prime + 3.10%, Floor rate 9.35%, Cap rate 10.35%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[41] |
2030-10
|
|
|
|
2030-10
|
|
2030-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[41] |
3.10%
|
|
|
|
3.10%
|
|
3.10%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[41] |
9.35%
|
|
|
|
9.35%
|
|
9.35%
|
|
|
|
|
|
| Investment, interest rate, cap |
[30],[41] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
|
|
| Investment exit fee |
[30],[41] |
5.45%
|
|
|
|
5.45%
|
|
5.45%
|
|
|
|
|
|
| Principal amount |
[41] |
$ 48,750,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
48,237,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 48,237,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Communications & Networking, Aryaka Networks, Inc., Senior Secured, December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 5.68% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36],[40] |
2028-12
|
|
|
|
2028-12
|
|
2028-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36],[40] |
1.80%
|
|
|
|
1.80%
|
|
1.80%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36],[40] |
9.30%
|
|
|
|
9.30%
|
|
9.30%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36],[40] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[36],[40] |
5.68%
|
|
|
|
5.68%
|
|
5.68%
|
|
|
|
|
|
| Principal amount |
[36],[40] |
$ 28,541,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36],[40] |
29,214,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36],[40] |
$ 23,670,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Communications & Networking, Tarana Wireless, Inc., Senior Secured, March 2030, Prime + 4.00%, Floor rate 10.75%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[37],[41] |
2030-03
|
|
|
|
2030-03
|
|
2030-03
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[37],[41] |
4.00%
|
|
|
|
4.00%
|
|
4.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[37],[41] |
10.75%
|
|
|
|
10.75%
|
|
10.75%
|
|
|
|
|
|
| Investment exit fee |
[30],[37],[41] |
3.95%
|
|
|
|
3.95%
|
|
3.95%
|
|
|
|
|
|
| Principal amount |
[37],[41] |
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[37],[41] |
9,893,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[37],[41] |
$ 9,963,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Products, Tonal Systems, Inc., Senior Secured, March 2029, Prime + 4.25%, Floor rate 11.00%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[37] |
2029-03
|
|
|
|
2029-03
|
|
2029-03
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[37] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[37] |
11.00%
|
|
|
|
11.00%
|
|
11.00%
|
|
|
|
|
|
| Investment exit fee |
[30],[37] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
|
|
| Principal amount |
[37] |
$ 19,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[37] |
18,923,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[37] |
$ 19,171,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Products, Weee! Inc., Senior Secured, April 2028, Prime + 2.25%, Floor rate 9.75%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[31] |
2028-04
|
|
|
|
2028-04
|
|
2028-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[31] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[31] |
9.75%
|
|
|
|
9.75%
|
|
9.75%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[31] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Principal amount |
[28],[31] |
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[31] |
20,001,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[31] |
$ 19,877,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Andesa Services, Inc., Senior Secured, March 2031, 1-month SOFR + 7.80%, Floor rate 8.80% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[29] |
2031-03
|
|
|
|
2031-03
|
|
2031-03
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[29],[30] |
7.80%
|
|
|
|
7.80%
|
|
7.80%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[29],[30] |
8.80%
|
|
|
|
8.80%
|
|
8.80%
|
|
|
|
|
|
| Principal amount |
[28],[29] |
$ 10,931,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[29] |
10,707,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[29] |
$ 10,720,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, AppDirect, Inc., Senior Secured, September 2029, Prime + 2.05%, Floor rate 8.55%, PIK Interest 1.00%, 4.70% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36] |
2029-09
|
|
|
|
2029-09
|
|
2029-09
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36] |
2.05%
|
|
|
|
2.05%
|
|
2.05%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36] |
8.55%
|
|
|
|
8.55%
|
|
8.55%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[30],[36] |
4.70%
|
|
|
|
4.70%
|
|
4.70%
|
|
|
|
|
|
| Principal amount |
[36] |
$ 65,022,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36] |
64,863,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36] |
$ 64,562,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Carwow LTD, Senior Secured, December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36],[38],[39] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36],[38],[39] |
4.70%
|
|
|
|
4.70%
|
|
4.70%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36],[38],[39] |
11.45%
|
|
|
|
11.45%
|
|
11.45%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36],[38],[39] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
|
|
| Investment exit fee |
[30],[36],[38],[39] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
|
|
| Principal amount | £ |
[36],[38],[39] |
|
|
|
|
|
|
£ 20,892
|
|
|
|
|
|
| Investment cost |
[3],[36],[38],[39] |
$ 29,122,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36],[38],[39] |
$ 28,391,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, GoEuro Travel GmbH, Senior Secured, November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[39] |
2029-11
|
|
|
|
2029-11
|
|
2029-11
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[38],[39] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[38],[39] |
10.45%
|
|
|
|
10.45%
|
|
10.45%
|
|
|
|
|
|
| Investment exit fee |
[30],[38],[39] |
4.50%
|
|
|
|
4.50%
|
|
4.50%
|
|
|
|
|
|
| Principal amount |
[38],[39] |
$ 58,036,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
58,371,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 58,410,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Houzz, Inc., Convertible Debt, May 2028, PIK Interest 12.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36],[43] |
2028-05
|
|
|
|
2028-05
|
|
2028-05
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36],[43] |
12.00%
|
|
|
|
12.00%
|
|
12.00%
|
|
|
|
|
|
| Principal amount |
[36],[43] |
$ 31,611,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36],[43] |
31,611,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36],[43] |
$ 30,316,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Jobandtalent USA, Inc., Senior Secured, October 2028, 1-month SOFR + 1.00%, Floor rate 1.00%, PIK Interest 9.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36],[38],[39] |
2028-10
|
|
|
|
2028-10
|
|
2028-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36],[38],[39] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36],[38],[39] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36],[38],[39] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Principal amount |
[36],[38],[39] |
$ 1,094,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36],[38],[39] |
1,094,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36],[38],[39] |
$ 1,094,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Jobandtalent USA, Inc., Senior Secured, October 2028, 1-month SOFR + 3.50%, Floor rate 4.50%, PIK Interest 3.25%, 10.47% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[34],[36],[38],[39] |
2028-10
|
|
|
|
2028-10
|
|
2028-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[34],[36],[38],[39] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[34],[36],[38],[39] |
4.50%
|
|
|
|
4.50%
|
|
4.50%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[34],[36],[38],[39] |
3.25%
|
|
|
|
3.25%
|
|
3.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[34],[36],[38],[39] |
10.47%
|
|
|
|
10.47%
|
|
10.47%
|
|
|
|
|
|
| Principal amount |
[34],[36],[38],[39] |
$ 14,652,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[34],[36],[38],[39] |
15,466,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[34],[36],[38],[39] |
$ 10,166,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Nerdy Inc., Senior Secured, November 2029, Prime + 3.50%, Floor rate 10.75%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
2029-11
|
|
|
|
2029-11
|
|
2029-11
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30] |
10.75%
|
|
|
|
10.75%
|
|
10.75%
|
|
|
|
|
|
| Investment exit fee |
[30] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
|
|
| Principal amount |
|
$ 21,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
20,990,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 20,781,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Peek Travel, Inc., Senior Secured, October 2028, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36] |
2028-10
|
|
|
|
2028-10
|
|
2028-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[30],[36] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
|
|
| Principal amount |
[36] |
$ 26,409,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36] |
26,306,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36] |
$ 25,986,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Perk International Holdings Ltd, Senior Secured, May 2031, 3-month SOFR + 7.00%, Floor rate 9.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[38],[39] |
2031-05
|
|
|
|
2031-05
|
|
2031-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[38],[39] |
7.00%
|
|
|
|
7.00%
|
|
7.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[38],[39] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Principal amount |
[28],[38],[39] |
$ 14,938,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[38],[39] |
14,651,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[38],[39] |
$ 14,651,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Provi, Senior Secured, December 2027, Prime + 4.40%, Floor rate 10.65%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35] |
2027-12
|
|
|
|
2027-12
|
|
2027-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35] |
4.40%
|
|
|
|
4.40%
|
|
4.40%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35] |
10.65%
|
|
|
|
10.65%
|
|
10.65%
|
|
|
|
|
|
| Investment exit fee |
[30],[35] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Principal amount |
[35] |
$ 14,160,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
14,315,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 14,311,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 9.50%, Floor rate 10.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[35],[36] |
2026-12
|
|
|
|
2026-12
|
|
2026-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[35],[36] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[35],[36] |
10.50%
|
|
|
|
10.50%
|
|
10.50%
|
|
|
|
|
|
| Principal amount |
[27],[35],[36] |
$ 25,809,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[35],[36] |
25,797,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[35],[36] |
$ 25,797,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Riviera Partners LLC, Senior Secured, March 2028, 3-month SOFR + 8.28%, Floor rate 9.28% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[29] |
2028-03
|
|
|
|
2028-03
|
|
2028-03
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[29],[30] |
8.28%
|
|
|
|
8.28%
|
|
8.28%
|
|
|
|
|
|
| Investment, interest rate, floor |
[29],[30] |
9.28%
|
|
|
|
9.28%
|
|
9.28%
|
|
|
|
|
|
| Principal amount |
[29] |
$ 35,850,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[29] |
35,660,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[29] |
$ 35,850,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Skyword, Inc., Senior Secured, November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[36] |
2027-11
|
|
|
|
2027-11
|
|
2027-11
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[36] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[36] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[27],[30],[36] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
|
|
| Investment exit fee |
[27],[30],[36] |
5.50%
|
|
|
|
5.50%
|
|
5.50%
|
|
|
|
|
|
| Principal amount |
[27],[36] |
$ 6,306,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[36] |
6,640,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[36] |
$ 6,486,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Tectura Corporation, Senior Secured, January 2027, FIXED 8.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[44] |
2027-01
|
|
|
|
2027-01
|
|
2027-01
|
|
|
|
|
|
| Investment, interest rate, paid in cash |
[30],[44] |
8.25%
|
|
|
|
8.25%
|
|
8.25%
|
|
|
|
|
|
| Principal amount |
[44] |
$ 8,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44] |
8,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44] |
8,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Total Jobandtalent USA, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
15,746,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
16,560,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 11,260,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Akeyless Security Ltd., Senior Secured, August 2028, Prime + 4.00%, Floor rate 11.00%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[38],[39] |
2028-08
|
|
|
|
2028-08
|
|
2028-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[38],[39] |
4.00%
|
|
|
|
4.00%
|
|
4.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[38],[39] |
11.00%
|
|
|
|
11.00%
|
|
11.00%
|
|
|
|
|
|
| Investment exit fee |
[6],[30],[38],[39] |
2.95%
|
|
|
|
2.95%
|
|
2.95%
|
|
|
|
|
|
| Principal amount |
[6],[38],[39] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
14,918,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 14,981,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Coronet Cyber Security Ltd., Senior Secured, October 2028, Prime + 2.90%, Floor rate 9.40% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6] |
2028-10
|
|
|
|
2028-10
|
|
2028-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30] |
2.90%
|
|
|
|
2.90%
|
|
2.90%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30] |
9.40%
|
|
|
|
9.40%
|
|
9.40%
|
|
|
|
|
|
| Principal amount |
[6] |
$ 7,464,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
7,395,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 7,205,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, DNSFilter, Inc., Senior Secured, October 2028, Prime + 2.15%, Floor rate 8.65%, PIK Interest 0.75%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[36],[37] |
2028-10
|
|
|
|
2028-10
|
|
2028-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30],[36],[37] |
2.15%
|
|
|
|
2.15%
|
|
2.15%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30],[36],[37] |
8.65%
|
|
|
|
8.65%
|
|
8.65%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[28],[30],[36],[37] |
0.75%
|
|
|
|
0.75%
|
|
0.75%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30],[36],[37] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
|
|
| Principal amount |
[6],[28],[36],[37] |
$ 7,540,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[36],[37] |
7,545,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[36],[37] |
$ 7,551,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Expel, Inc., Senior Secured, April 2029, Prime + 3.90%, Floor rate 10.65%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30] |
3.90%
|
|
|
|
3.90%
|
|
3.90%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30] |
10.65%
|
|
|
|
10.65%
|
|
10.65%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Principal amount |
[6],[28] |
$ 11,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28] |
10,934,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28] |
$ 10,773,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, LogRhythm, Inc., Senior Secured, July 2029, 3-month SOFR + 7.50%, Floor rate 8.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[36] |
2029-07
|
|
|
|
2029-07
|
|
2029-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[36] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[36] |
8.50%
|
|
|
|
8.50%
|
|
8.50%
|
|
|
|
|
|
| Principal amount |
[6],[36] |
$ 26,609,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[36] |
26,139,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[36] |
$ 15,236,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, LogRhythm, Inc., Senior Secured, October 2026, 3-month SOFR + 5.50%, Floor rate 6.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6] |
2026-10
|
|
|
|
2026-10
|
|
2026-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30] |
5.50%
|
|
|
|
5.50%
|
|
5.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
|
|
| Principal amount |
[6] |
$ 438,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
438,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 438,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Morphisec Information Security 2014 Ltd., Senior Secured, October 2027, Prime + 3.45%, Floor rate 11.70%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[38],[39] |
2027-10
|
|
|
|
2027-10
|
|
2027-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[38],[39] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[38],[39] |
11.70%
|
|
|
|
11.70%
|
|
11.70%
|
|
|
|
|
|
| Investment exit fee |
[6],[30],[38],[39] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
|
|
| Principal amount |
[6],[38],[39] |
$ 11,435,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
11,848,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 11,642,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Semperis Technologies Inc., Senior Secured, April 2029, Prime + 2.50%, Floor rate 9.00%, PIK Interest 1.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[36],[37] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[36],[37] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[36],[37] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[30],[36],[37] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
|
|
| Principal amount |
[6],[36],[37] |
$ 24,892,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[36],[37] |
24,661,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[36],[37] |
$ 24,921,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Semperis Technologies Inc., Senior Secured, April 2029, Prime - 0.50%, Floor rate 8.00%, PIK Interest 3.85% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[36],[37] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[36],[37] |
(0.50%)
|
|
|
|
(0.50%)
|
|
(0.50%)
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[36],[37] |
8.00%
|
|
|
|
8.00%
|
|
8.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[30],[36],[37] |
3.85%
|
|
|
|
3.85%
|
|
3.85%
|
|
|
|
|
|
| Principal amount |
[6],[36],[37] |
$ 34,818,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[36],[37] |
34,437,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[36],[37] |
$ 34,553,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Semperis Technologies Inc., Senior Secured, April 2029, Prime - 1.75%, Floor rate 6.75%, PIK Interest 3.25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[31],[36],[37] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[31],[36],[37] |
(1.75%)
|
|
|
|
(1.75%)
|
|
(1.75%)
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[31],[36],[37] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[30],[31],[36],[37] |
3.25%
|
|
|
|
3.25%
|
|
3.25%
|
|
|
|
|
|
| Principal amount |
[6],[31],[36],[37] |
$ 24,099,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[31],[36],[37] |
23,939,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[31],[36],[37] |
$ 24,014,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Sumo Logic, Inc., Senior Secured, May 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[36] |
2030-05
|
|
|
|
2030-05
|
|
2030-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30],[36] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30],[36] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
|
|
| Principal amount |
[6],[28],[36] |
$ 23,943,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[36] |
23,591,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[36] |
23,078,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Total LogRhythm, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[6] |
27,047,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
26,577,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
15,674,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Total Semperis Technologies Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[6] |
83,809,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
83,037,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
83,488,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Total Zimperium, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[6] |
19,462,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
19,390,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 19,390,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Zimperium, Inc., Senior Secured, May 2027, 3-month SOFR + 5.39%, Floor rate 6.39% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[29] |
2027-05
|
|
|
|
2027-05
|
|
2027-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[29],[30] |
5.39%
|
|
|
|
5.39%
|
|
5.39%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[29],[30] |
6.39%
|
|
|
|
6.39%
|
|
6.39%
|
|
|
|
|
|
| Principal amount |
[6],[28],[29] |
$ 1,766,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[29] |
1,756,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[29] |
$ 1,756,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Zimperium, Inc., Senior Secured, May 2027, 3-month SOFR + 8.10%, Floor rate 9.10% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[29] |
2027-05
|
|
|
|
2027-05
|
|
2027-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[29],[30] |
8.10%
|
|
|
|
8.10%
|
|
8.10%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[29],[30] |
9.10%
|
|
|
|
9.10%
|
|
9.10%
|
|
|
|
|
|
| Principal amount |
[6],[28],[29] |
$ 17,696,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[29] |
17,634,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[29] |
$ 17,634,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Defense Technologies, Allen Control Systems Inc., Senior Secured, September 2030, Prime + 3.25%, Floor rate 9.50%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[37] |
2030-09
|
|
|
|
2030-09
|
|
2030-09
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[37] |
3.25%
|
|
|
|
3.25%
|
|
3.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[37] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment exit fee |
[30],[37] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Principal amount |
[37] |
$ 14,583,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[37] |
14,149,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[37] |
$ 14,149,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Defense Technologies, Hermeus Corporation, Senior Secured, March 2030, Prime + 2.75%, Floor rate 10.00%, PIK Interest 1.00%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[31],[36] |
2030-03
|
|
|
|
2030-03
|
|
2030-03
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[31],[36] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[31],[36] |
10.00%
|
|
|
|
10.00%
|
|
10.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[31],[36] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[31],[36] |
4.50%
|
|
|
|
4.50%
|
|
4.50%
|
|
|
|
|
|
| Principal amount |
[28],[31],[36] |
$ 15,768,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[31],[36] |
15,348,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[31],[36] |
$ 15,520,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Defense Technologies, Saronic Technologies, Inc., Senior Secured, June 2030, Prime + 2.50%, Floor rate 9.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[35],[41],[42] |
2030-06
|
|
|
|
2030-06
|
|
2030-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[35],[41],[42] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[35],[41],[42] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[35],[41],[42] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Principal amount |
[28],[35],[41],[42] |
$ 115,914,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[35],[41],[42] |
114,277,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35],[41],[42] |
$ 119,391,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Defense Technologies, Shield AI, Inc., Senior Secured, February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36],[40],[42] |
2029-02
|
|
|
|
2029-02
|
|
2029-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36],[40],[42] |
0.85%
|
|
|
|
0.85%
|
|
0.85%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36],[40],[42] |
6.85%
|
|
|
|
6.85%
|
|
6.85%
|
|
|
|
|
|
| Investment, interest rate, cap |
[30],[36],[40],[42] |
9.60%
|
|
|
|
9.60%
|
|
9.60%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36],[40],[42] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Investment exit fee |
[30],[36],[40],[42] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Principal amount |
[36],[40],[42] |
$ 148,122,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36],[40],[42] |
148,415,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36],[40],[42] |
$ 151,660,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Diversified Financial Services, Gibraltar Acquisition LLC, Unsecured, July 2029, FIXED 11.50% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36],[44],[45] |
2029-07
|
|
|
|
2029-07
|
|
2029-07
|
|
|
|
|
|
| Investment, interest rate, paid in cash |
[30],[36],[44],[45] |
11.50%
|
|
|
|
11.50%
|
|
11.50%
|
|
|
|
|
|
| Principal amount |
[36],[44],[45] |
$ 28,805,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36],[44],[45] |
28,486,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36],[44],[45] |
$ 28,486,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Diversified Financial Services, Gibraltar Acquisition LLC, Unsecured, July 2029, FIXED 11.95% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[44],[45] |
2029-07
|
|
|
|
2029-07
|
|
2029-07
|
|
|
|
|
|
| Investment, interest rate, paid in cash |
[30],[44],[45] |
11.95%
|
|
|
|
11.95%
|
|
11.95%
|
|
|
|
|
|
| Principal amount |
[44],[45] |
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44],[45] |
9,871,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44],[45] |
$ 9,871,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Diversified Financial Services, Hercules Adviser LLC, Unsecured, March 2027, FIXED 6.75% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[44],[46] |
2027-03
|
|
|
|
2027-03
|
|
2027-03
|
|
|
|
|
|
| Investment, interest rate, paid in cash |
[30],[44],[46] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
|
|
| Principal amount |
[44],[46] |
$ 8,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44],[46] |
8,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44],[46] |
8,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Diversified Financial Services, Total Gibraltar Acquisition LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
38,805,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
38,357,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 38,357,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, 4D Molecular Therapeutics, Inc., Senior Secured, June 2031, Prime + 2.00%, Floor rate 8.75%, Cap rate 9.50%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[38],[41] |
2031-06
|
|
|
|
2031-06
|
|
2031-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[38],[41] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[38],[41] |
8.75%
|
|
|
|
8.75%
|
|
8.75%
|
|
|
|
|
|
| Investment, interest rate, cap |
[28],[30],[38],[41] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[38],[41] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
|
|
| Principal amount |
[28],[38],[41] |
$ 14,200,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[38],[41] |
14,111,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[38],[41] |
$ 14,111,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Altimmune, Inc., Senior Secured, June 2029, Prime + 2.45%, Floor rate 9.70%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[38],[41] |
2029-06
|
|
|
|
2029-06
|
|
2029-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[38],[41] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[38],[41] |
9.70%
|
|
|
|
9.70%
|
|
9.70%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[38],[41] |
6.25%
|
|
|
|
6.25%
|
|
6.25%
|
|
|
|
|
|
| Principal amount |
[35],[38],[41] |
$ 17,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[38],[41] |
17,701,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[38],[41] |
$ 17,800,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Arcus Biosciences, Inc., Senior Secured, September 2030, Prime - 0.05%, Floor rate 8.45%, PIK Interest 2.20%, 9.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[35],[36],[38],[41] |
2030-09
|
|
|
|
2030-09
|
|
2030-09
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[35],[36],[38],[41] |
(0.05%)
|
|
|
|
(0.05%)
|
|
(0.05%)
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[35],[36],[38],[41] |
8.45%
|
|
|
|
8.45%
|
|
8.45%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[31],[35],[36],[38],[41] |
2.20%
|
|
|
|
2.20%
|
|
2.20%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[35],[36],[38],[41] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Principal amount |
[31],[35],[36],[38],[41] |
$ 76,981,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[35],[36],[38],[41] |
78,337,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[35],[36],[38],[41] |
$ 81,786,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Beren Therapeutics P.B.C., Senior Secured, October 2029, Prime + 2.45%, Floor rate 9.95%, 5.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[41] |
2029-10
|
|
|
|
2029-10
|
|
2029-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[41] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[41] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[41] |
5.25%
|
|
|
|
5.25%
|
|
5.25%
|
|
|
|
|
|
| Principal amount |
[31],[41] |
$ 17,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[41] |
17,080,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[41] |
$ 16,936,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Braeburn, Inc., Senior Secured, October 2028, Prime + 3.00%, Floor rate 10.50%, PIK Interest 0.25%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36] |
2028-10
|
|
|
|
2028-10
|
|
2028-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36] |
10.50%
|
|
|
|
10.50%
|
|
10.50%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36] |
0.25%
|
|
|
|
0.25%
|
|
0.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[36] |
5.45%
|
|
|
|
5.45%
|
|
5.45%
|
|
|
|
|
|
| Principal amount |
[36] |
$ 53,735,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36] |
55,118,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36] |
$ 56,524,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, COMPASS Pathways plc, Senior Secured, January 2031, Prime + 2.75%, Floor rate 9.75%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[38],[39] |
2031-01
|
|
|
|
2031-01
|
|
2031-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[38],[39] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[38],[39] |
9.75%
|
|
|
|
9.75%
|
|
9.75%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[38],[39] |
7.75%
|
|
|
|
7.75%
|
|
7.75%
|
|
|
|
|
|
| Principal amount |
[31],[38],[39] |
$ 42,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[38],[39] |
42,758,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[38],[39] |
$ 43,833,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Disc Medicine, Inc., Senior Secured, December 2029, Prime + 1.75%, Floor rate 8.25%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[35],[38],[41] |
2029-12
|
|
|
|
2029-12
|
|
2029-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[35],[38],[41] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[35],[38],[41] |
8.25%
|
|
|
|
8.25%
|
|
8.25%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[35],[38],[41] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
|
|
| Principal amount |
[28],[35],[38],[41] |
$ 34,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[35],[38],[41] |
34,377,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35],[38],[41] |
$ 35,726,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Dyne Therapeutics, Inc., Senior Secured, July 2030, Prime + 2.45%, Floor rate 9.95%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[38],[40],[41],[42] |
2030-07
|
|
|
|
2030-07
|
|
2030-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[38],[40],[41],[42] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[38],[40],[41],[42] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[38],[40],[41],[42] |
5.50%
|
|
|
|
5.50%
|
|
5.50%
|
|
|
|
|
|
| Principal amount |
[35],[38],[40],[41],[42] |
$ 125,615,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[38],[40],[41],[42] |
125,751,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[38],[40],[41],[42] |
$ 128,465,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Heron Therapeutics, Inc., Senior Secured, September 2030, Prime + 1.95%, Floor rate 9.45%, PIK Interest 1.00%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[36] |
2030-09
|
|
|
|
2030-09
|
|
2030-09
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[36] |
1.95%
|
|
|
|
1.95%
|
|
1.95%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[36] |
9.45%
|
|
|
|
9.45%
|
|
9.45%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[35],[36] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[36] |
6.50%
|
|
|
|
6.50%
|
|
6.50%
|
|
|
|
|
|
| Principal amount |
[35],[36] |
$ 68,316,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[36] |
68,668,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
$ 68,264,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Kura Oncology, Inc., Senior Secured, November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[38] |
2027-11
|
|
|
|
2027-11
|
|
2027-11
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[38] |
2.40%
|
|
|
|
2.40%
|
|
2.40%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[38] |
8.65%
|
|
|
|
8.65%
|
|
8.65%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[38] |
6.05%
|
|
|
|
6.05%
|
|
6.05%
|
|
|
|
|
|
| Principal amount |
[35],[38] |
$ 5,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[38] |
5,763,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[38] |
$ 5,882,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Lexicon Pharmaceuticals, Inc., Senior Secured, May 2030, Prime + 3.10%, Floor rate 9.85%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[40],[41] |
2030-05
|
|
|
|
2030-05
|
|
2030-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[38],[40],[41] |
3.10%
|
|
|
|
3.10%
|
|
3.10%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[38],[40],[41] |
9.85%
|
|
|
|
9.85%
|
|
9.85%
|
|
|
|
|
|
| Investment exit fee |
[30],[38],[40],[41] |
6.25%
|
|
|
|
6.25%
|
|
6.25%
|
|
|
|
|
|
| Principal amount |
[38],[40],[41] |
$ 38,875,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[40],[41] |
38,384,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[40],[41] |
$ 38,384,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Maze Therapeutics, Inc., Senior Secured, February 2031, Prime + 0.95%, Floor rate 7.95%, 6.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[31],[38],[41] |
2031-02
|
|
|
|
2031-02
|
|
2031-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[31],[38],[41] |
0.95%
|
|
|
|
0.95%
|
|
0.95%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[31],[38],[41] |
7.95%
|
|
|
|
7.95%
|
|
7.95%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[31],[38],[41] |
6.45%
|
|
|
|
6.45%
|
|
6.45%
|
|
|
|
|
|
| Principal amount |
[28],[31],[38],[41] |
$ 27,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[31],[38],[41] |
26,954,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[31],[38],[41] |
$ 27,588,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, MoonLake Immunotherapeutics, Senior Secured, April 2030, Prime + 1.45%, Floor rate 8.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[39] |
2030-04
|
|
|
|
2030-04
|
|
2030-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[38],[39] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[38],[39] |
8.45%
|
|
|
|
8.45%
|
|
8.45%
|
|
|
|
|
|
| Investment exit fee |
[30],[38],[39] |
6.95%
|
|
|
|
6.95%
|
|
6.95%
|
|
|
|
|
|
| Principal amount |
[38],[39] |
$ 46,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
46,382,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 47,397,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, NorthSea Therapeutics, Convertible Debt, June 2027, FIXED 6.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[39],[43] |
2027-06
|
|
|
|
2027-06
|
|
2027-06
|
|
|
|
|
|
| Investment, interest rate, paid in cash |
[30],[38],[39],[43] |
6.00%
|
|
|
|
6.00%
|
|
6.00%
|
|
|
|
|
|
| Principal amount |
[38],[39],[43] |
$ 473,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39],[43] |
473,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39],[43] |
$ 473,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Phathom Pharmaceuticals, Inc., Senior Secured, February 2029, Prime + 3.10%, Floor rate 9.85%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[40],[41],[42],[47] |
2029-02
|
|
|
|
2029-02
|
|
2029-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[38],[40],[41],[42],[47] |
3.10%
|
|
|
|
3.10%
|
|
3.10%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[38],[40],[41],[42],[47] |
9.85%
|
|
|
|
9.85%
|
|
9.85%
|
|
|
|
|
|
| Investment exit fee |
[30],[38],[40],[41],[42],[47] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Principal amount |
[38],[40],[41],[42],[47] |
$ 131,832,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[40],[41],[42],[47] |
131,312,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[40],[41],[42],[47] |
$ 133,179,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Replimune Group, Inc., Senior Secured, October 2029, Prime + 1.75%, Floor rate 8.50%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[28],[36],[38],[40] |
2029-10
|
|
|
|
2029-10
|
|
2029-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[30],[36],[38],[40] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[28],[30],[36],[38],[40] |
8.50%
|
|
|
|
8.50%
|
|
8.50%
|
|
|
|
|
|
| Investment, interest rate, cap |
[27],[28],[30],[36],[38],[40] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[27],[28],[30],[36],[38],[40] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
|
|
| Investment exit fee |
[27],[28],[30],[36],[38],[40] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
|
|
| Principal amount |
[27],[28],[36],[38],[40] |
$ 67,970,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[28],[36],[38],[40] |
69,288,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[28],[36],[38],[40] |
$ 70,118,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Rocket Pharmaceuticals, Inc., Senior Secured, October 2030, Prime + 2.40%, Floor rate 9.15%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[38],[41] |
2030-10
|
|
|
|
2030-10
|
|
2030-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[38],[41] |
2.40%
|
|
|
|
2.40%
|
|
2.40%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[38],[41] |
9.15%
|
|
|
|
9.15%
|
|
9.15%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[38],[41] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
|
|
| Principal amount |
[28],[38],[41] |
$ 26,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[38],[41] |
25,563,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[38],[41] |
$ 25,563,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Savara, Inc., Senior Secured, April 2030, Prime + 1.45%, Floor rate 7.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[38],[41] |
2030-04
|
|
|
|
2030-04
|
|
2030-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[38],[41] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[38],[41] |
7.45%
|
|
|
|
7.45%
|
|
7.45%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[38],[41] |
6.95%
|
|
|
|
6.95%
|
|
6.95%
|
|
|
|
|
|
| Principal amount |
[35],[38],[41] |
$ 21,450,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[38],[41] |
21,815,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[38],[41] |
$ 22,245,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, SynOx Therapeutics Limited, Senior Secured, May 2028, Prime + 1.40%, Floor rate 9.90%, 7.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[38],[39] |
2028-05
|
|
|
|
2028-05
|
|
2028-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[38],[39] |
1.40%
|
|
|
|
1.40%
|
|
1.40%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[38],[39] |
9.90%
|
|
|
|
9.90%
|
|
9.90%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[38],[39] |
7.25%
|
|
|
|
7.25%
|
|
7.25%
|
|
|
|
|
|
| Principal amount |
[31],[38],[39] |
$ 10,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[38],[39] |
10,662,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[38],[39] |
$ 10,741,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Tenpoint Therapeutics Limited, Senior Secured, October 2029, Prime + 2.90%, Floor rate 10.40%, 6.65% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[38],[39] |
2029-10
|
|
|
|
2029-10
|
|
2029-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[38],[39] |
2.90%
|
|
|
|
2.90%
|
|
2.90%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[38],[39] |
10.40%
|
|
|
|
10.40%
|
|
10.40%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[38],[39] |
6.65%
|
|
|
|
6.65%
|
|
6.65%
|
|
|
|
|
|
| Principal amount |
[31],[38],[39] |
$ 18,750,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[38],[39] |
18,833,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[38],[39] |
18,367,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Total X4 Pharmaceuticals, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
75,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
77,246,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 78,538,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, X4 Pharmaceuticals, Inc., Senior Secured, July 2027, Prime + 3.15%, Floor rate 10.15%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[40] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[40] |
3.15%
|
|
|
|
3.15%
|
|
3.15%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[40] |
10.15%
|
|
|
|
10.15%
|
|
10.15%
|
|
|
|
|
|
| Investment exit fee |
[27],[30],[40] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Principal amount |
[27],[40] |
$ 42,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[40] |
43,717,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[40] |
$ 44,413,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, X4 Pharmaceuticals, Inc., Senior Secured, July 2027, Prime + 3.15%, Floor rate 10.15%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[31],[40] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[31],[40] |
3.15%
|
|
|
|
3.15%
|
|
3.15%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[31],[40] |
10.15%
|
|
|
|
10.15%
|
|
10.15%
|
|
|
|
|
|
| Investment exit fee |
[27],[30],[31],[40] |
4.00%
|
|
|
|
4.00%
|
|
4.00%
|
|
|
|
|
|
| Principal amount |
[27],[31],[40] |
$ 32,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[31],[40] |
33,529,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[31],[40] |
$ 34,125,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, enGene Therapeutics Inc. (p.k.a. enGene, Inc.), Senior Secured, January 2030, Prime + 2.25%, Floor rate 9.25%, Cap rate 10.25%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[39] |
2030-01
|
|
|
|
2030-01
|
|
2030-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[38],[39] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[38],[39] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
|
|
| Investment, interest rate, cap |
[30],[38],[39] |
10.25%
|
|
|
|
10.25%
|
|
10.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[38],[39] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
|
|
| Principal amount |
[38],[39] |
$ 17,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
18,032,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 18,079,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, uniQure B.V., Senior Secured, October 2030, Prime + 2.45%, Floor rate 9.45%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[38],[39] |
2030-10
|
|
|
|
2030-10
|
|
2030-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[38],[39] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[38],[39] |
9.45%
|
|
|
|
9.45%
|
|
9.45%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[38],[39] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
|
|
| Principal amount |
[31],[38],[39] |
$ 27,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[38],[39] |
27,728,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[38],[39] |
$ 28,404,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Electronics & Computer Hardware, Locus Robotics Corp., Senior Secured, December 2028, Prime + 3.00%, Floor rate 9.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[35],[40],[41] |
2028-12
|
|
|
|
2028-12
|
|
2028-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[35],[40],[41] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[35],[40],[41] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[35],[40],[41] |
4.00%
|
|
|
|
4.00%
|
|
4.00%
|
|
|
|
|
|
| Principal amount |
[31],[35],[40],[41] |
$ 65,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[35],[40],[41] |
65,694,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[35],[40],[41] |
$ 65,831,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Antares Nuclear, Inc., Senior Secured 1, September 2030, Prime + 2.75%, Floor rate 9.50%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28] |
2030-09
|
|
|
|
2030-09
|
|
2030-09
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Principal amount |
[6],[28] |
$ 4,219,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28] |
4,090,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28] |
$ 4,090,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Antares Nuclear, Inc., Senior Secured 2, September 2030, Prime + 2.75%, Floor rate 9.50%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[48] |
2030-09
|
|
|
|
2030-09
|
|
2030-09
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30],[48] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30],[48] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30],[48] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Principal amount |
[6],[28],[48] |
$ 469,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[48] |
454,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[48] |
$ 454,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 5.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[35],[36],[37] |
2028-05
|
|
|
|
2028-05
|
|
2028-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[35],[36],[37] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[35],[36],[37] |
10.75%
|
|
|
|
10.75%
|
|
10.75%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[30],[35],[36],[37] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
|
|
| Investment exit fee |
[6],[30],[35],[36],[37] |
5.75%
|
|
|
|
5.75%
|
|
5.75%
|
|
|
|
|
|
| Principal amount |
[6],[35],[36],[37] |
$ 12,891,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[35],[36],[37] |
13,088,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[35],[36],[37] |
$ 12,971,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 7.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[35],[36],[37] |
2028-05
|
|
|
|
2028-05
|
|
2028-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[35],[36],[37] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[35],[36],[37] |
10.75%
|
|
|
|
10.75%
|
|
10.75%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[30],[35],[36],[37] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
|
|
| Investment exit fee |
[6],[30],[35],[36],[37] |
7.45%
|
|
|
|
7.45%
|
|
7.45%
|
|
|
|
|
|
| Principal amount |
[6],[35],[36],[37] |
$ 17,777,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[35],[36],[37] |
18,179,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[35],[36],[37] |
$ 18,015,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Renew Home, LLC, Senior Secured, March 2030, Prime + 3.00%, Floor rate 9.25%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[37] |
2030-03
|
|
|
|
2030-03
|
|
2030-03
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30],[37] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30],[37] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30],[37] |
5.00%
|
|
|
|
5.00%
|
|
5.00%
|
|
|
|
|
|
| Principal amount |
[6],[28],[37] |
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[37] |
4,012,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[37] |
4,020,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Total Antares Nuclear, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[6] |
4,688,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
4,544,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
4,544,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Total Electric Hydrogen Co. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
[6] |
30,668,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
31,267,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 30,986,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Valar Atomics Inc., Senior Secured, August 2029, Prime + 4.35%, Floor rate 11.10% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[48] |
2029-08
|
|
|
|
2029-08
|
|
2029-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[48] |
4.35%
|
|
|
|
4.35%
|
|
4.35%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[48] |
11.10%
|
|
|
|
11.10%
|
|
11.10%
|
|
|
|
|
|
| Principal amount |
[6],[48] |
$ 19,444,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[48] |
19,218,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[48] |
19,218,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Equipment Financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
|
35,900,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 37,400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Financial Technologies, Finix Payments, Inc., Senior Secured, December 2029, Prime + 2.50%, Floor rate 9.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[41] |
2029-12
|
|
|
|
2029-12
|
|
2029-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30],[41] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30],[41] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30],[41] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
|
|
| Principal amount |
[6],[28],[41] |
$ 24,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[41] |
24,294,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[41] |
$ 24,400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Belong Health, Inc., Senior Secured, November 2029, Prime + 2.25%, Floor rate 9.75%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[41] |
2029-11
|
|
|
|
2029-11
|
|
2029-11
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[41] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[41] |
9.75%
|
|
|
|
9.75%
|
|
9.75%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[41] |
5.45%
|
|
|
|
5.45%
|
|
5.45%
|
|
|
|
|
|
| Principal amount |
[28],[41] |
$ 11,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[41] |
11,097,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[41] |
$ 11,094,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Blue Sprig Pediatrics, Inc., Senior Secured, May 2029, 1-month SOFR + 7.75%, Floor rate 10.75%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[31],[40] |
2029-05
|
|
|
|
2029-05
|
|
2029-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[31],[40] |
7.75%
|
|
|
|
7.75%
|
|
7.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[31],[40] |
10.75%
|
|
|
|
10.75%
|
|
10.75%
|
|
|
|
|
|
| Investment exit fee |
[27],[30],[31],[40] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Principal amount |
[27],[31],[40] |
$ 67,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[31],[40] |
66,918,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[31],[40] |
$ 65,677,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, ChenMed, LLC, Senior Secured, May 2030, Prime + 2.45%, Floor rate 9.45%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[42] |
2030-05
|
|
|
|
2030-05
|
|
2030-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[42] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[42] |
9.45%
|
|
|
|
9.45%
|
|
9.45%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[42] |
3.75%
|
|
|
|
3.75%
|
|
3.75%
|
|
|
|
|
|
| Principal amount |
[28],[42] |
$ 130,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[42] |
129,058,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[42] |
$ 129,351,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Connections Health Holdings, LLC, Senior Secured, May 2030, Prime + 1.20%, Floor rate 7.95%, PIK Interest 1.00%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36],[41] |
2030-05
|
|
|
|
2030-05
|
|
2030-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36],[41] |
1.20%
|
|
|
|
1.20%
|
|
1.20%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36],[41] |
7.95%
|
|
|
|
7.95%
|
|
7.95%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36],[41] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36],[41] |
6.95%
|
|
|
|
6.95%
|
|
6.95%
|
|
|
|
|
|
| Principal amount |
[28],[36],[41] |
$ 7,521,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36],[41] |
7,391,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36],[41] |
$ 7,391,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Consensus Intermediate Holdco, LLC, Senior Secured, June 2030, Prime + 3.20%, Floor rate 9.95%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[41] |
2030-06
|
|
|
|
2030-06
|
|
2030-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[41] |
3.20%
|
|
|
|
3.20%
|
|
3.20%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[41] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
|
|
| Investment exit fee |
[30],[41] |
3.95%
|
|
|
|
3.95%
|
|
3.95%
|
|
|
|
|
|
| Principal amount |
[41] |
$ 14,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
13,883,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 13,883,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Curana Health Holdings, LLC, Senior Secured, October 2029, Prime + 1.45%, Floor rate 9.20%, 7.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[37] |
2029-10
|
|
|
|
2029-10
|
|
2029-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[37] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[37] |
9.20%
|
|
|
|
9.20%
|
|
9.20%
|
|
|
|
|
|
| Investment exit fee |
[27],[30],[37] |
7.45%
|
|
|
|
7.45%
|
|
7.45%
|
|
|
|
|
|
| Principal amount |
[27],[37] |
$ 60,750,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[37] |
61,810,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[37] |
$ 62,210,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Ennoble Care LLC, Senior Secured, February 2030, Prime + 2.60%, Floor rate 10.35%, 7.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[41] |
2030-02
|
|
|
|
2030-02
|
|
2030-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[41] |
2.60%
|
|
|
|
2.60%
|
|
2.60%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[41] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[41] |
7.95%
|
|
|
|
7.95%
|
|
7.95%
|
|
|
|
|
|
| Principal amount |
[35],[41] |
$ 60,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41] |
59,985,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41] |
$ 60,573,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Equality Health, LLC, Senior Secured, February 2028, Prime + 5.85%, Floor rate 9.50%, PIK Interest 1.95% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[36],[40] |
2028-02
|
|
|
|
2028-02
|
|
2028-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[36],[40] |
5.85%
|
|
|
|
5.85%
|
|
5.85%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[36],[40] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[31],[36],[40] |
1.95%
|
|
|
|
1.95%
|
|
1.95%
|
|
|
|
|
|
| Principal amount |
[31],[36],[40] |
$ 73,018,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[36],[40] |
72,684,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[36],[40] |
$ 71,989,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Main Street Rural, Inc., Senior Secured, July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[27],[35],[40] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[30],[35],[40] |
1.95%
|
|
|
|
1.95%
|
|
1.95%
|
|
|
|
|
|
| Investment, interest rate, floor |
[27],[30],[35],[40] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
|
|
| Investment exit fee |
[27],[30],[35],[40] |
6.85%
|
|
|
|
6.85%
|
|
6.85%
|
|
|
|
|
|
| Principal amount |
[27],[35],[40] |
$ 73,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[27],[35],[40] |
76,682,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[27],[35],[40] |
$ 76,682,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Marathon Health, LLC, Senior Secured, February 2029, Prime + 0.25%, Floor rate 8.25%, PIK Interest 2.25%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36],[42] |
2029-02
|
|
|
|
2029-02
|
|
2029-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36],[42] |
0.25%
|
|
|
|
0.25%
|
|
0.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36],[42] |
8.25%
|
|
|
|
8.25%
|
|
8.25%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36],[42] |
2.25%
|
|
|
|
2.25%
|
|
2.25%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36],[42] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Principal amount |
[28],[36],[42] |
$ 185,989,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36],[42] |
187,183,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36],[42] |
$ 186,736,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, NeueHealth, Inc., Senior Secured, June 2028, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36],[40] |
2028-06
|
|
|
|
2028-06
|
|
2028-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36],[40] |
3.65%
|
|
|
|
3.65%
|
|
3.65%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36],[40] |
12.15%
|
|
|
|
12.15%
|
|
12.15%
|
|
|
|
|
|
| Investment exit fee |
[30],[36],[40] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Principal amount |
[36],[40] |
$ 89,376,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36],[40] |
87,784,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36],[40] |
$ 87,191,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Octave Health Group, Inc., Senior Secured, October 2029, Prime + 2.70%, Floor rate 9.95%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[41] |
2029-10
|
|
|
|
2029-10
|
|
2029-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[41] |
2.70%
|
|
|
|
2.70%
|
|
2.70%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[41] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
|
|
| Investment exit fee |
[30],[41] |
5.35%
|
|
|
|
5.35%
|
|
5.35%
|
|
|
|
|
|
| Principal amount |
[41] |
$ 12,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
12,365,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 12,397,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Strive Health Holdings, LLC, Senior Secured, August 2029, Prime + 1.05%, Floor rate 9.55%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[40] |
2029-08
|
|
|
|
2029-08
|
|
2029-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[40] |
1.05%
|
|
|
|
1.05%
|
|
1.05%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[40] |
9.55%
|
|
|
|
9.55%
|
|
9.55%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[40] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
|
|
| Principal amount |
[35],[40] |
$ 36,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[40] |
36,234,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[40] |
$ 36,407,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, The Good Health Group, LLC, Senior Secured, June 2030, Prime + 3.45%, Floor rate 10.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
2030-06
|
|
|
|
2030-06
|
|
2030-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30] |
10.20%
|
|
|
|
10.20%
|
|
10.20%
|
|
|
|
|
|
| Investment exit fee |
[30] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
|
|
| Principal amount |
|
$ 18,125,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
18,008,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 18,008,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Tungsten Health Holdings, LLC, Senior Secured, December 2029, Prime + 1.00%, Floor rate 8.50%, Cap rate 9.00%, PIK Interest 1.25%, 8.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[36] |
2029-12
|
|
|
|
2029-12
|
|
2029-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[36] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[36] |
8.50%
|
|
|
|
8.50%
|
|
8.50%
|
|
|
|
|
|
| Investment, interest rate, cap |
[30],[36] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[36] |
1.25%
|
|
|
|
1.25%
|
|
1.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[36] |
8.35%
|
|
|
|
8.35%
|
|
8.35%
|
|
|
|
|
|
| Principal amount |
[36] |
$ 23,711,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[36] |
23,644,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[36] |
$ 23,879,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, WellBe Senior Medical, LLC, Senior Secured, May 2029, Prime + 2.00%, Floor rate 9.00%, PIK Interest 1.40%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[36] |
2029-05
|
|
|
|
2029-05
|
|
2029-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[36] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[36] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[35],[36] |
1.40%
|
|
|
|
1.40%
|
|
1.40%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[36] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
|
|
| Principal amount |
[35],[36] |
$ 33,722,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[36] |
34,277,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
$ 33,869,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, CollectiveHealth, Inc., Senior Secured, February 2030, Prime + 3.50%, Floor rate 10.25%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28] |
2030-02
|
|
|
|
2030-02
|
|
2030-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30] |
10.25%
|
|
|
|
10.25%
|
|
10.25%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30] |
3.95%
|
|
|
|
3.95%
|
|
3.95%
|
|
|
|
|
|
| Principal amount |
[6],[28] |
$ 10,125,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28] |
10,068,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28] |
$ 9,861,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Elation Health, Inc., Senior Secured, April 2029, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.30%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[31],[36],[37] |
2029-04
|
|
|
|
2029-04
|
|
2029-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30],[31],[36],[37] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30],[31],[36],[37] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[28],[30],[31],[36],[37] |
1.30%
|
|
|
|
1.30%
|
|
1.30%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30],[31],[36],[37] |
3.95%
|
|
|
|
3.95%
|
|
3.95%
|
|
|
|
|
|
| Principal amount |
[6],[28],[31],[36],[37] |
$ 21,257,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[31],[36],[37] |
21,062,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[31],[36],[37] |
$ 21,240,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Imagen Technologies, Inc., Senior Secured, November 2028, Prime + 1.55%, Floor rate 9.05%, PIK Interest 1.00%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[36],[41] |
2028-11
|
|
|
|
2028-11
|
|
2028-11
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[36],[41] |
1.55%
|
|
|
|
1.55%
|
|
1.55%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[36],[41] |
9.05%
|
|
|
|
9.05%
|
|
9.05%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[30],[36],[41] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[6],[30],[36],[41] |
3.95%
|
|
|
|
3.95%
|
|
3.95%
|
|
|
|
|
|
| Principal amount |
[6],[36],[41] |
$ 7,558,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[36],[41] |
7,529,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[36],[41] |
$ 7,607,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Modern Life, Inc., Senior Secured, February 2029, Prime + 2.75%, Floor rate 10.25%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[27] |
2029-02
|
|
|
|
2029-02
|
|
2029-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[27],[30] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[27],[30] |
10.25%
|
|
|
|
10.25%
|
|
10.25%
|
|
|
|
|
|
| Investment exit fee |
[6],[27],[30] |
5.00%
|
|
|
|
5.00%
|
|
5.00%
|
|
|
|
|
|
| Principal amount |
[6],[27] |
$ 18,429,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[27] |
18,711,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[27] |
$ 18,605,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Saama Technologies, LLC, Senior Secured, July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[36],[40] |
2027-07
|
|
|
|
2027-07
|
|
2027-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[30],[36],[40] |
0.70%
|
|
|
|
0.70%
|
|
0.70%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[30],[36],[40] |
8.95%
|
|
|
|
8.95%
|
|
8.95%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[6],[30],[36],[40] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment exit fee |
[6],[30],[36],[40] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
|
|
| Principal amount |
[6],[36],[40] |
$ 24,408,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[36],[40] |
24,850,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[36],[40] |
$ 24,850,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, SonderMind Inc., Senior Secured, July 2030, Prime + 2.75%, Floor rate 9.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[28],[31],[41] |
2030-07
|
|
|
|
2030-07
|
|
2030-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[28],[30],[31],[41] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[28],[30],[31],[41] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment exit fee |
[6],[28],[30],[31],[41] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
|
|
| Principal amount |
[6],[28],[31],[41] |
$ 29,490,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[28],[31],[41] |
29,256,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[28],[31],[41] |
$ 29,256,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Streamline Healthcare Solutions, Senior Secured, June 2030, 3-month SOFR + 7.30%, Floor rate 8.30% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[6],[27],[28],[29],[31],[35],[41] |
2030-06
|
|
|
|
2030-06
|
|
2030-06
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[27],[28],[29],[30],[31],[35],[41] |
7.30%
|
|
|
|
7.30%
|
|
7.30%
|
|
|
|
|
|
| Investment, interest rate, floor |
[6],[27],[28],[29],[30],[31],[35],[41] |
8.30%
|
|
|
|
8.30%
|
|
8.30%
|
|
|
|
|
|
| Principal amount |
[6],[27],[28],[29],[31],[35],[41] |
$ 22,260,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[27],[28],[29],[31],[35],[41] |
21,743,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[27],[28],[29],[31],[35],[41] |
21,914,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Manufacturing Technology, Total VulcanForms Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
36,240,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
36,543,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 38,752,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Manufacturing Technology, VulcanForms Inc., Senior Secured, February 2029, Prime + 0.00%, Floor rate 6.75%, 9.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[48] |
2029-02
|
|
|
|
2029-02
|
|
2029-02
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[48] |
0.00%
|
|
|
|
0.00%
|
|
0.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[48] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
|
|
| Investment exit fee |
[30],[48] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Principal amount |
[48] |
$ 16,240,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[48] |
16,230,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[48] |
$ 17,702,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Manufacturing Technology, VulcanForms Inc., Senior Secured, January 2028, Prime + 4.25%, Floor rate 11.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[37] |
2028-01
|
|
|
|
2028-01
|
|
2028-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[37] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[37] |
11.25%
|
|
|
|
11.25%
|
|
11.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[37] |
4.25%
|
|
|
|
4.25%
|
|
4.25%
|
|
|
|
|
|
| Principal amount |
[31],[37] |
$ 20,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[37] |
20,313,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[37] |
$ 21,050,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Cognito Therapeutics Group, Inc., Senior Secured, January 2030, Prime + 2.70%, Floor rate 9.95%, 5.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[41] |
2030-01
|
|
|
|
2030-01
|
|
2030-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[41] |
2.70%
|
|
|
|
2.70%
|
|
2.70%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[41] |
9.95%
|
|
|
|
9.95%
|
|
9.95%
|
|
|
|
|
|
| Investment exit fee |
[30],[41] |
5.75%
|
|
|
|
5.75%
|
|
5.75%
|
|
|
|
|
|
| Principal amount |
[41] |
$ 3,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
3,392,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 3,374,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Orchestra BioMed Holdings, Inc., Senior Secured, November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[41] |
2028-11
|
|
|
|
2028-11
|
|
2028-11
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[41] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[41] |
9.50%
|
|
|
|
9.50%
|
|
9.50%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[41] |
6.35%
|
|
|
|
6.35%
|
|
6.35%
|
|
|
|
|
|
| Principal amount |
[35],[41] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41] |
15,274,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41] |
$ 15,408,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Senseonics Holdings, Inc., Senior Secured, August 2029, Prime + 2.40%, Floor rate 9.90%, 13.40% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[31],[40] |
2029-08
|
|
|
|
2029-08
|
|
2029-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[31],[40] |
2.40%
|
|
|
|
2.40%
|
|
2.40%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[31],[40] |
9.90%
|
|
|
|
9.90%
|
|
9.90%
|
|
|
|
|
|
| Investment exit fee |
[30],[31],[40] |
13.40%
|
|
|
|
13.40%
|
|
13.40%
|
|
|
|
|
|
| Principal amount |
[31],[40] |
$ 30,625,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[31],[40] |
32,189,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[40] |
$ 32,696,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Senseonics Holdings, Inc., Senior Secured, August 2029, Prime + 2.40%, Floor rate 9.90%, 6.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[40] |
2029-08
|
|
|
|
2029-08
|
|
2029-08
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[38],[40] |
2.40%
|
|
|
|
2.40%
|
|
2.40%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[38],[40] |
9.90%
|
|
|
|
9.90%
|
|
9.90%
|
|
|
|
|
|
| Investment exit fee |
[30],[38],[40] |
6.45%
|
|
|
|
6.45%
|
|
6.45%
|
|
|
|
|
|
| Principal amount |
[38],[40] |
$ 15,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[40] |
15,382,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[40] |
$ 15,592,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Sight Sciences, Inc., Senior Secured, July 2028, Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[40],[41] |
2028-07
|
|
|
|
2028-07
|
|
2028-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[40],[41] |
2.35%
|
|
|
|
2.35%
|
|
2.35%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[40],[41] |
10.35%
|
|
|
|
10.35%
|
|
10.35%
|
|
|
|
|
|
| Investment exit fee |
[30],[40],[41] |
5.95%
|
|
|
|
5.95%
|
|
5.95%
|
|
|
|
|
|
| Principal amount |
[40],[41] |
$ 28,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[40],[41] |
28,837,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[40],[41] |
29,051,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Total Senseonics Holdings, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
46,125,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
47,571,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 48,288,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, restor3d, Inc., Senior Secured, October 2031, Prime + 2.65%, Floor rate 9.15%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[41] |
2031-10
|
|
|
|
2031-10
|
|
2031-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[41] |
2.65%
|
|
|
|
2.65%
|
|
2.65%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[41] |
9.15%
|
|
|
|
9.15%
|
|
9.15%
|
|
|
|
|
|
| Investment exit fee |
[30],[41] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
|
|
| Principal amount |
[41] |
$ 18,750,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
18,541,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 18,541,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Space Technologies, LeoLabs, Inc., Senior Secured, April 2030, Prime + 2.90%, Floor rate 9.65%, PIK Interest 0.95%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36] |
2030-04
|
|
|
|
2030-04
|
|
2030-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36] |
2.90%
|
|
|
|
2.90%
|
|
2.90%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36] |
9.65%
|
|
|
|
9.65%
|
|
9.65%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36] |
0.95%
|
|
|
|
0.95%
|
|
0.95%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Principal amount |
[28],[36] |
$ 6,625,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36] |
6,559,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36] |
$ 6,559,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Space Technologies, Loft Orbital Solutions Inc., Senior Secured, December 2029, Prime + 1.75%, Floor rate 8.75%, PIK Interest 1.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36],[37] |
2029-12
|
|
|
|
2029-12
|
|
2029-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36],[37] |
1.75%
|
|
|
|
1.75%
|
|
1.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36],[37] |
8.75%
|
|
|
|
8.75%
|
|
8.75%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36],[37] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36],[37] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
|
|
| Principal amount |
[28],[36],[37] |
$ 9,657,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36],[37] |
9,493,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36],[37] |
$ 9,609,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Space Technologies, Stoke Space Technologies, Inc., Senior Secured, May 2029, Prime + 1.00%, Floor rate 7.50%, PIK Interest 2.00%, 5.25% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[35],[36],[41] |
2029-05
|
|
|
|
2029-05
|
|
2029-05
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[35],[36],[41] |
1.00%
|
|
|
|
1.00%
|
|
1.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[35],[36],[41] |
7.50%
|
|
|
|
7.50%
|
|
7.50%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[30],[35],[36],[41] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment exit fee |
[30],[35],[36],[41] |
5.25%
|
|
|
|
5.25%
|
|
5.25%
|
|
|
|
|
|
| Principal amount |
[35],[36],[41] |
$ 28,720,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[36],[41] |
28,514,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[41] |
$ 29,095,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Sustainable and Renewable Technology, Tidal Vision Products, Inc., Senior Secured, October 2028, Prime + 2.45%, Floor rate 9.70%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[41] |
2028-10
|
|
|
|
2028-10
|
|
2028-10
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[41] |
2.45%
|
|
|
|
2.45%
|
|
2.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[41] |
9.70%
|
|
|
|
9.70%
|
|
9.70%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[41] |
3.45%
|
|
|
|
3.45%
|
|
3.45%
|
|
|
|
|
|
| Principal amount |
[28],[41] |
$ 7,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[41] |
7,240,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[41] |
$ 7,332,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, ControlUp, Inc., Senior Secured, January 2031, Prime + 0.25%, Floor rate 6.75%, PIK Interest 2.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[36] |
2031-01
|
|
|
|
2031-01
|
|
2031-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[36] |
0.25%
|
|
|
|
0.25%
|
|
0.25%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[36] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[36] |
2.00%
|
|
|
|
2.00%
|
|
2.00%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[36] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Principal amount |
[28],[36] |
$ 10,135,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[36] |
10,069,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[36] |
$ 10,129,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, CoreView USA, Inc., Senior Secured, January 2029, Prime + 2.50%, Floor rate 9.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
|
2029-01
|
|
|
|
2029-01
|
|
2029-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30] |
2.50%
|
|
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30] |
9.00%
|
|
|
|
9.00%
|
|
9.00%
|
|
|
|
|
|
| Investment exit fee |
[30] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
|
|
| Principal amount |
|
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
9,897,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 10,112,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, CoreView USA, Inc., Senior Secured, January 2029, Prime + 2.75%, Floor rate 9.25%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[41] |
2029-01
|
|
|
|
2029-01
|
|
2029-01
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[41] |
2.75%
|
|
|
|
2.75%
|
|
2.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[41] |
9.25%
|
|
|
|
9.25%
|
|
9.25%
|
|
|
|
|
|
| Investment exit fee |
[30],[41] |
4.95%
|
|
|
|
4.95%
|
|
4.95%
|
|
|
|
|
|
| Principal amount |
[41] |
$ 25,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
25,307,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 25,546,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, Neo4j, Inc., Senior Secured, April 2030, Prime + 2.60%, Floor rate 9.10%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28] |
2030-04
|
|
|
|
2030-04
|
|
2030-04
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30] |
2.60%
|
|
|
|
2.60%
|
|
2.60%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30] |
9.10%
|
|
|
|
9.10%
|
|
9.10%
|
|
|
|
|
|
| Investment exit fee |
[28],[30] |
3.50%
|
|
|
|
3.50%
|
|
3.50%
|
|
|
|
|
|
| Principal amount |
[28] |
$ 9,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28] |
8,910,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28] |
$ 8,990,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, New Relic, Inc., Senior Secured, November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28] |
2030-11
|
|
|
|
2030-11
|
|
2030-11
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30] |
6.75%
|
|
|
|
6.75%
|
|
6.75%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30] |
7.75%
|
|
|
|
7.75%
|
|
7.75%
|
|
|
|
|
|
| Principal amount |
[28] |
$ 21,890,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28] |
21,517,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28] |
$ 21,633,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, PayIt, LLC, Senior Secured, December 2028, Prime + 1.45%, Floor rate 7.95%, PIK Interest 1.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[35],[36],[37],[41] |
2028-12
|
|
|
|
2028-12
|
|
2028-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[35],[36],[37],[41] |
1.45%
|
|
|
|
1.45%
|
|
1.45%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[35],[36],[37],[41] |
7.95%
|
|
|
|
7.95%
|
|
7.95%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[35],[36],[37],[41] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[35],[36],[37],[41] |
5.00%
|
|
|
|
5.00%
|
|
5.00%
|
|
|
|
|
|
| Principal amount |
[28],[35],[36],[37],[41] |
$ 26,569,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[35],[36],[37],[41] |
26,783,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35],[36],[37],[41] |
$ 26,700,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, PayIt, LLC, Senior Secured, December 2028, Prime + 3.00%, Floor rate 10.25%, PIK Interest 1.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[28],[35],[36],[37] |
2028-12
|
|
|
|
2028-12
|
|
2028-12
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[28],[30],[35],[36],[37] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[28],[30],[35],[36],[37] |
10.25%
|
|
|
|
10.25%
|
|
10.25%
|
|
|
|
|
|
| Investment, interest rate, paid in kind |
[28],[30],[35],[36],[37] |
1.50%
|
|
|
|
1.50%
|
|
1.50%
|
|
|
|
|
|
| Investment exit fee |
[28],[30],[35],[36],[37] |
5.00%
|
|
|
|
5.00%
|
|
5.00%
|
|
|
|
|
|
| Principal amount |
[28],[35],[36],[37] |
$ 2,813,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[35],[36],[37] |
2,796,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35],[36],[37] |
$ 2,817,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, Scylla DB Ltd., Senior Secured, July 2029, Prime + 3.00%, Floor rate 10.50%, 0.75% Exit Fee |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturity Date |
[38],[39] |
2029-07
|
|
|
|
2029-07
|
|
2029-07
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[30],[38],[39] |
3.00%
|
|
|
|
3.00%
|
|
3.00%
|
|
|
|
|
|
| Investment, interest rate, floor |
[30],[38],[39] |
10.50%
|
|
|
|
10.50%
|
|
10.50%
|
|
|
|
|
|
| Investment exit fee |
[30],[38],[39] |
0.75%
|
|
|
|
0.75%
|
|
0.75%
|
|
|
|
|
|
| Principal amount |
[38],[39] |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
14,856,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
14,730,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, Total CoreView USA, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
35,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
35,204,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
35,658,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, Total PayIt, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Principal amount |
|
29,382,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
29,579,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
29,517,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Black Crow AI, Inc. affiliates and Equity and Acquisition Date 3/24/2021 and Preferred Note |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[49] |
|
|
2,846,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[49] |
|
|
$ 2,846,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[49],[50] |
|
|
Mar. 24, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[49] |
|
|
3
|
|
|
|
|
|
3
|
|
3
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and CapLinked, Inc. and Equity and Acquisition Date 10/26/2012 and Preferred Series A-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 51,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Oct. 26, 2012
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
53,614
|
|
|
|
|
|
53,614
|
|
53,614
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and HighRoads, Inc. and Equity and Acquisition Date 1/18/2013 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 307,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Jan. 18, 2013
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
190
|
|
|
|
|
|
190
|
|
190
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Khoros, LLC and Equity and Acquisition Date 5/23/2025 and Earnout Interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[51] |
|
|
$ 5,242,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[51] |
|
|
$ 3,651,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50],[51] |
|
|
May 23, 2025
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Khoros, LLC., Equity, Acquisition Date 5/23/2025, Series Earnout Interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
|
|
|
$ 5,200,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
3,700,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Leapwork ApS and Equity and Acquisition Date 8/25/2023 and Preferred Series B2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
$ 135,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[20],[50] |
|
|
Aug. 25, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[20] |
|
|
183,073
|
|
|
|
|
|
183,073
|
|
183,073
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Nextdoor.com, Inc. and Equity and Acquisition Date 8/1/2018 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[50] |
|
|
$ 4,854,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[50] |
|
|
$ 2,140,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Aug. 01, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[50] |
|
|
1,019,255
|
|
|
|
|
|
1,019,255
|
|
1,019,255
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and SirionLabs Pte. Ltd. and Equity and Acquisition Date 6/30/2024 and Preferred Series F1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
$ 1,792,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
$ 1,827,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[20],[50] |
|
|
Jun. 30, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[20] |
|
|
152,250
|
|
|
|
|
|
152,250
|
|
152,250
|
|
| Investment, Identifier [Axis]: Equity Investments Biotechnology Tools and Alamar Biosciences, Inc., Equity, Acquisition Date 2/21/2024, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 841,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Feb. 21, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
503,778
|
|
|
|
|
|
503,778
|
|
503,778
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,101,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 275,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jul. 16, 2013
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
130,191
|
|
|
|
|
|
130,191
|
|
130,191
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 128,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 42,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Apr. 30, 2010
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
42,989
|
|
|
|
|
|
42,989
|
|
42,989
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 433,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 14,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Apr. 30, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
12,260
|
|
|
|
|
|
12,260
|
|
12,260
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 13,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 183,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Apr. 30, 2010
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
172,328
|
|
|
|
|
|
172,328
|
|
172,328
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Total Fabletics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,229,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 317,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
173,180
|
|
|
|
|
|
173,180
|
|
173,180
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
$ 1,151,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 1,036,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Dec. 15, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20] |
|
|
216,073
|
|
|
|
|
|
216,073
|
|
216,073
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Jobandtalent USA, Inc. and Equity and Acquisition Date 2/11/2025 and Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
$ 563,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 225,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Feb. 11, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20] |
|
|
47,754
|
|
|
|
|
|
47,754
|
|
47,754
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 5,263,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 1,951,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Dec. 26, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
100,738
|
|
|
|
|
|
100,738
|
|
100,738
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 104,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Sep. 17, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
100,000
|
|
|
|
|
|
100,000
|
|
100,000
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,663,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 427,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Oct. 25, 2016
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
286,080
|
|
|
|
|
|
286,080
|
|
286,080
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 39,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jul. 31, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
3,095
|
|
|
|
|
|
3,095
|
|
3,095
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jan. 24, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
7,063
|
|
|
|
|
|
7,063
|
|
7,063
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24] |
|
|
$ 13,263,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24] |
|
|
$ 1,250,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[24],[50] |
|
|
Dec. 29, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[24] |
|
|
3,235,298
|
|
|
|
|
|
3,235,298
|
|
3,235,298
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24] |
|
|
$ 900,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[24],[50] |
|
|
May 23, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[24] |
|
|
414,994,863
|
|
|
|
|
|
414,994,863
|
|
414,994,863
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[24],[50] |
|
|
Jun. 06, 2016
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[24] |
|
|
1,000,000
|
|
|
|
|
|
1,000,000
|
|
1,000,000
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 2,295,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 589,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
394,790
|
|
|
|
|
|
394,790
|
|
394,790
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 14,163,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 1,250,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
419,230,161
|
|
|
|
|
|
419,230,161
|
|
419,230,161
|
|
| Investment, Identifier [Axis]: Equity Investments Cybersecurity and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 4,190,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Oct. 22, 2015
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
458,841
|
|
|
|
|
|
458,841
|
|
458,841
|
|
| Investment, Identifier [Axis]: Equity Investments Cybersecurity and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 873,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Aug. 24, 2017
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
93,620
|
|
|
|
|
|
93,620
|
|
93,620
|
|
| Investment, Identifier [Axis]: Equity Investments Cybersecurity, Total Druva Holdings, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 1,300,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 5,063,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
552,461
|
|
|
|
|
|
552,461
|
|
552,461
|
|
| Investment, Identifier [Axis]: Equity Investments Defense Technologies and Shield AI, Inc., Equity and Acquisition Date 2/7/2025 and Series Preferred Series F1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[22] |
|
|
$ 2,250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[22] |
|
|
$ 1,284,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[22],[50] |
|
|
Feb. 07, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[22] |
|
|
28,900
|
|
|
|
|
|
28,900
|
|
28,900
|
|
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition LLC, Equity, Acquisition Date 3/1/2018, Series Member Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24],[25] |
|
|
$ 32,456,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[25] |
|
|
$ 23,963,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[24],[25],[50] |
|
|
Mar. 01, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[24],[25] |
|
|
1
|
|
|
|
|
|
1
|
|
1
|
|
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24],[52] |
|
|
$ 12,035,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[52] |
|
|
$ 43,274,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[24],[50],[52] |
|
|
Mar. 26, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[24],[52] |
|
|
1
|
|
|
|
|
|
1
|
|
1
|
|
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 403,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 404,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Sep. 30, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
210,282
|
|
|
|
|
|
210,282
|
|
210,282
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 28, 2014
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
680
|
|
|
|
|
|
680
|
|
680
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Dec. 08, 2015
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
165,000
|
|
|
|
|
|
165,000
|
|
165,000
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 309,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Apr. 06, 2015
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
2,498
|
|
|
|
|
|
2,498
|
|
2,498
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 1,329,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 10,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Dec. 10, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
8,836
|
|
|
|
|
|
8,836
|
|
8,836
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Arcus Biosciences, Inc., Equity, Acquisition Date 2/19/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[50] |
|
|
$ 2,250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[50] |
|
|
$ 4,874,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[50] |
|
|
Feb. 19, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[50] |
|
|
204,545
|
|
|
|
|
|
204,545
|
|
204,545
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Aug. 19, 2014
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
42
|
|
|
|
|
|
42
|
|
42
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20],[50] |
|
|
$ 1,871,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20],[50] |
|
|
$ 695,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Oct. 05, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20],[50] |
|
|
98,100
|
|
|
|
|
|
98,100
|
|
98,100
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jan. 08, 2015
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
1,129
|
|
|
|
|
|
1,129
|
|
1,129
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[50] |
|
|
$ 550,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[50] |
|
|
$ 308,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[50] |
|
|
Jul. 22, 2015
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[50] |
|
|
20,000
|
|
|
|
|
|
20,000
|
|
20,000
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dyne Therapeutics, Inc., Equity, Acquisition Date 7/2/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[50] |
|
|
$ 1,400,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[50] |
|
|
$ 3,319,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[50] |
|
|
Jul. 02, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[50] |
|
|
169,697
|
|
|
|
|
|
169,697
|
|
169,697
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 474,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jul. 25, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
364,963
|
|
|
|
|
|
364,963
|
|
364,963
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 4,250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 222,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
May 07, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
3,466,840
|
|
|
|
|
|
3,466,840
|
|
3,466,840
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[50] |
|
|
$ 550,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[50] |
|
|
$ 497,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[50] |
|
|
Jun. 16, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[50] |
|
|
47,826
|
|
|
|
|
|
47,826
|
|
47,826
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and MoonLake Immunotherapeutics, Equity, Acquisition Date 11/6/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20],[50] |
|
|
$ 1,002,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20],[50] |
|
|
$ 1,259,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Nov. 06, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20],[50] |
|
|
95,500
|
|
|
|
|
|
95,500
|
|
95,500
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 1,278,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Dec. 15, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20] |
|
|
983
|
|
|
|
|
|
983
|
|
983
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[22],[50] |
|
|
$ 1,730,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[22],[50] |
|
|
$ 2,443,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[22],[50] |
|
|
Jun. 09, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[22],[50] |
|
|
147,233
|
|
|
|
|
|
147,233
|
|
147,233
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rafael Holdings, Inc. (p.k.a. Cyclo Therapeutics, Inc.), Equity, Acquisition Date 4/6/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[50] |
|
|
$ 42,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[50] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[50] |
|
|
Apr. 06, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[50] |
|
|
48
|
|
|
|
|
|
48
|
|
48
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 3,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Aug. 22, 2007
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
944
|
|
|
|
|
|
944
|
|
944
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 203,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 67,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Aug. 11, 2015
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
11,119
|
|
|
|
|
|
11,119
|
|
11,119
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 2,222,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
680,410
|
|
|
|
|
|
680,410
|
|
680,410
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Verge Analytics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,603,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 2,485,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
208,588
|
|
|
|
|
|
208,588
|
|
208,588
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 827,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Oct. 31, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
170,102
|
|
|
|
|
|
170,102
|
|
170,102
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 3,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 1,395,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Dec. 11, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
510,308
|
|
|
|
|
|
510,308
|
|
510,308
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 7/2/2025, Series SAFE |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[53] |
|
|
$ 103,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[53] |
|
|
$ 103,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50],[53] |
|
|
Jul. 02, 2025
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 2,382,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Sep. 06, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
208,588
|
|
|
|
|
|
208,588
|
|
208,588
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[50] |
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[50] |
|
|
$ 1,005,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[50] |
|
|
Nov. 06, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[50] |
|
|
32,310
|
|
|
|
|
|
32,310
|
|
32,310
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 2,945,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 209,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Nov. 26, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
52,202
|
|
|
|
|
|
52,202
|
|
52,202
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20],[50] |
|
|
$ 332,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20],[50] |
|
|
$ 411,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Jan. 31, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20],[50] |
|
|
17,175
|
|
|
|
|
|
17,175
|
|
17,175
|
|
| Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 650,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 348,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Nov. 17, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
15,116
|
|
|
|
|
|
15,116
|
|
15,116
|
|
| Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 624,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 08, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
248,900
|
|
|
|
|
|
248,900
|
|
248,900
|
|
| Investment, Identifier [Axis]: Equity Investments Financial Technologies and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[50] |
|
|
$ 577,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[50] |
|
|
$ 256,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[50] |
|
|
Jun. 28, 2013
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7],[50] |
|
|
48,365
|
|
|
|
|
|
48,365
|
|
48,365
|
|
| Investment, Identifier [Axis]: Equity Investments Financial Technologies and Worldremit Group Limited, Equity, Acquisition Date 6/24/2024, Series Preferred Series X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[9],[20] |
|
|
$ 922,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[9],[20] |
|
|
$ 922,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[9],[20],[50] |
|
|
Jun. 24, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7],[9],[20] |
|
|
9,737
|
|
|
|
|
|
9,737
|
|
9,737
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,910,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 30, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
390,809
|
|
|
|
|
|
390,809
|
|
390,809
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Curana Health Holdings, LLC, Equity, Acquisition Date 5/13/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 2,500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 3,664,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
May 13, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
1,114,380
|
|
|
|
|
|
1,114,380
|
|
1,114,380
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Main Street Rural, Inc., Equity, Acquisition Date 10/28/2024, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 874,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 1,166,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Oct. 28, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
496
|
|
|
|
|
|
496
|
|
496
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and NH Holdings 2025 SPV, L.P., Equity, Acquisition Date 6/21/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,848,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 2,439,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 21, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
339,806
|
|
|
|
|
|
339,806
|
|
339,806
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Strive Health Holdings, LLC, Equity, Acquisition Date 6/27/2025, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 599,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 814,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 27, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
82,043
|
|
|
|
|
|
82,043
|
|
82,043
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Equity, Acquisition Date 6/10/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,600,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 1,762,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 10, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
181,163
|
|
|
|
|
|
181,163
|
|
181,163
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Technology & Digital Health and Click Therapeutics, Inc., Equity, Acquisition Date 5/20/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[8] |
|
|
$ 1,662,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[8] |
|
|
$ 2,074,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[8],[50] |
|
|
May 20, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7],[8] |
|
|
560,000
|
|
|
|
|
|
560,000
|
|
560,000
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Technology & Digital Health and DNAnexus, Inc. and Equity and Acquisition Date 3/21/2014 and Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 97,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 8,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Mar. 21, 2014
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
51,948
|
|
|
|
|
|
51,948
|
|
51,948
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Technology & Digital Health and Verana Health, Inc. and Equity and Acquisition Date 7/8/2021 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Jul. 08, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
23,814
|
|
|
|
|
|
23,814
|
|
23,814
|
|
| Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 3,825,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 3,200,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Dec. 30, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
41,021
|
|
|
|
|
|
41,021
|
|
41,021
|
|
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[24],[50] |
|
|
Oct. 15, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[24] |
|
|
180,000
|
|
|
|
|
|
180,000
|
|
180,000
|
|
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[24] |
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[24] |
|
|
$ 218,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[24],[50] |
|
|
Oct. 15, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[24] |
|
|
5,000,000
|
|
|
|
|
|
5,000,000
|
|
5,000,000
|
|
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Equity, Acquisition Date 8/4/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 1,509,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Aug. 04, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
363,636
|
|
|
|
|
|
363,636
|
|
363,636
|
|
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Total Coronado Aesthetics, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 218,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
5,180,000
|
|
|
|
|
|
5,180,000
|
|
5,180,000
|
|
| Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 6/26/2015, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 7,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 102,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 26, 2015
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
497,767
|
|
|
|
|
|
497,767
|
|
497,767
|
|
| Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 160,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 7,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jul. 01, 2011
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
277,995
|
|
|
|
|
|
277,995
|
|
277,995
|
|
| Investment, Identifier [Axis]: Equity Investments Semiconductors and Total Achronix Semiconductor Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 167,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 109,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
775,762
|
|
|
|
|
|
775,762
|
|
775,762
|
|
| Investment, Identifier [Axis]: Equity Investments Space Technologies and Stoke Space Technologies, Inc., Equity, Acquisition Date 9/23/2025, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,406,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 1,256,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Sep. 23, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
43,867
|
|
|
|
|
|
43,867
|
|
43,867
|
|
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 106,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
May 10, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
188,611
|
|
|
|
|
|
188,611
|
|
188,611
|
|
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 01, 2015
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
1,035
|
|
|
|
|
|
1,035
|
|
1,035
|
|
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 4,500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 397,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 28, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
593,080
|
|
|
|
|
|
593,080
|
|
593,080
|
|
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and SUNation Energy, Inc., Equity, Acquisition Date 12/10/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 3,153,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Dec. 10, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
3
|
|
|
|
|
|
3
|
|
3
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Armis, Inc., Equity, Acquisition Date 10/18/2024, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[22] |
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[22] |
|
|
$ 3,860,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[22],[50] |
|
|
Oct. 18, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[22] |
|
|
294,213
|
|
|
|
|
|
294,213
|
|
294,213
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
$ 919,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[20],[50] |
|
|
Nov. 20, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[20] |
|
|
108,500
|
|
|
|
|
|
108,500
|
|
108,500
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
$ 138,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
$ 330,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[20],[50] |
|
|
Dec. 22, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[20] |
|
|
41,000
|
|
|
|
|
|
41,000
|
|
41,000
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 4,284,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Nov. 29, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
20,000
|
|
|
|
|
|
20,000
|
|
20,000
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 265,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 19,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Dec. 04, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
38,461
|
|
|
|
|
|
38,461
|
|
38,461
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Total Contentful Global, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 638,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 1,249,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
149,500
|
|
|
|
|
|
149,500
|
|
149,500
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Annex Cloud, Equity, 7/10/2026, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[33] |
7,359,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[33] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[33],[54] |
Jul. 10, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[33] |
175,211
|
|
|
|
175,211
|
|
175,211
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Black Crow AI, Inc. affiliates, Equity, 3/24/2021, Preferred Note |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[55] |
$ 3,058,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[55] |
$ 3,058,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54],[55] |
Mar. 24, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[55] |
3
|
|
|
|
3
|
|
3
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, CapLinked, Inc., Equity, 10/26/2012, Preferred Series A-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 51,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Oct. 26, 2012
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
53,614
|
|
|
|
53,614
|
|
53,614
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Khoros, LLC, Equity, 5/23/2025, Earnout Interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[56] |
$ 5,242,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[56] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54],[56] |
May 23, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Khoros, LLC., Equity, 5/23/2025, Earnout Interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
|
$ 5,200,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Leapwork ApS, Equity, 8/25/2023, Preferred Series B2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 90,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Aug. 25, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
183,073
|
|
|
|
183,073
|
|
183,073
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Nextdoor.com, Inc., Equity, 8/1/2018, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 4,854,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 2,477,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 01, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
1,019,255
|
|
|
|
1,019,255
|
|
1,019,255
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, micro1 Inc., Equity, 6/26/2026, SAFE |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[57] |
$ 1,813,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[57] |
$ 1,813,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54],[57] |
Jun. 26, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Biotechnology Tools, Alamar Biosciences, Inc., Equity, 2/21/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 7,098,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Feb. 21, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
208,344
|
|
|
|
208,344
|
|
208,344
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Fabletics, Inc., Equity, 4/30/2010, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 128,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 11,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Apr. 30, 2010
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
42,989
|
|
|
|
42,989
|
|
42,989
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Fabletics, Inc., Equity, 7/16/2013, Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,101,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 115,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jul. 16, 2013
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
130,191
|
|
|
|
130,191
|
|
130,191
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Grove Collaborative, Inc., Equity, 4/30/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 433,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 13,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Apr. 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
12,260
|
|
|
|
12,260
|
|
12,260
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Savage X Holding, LLC, Equity, 4/30/2010, Class A Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 13,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 176,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Apr. 30, 2010
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
172,328
|
|
|
|
172,328
|
|
172,328
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Total Fabletics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,229,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 126,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
173,180
|
|
|
|
173,180
|
|
173,180
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Carwow LTD, Equity, 12/15/2021, Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 1,151,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 828,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Dec. 15, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
216,073
|
|
|
|
216,073
|
|
216,073
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Jobandtalent USA, Inc., Equity, 2/11/2025, Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 563,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Feb. 11, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
47,754
|
|
|
|
47,754
|
|
47,754
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Lyft, Inc., Equity, 12/26/2018, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 5,263,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 1,512,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 26, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
100,738
|
|
|
|
100,738
|
|
100,738
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Nerdy Inc., Equity, 9/17/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 54,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 17, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
6,666
|
|
|
|
6,666
|
|
6,666
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, OfferUp, Inc., Equity, 10/25/2016, Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,663,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 302,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Oct. 25, 2016
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
286,080
|
|
|
|
286,080
|
|
286,080
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, OfferUp, Inc., Equity, 10/25/2016, Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 632,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 115,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Oct. 25, 2016
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
108,710
|
|
|
|
108,710
|
|
108,710
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Reischling Press, Inc., Equity, 7/31/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 39,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jul. 31, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
3,095
|
|
|
|
3,095
|
|
3,095
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Rhino Labs, Inc., Equity, 1/24/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jan. 24, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
7,063
|
|
|
|
7,063
|
|
7,063
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Tectura Corporation, Equity, 12/29/2023, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44] |
$ 13,263,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44] |
$ 1,522,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[44],[54] |
Dec. 29, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[44] |
3,235,298
|
|
|
|
3,235,298
|
|
3,235,298
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Tectura Corporation, Equity, 5/23/2018, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44] |
$ 900,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[44],[54] |
May 23, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[44] |
414,994,863
|
|
|
|
414,994,863
|
|
414,994,863
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Tectura Corporation, Equity, 6/6/2016, Preferred Series BB |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[44],[54] |
Jun. 06, 2016
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[44] |
1,000,000
|
|
|
|
1,000,000
|
|
1,000,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Total OfferUp, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 2,295,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 417,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
394,790
|
|
|
|
394,790
|
|
394,790
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Total Tectura Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 14,163,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,522,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
419,230,161
|
|
|
|
419,230,161
|
|
419,230,161
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Cybersecurity, Druva Holdings, Inc., Equity, 10/22/2015, Preferred Series 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 4,077,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Oct. 22, 2015
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
458,841
|
|
|
|
458,841
|
|
458,841
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Cybersecurity, Druva Holdings, Inc., Equity, 8/24/2017, Preferred Series 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 300,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 850,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Aug. 24, 2017
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
93,620
|
|
|
|
93,620
|
|
93,620
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Cybersecurity, Total Druva Holdings, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 1,300,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 4,927,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
552,461
|
|
|
|
552,461
|
|
552,461
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Defense Technologies, Saronic Technologies, Inc., Equity, 3/27/2026, Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[42] |
$ 4,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
$ 4,662,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[42],[54] |
Mar. 27, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[42] |
154,854
|
|
|
|
154,854
|
|
154,854
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Defense Technologies, Shield AI, Inc., Equity, 2/7/2025, Preferred Series F1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[42] |
$ 2,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
$ 2,825,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[42],[54] |
Feb. 07, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[42] |
28,900
|
|
|
|
28,900
|
|
28,900
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Diversified Financial Services, Gibraltar Acquisition LLC, Equity, 3/1/2018, Member Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44],[45] |
$ 31,456,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44],[45] |
$ 23,779,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[44],[45],[54] |
Mar. 01, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[44],[45] |
1
|
|
|
|
1
|
|
1
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Diversified Financial Services, Hercules Adviser LLC, Equity, 3/26/2021, Member Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44],[46] |
$ 14,183,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44],[46] |
$ 41,942,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[44],[46],[54] |
Mar. 26, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[44],[46] |
1
|
|
|
|
1
|
|
1
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Delivery, Aytu BioScience, Inc., Equity, 3/28/2014, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 2,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 28, 2014
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
680
|
|
|
|
680
|
|
680
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Delivery, BioQ Pharma Incorporated, Equity, 12/8/2015, Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 08, 2015
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
165,000
|
|
|
|
165,000
|
|
165,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Delivery, PDS Biotechnology Corporation, Equity, 4/6/2015, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 309,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 2,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Apr. 06, 2015
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
2,498
|
|
|
|
2,498
|
|
2,498
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Delivery, Talphera, Inc., Equity, 12/10/2018, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 1,329,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 10,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 10, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
8,836
|
|
|
|
8,836
|
|
8,836
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Arcus Biosciences, Inc., Equity, 2/19/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[54] |
$ 2,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[54] |
$ 5,283,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[54] |
Feb. 19, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[54] |
204,545
|
|
|
|
204,545
|
|
204,545
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Avalo Therapeutics, Inc., Equity, 8/19/2014, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 19, 2014
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
42
|
|
|
|
42
|
|
42
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Bicycle Therapeutics PLC, Equity, 10/5/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39],[54] |
$ 1,871,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39],[54] |
$ 361,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Oct. 05, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39],[54] |
98,100
|
|
|
|
98,100
|
|
98,100
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Daré Bioscience, Inc., Equity, 1/8/2015, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jan. 08, 2015
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
1,129
|
|
|
|
1,129
|
|
1,129
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Dyne Therapeutics, Inc., Equity, 7/2/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[42],[54] |
$ 1,400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[42],[54] |
$ 2,734,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[42],[54] |
Jul. 02, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[42],[54] |
169,697
|
|
|
|
169,697
|
|
169,697
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Heron Therapeutics, Inc., Equity, 7/25/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 114,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jul. 25, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
364,963
|
|
|
|
364,963
|
|
364,963
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Hibercell, Inc., Equity, 5/7/2021, Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 4,250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 176,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
May 07, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
3,466,840
|
|
|
|
3,466,840
|
|
3,466,840
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Kura Oncology, Inc., Equity, 6/16/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[54] |
$ 550,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[54] |
$ 512,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[54] |
Jun. 16, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[54] |
47,826
|
|
|
|
47,826
|
|
47,826
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Maze Therapeutics, Inc., Equity, 4/23/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[54] |
$ 2,056,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[54] |
$ 2,378,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[54] |
Apr. 23, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[54] |
87,500
|
|
|
|
87,500
|
|
87,500
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, MoonLake Immunotherapeutics, Equity, 11/6/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39],[54] |
$ 1,002,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39],[54] |
$ 1,117,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Nov. 06, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39],[54] |
95,500
|
|
|
|
95,500
|
|
95,500
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, NorthSea Therapeutics, Equity, 12/15/2021, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 563,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Dec. 15, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
983
|
|
|
|
983
|
|
983
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Phathom Pharmaceuticals, Inc., Equity, 6/9/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[42],[54] |
$ 1,730,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[42],[54] |
$ 1,075,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[42],[54] |
Jun. 09, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[42],[54] |
147,233
|
|
|
|
147,233
|
|
147,233
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Rafael Holdings, Inc., Equity, 4/6/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[54] |
$ 42,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[54] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[54] |
Apr. 06, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[54] |
48
|
|
|
|
48
|
|
48
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Rocket Pharmaceuticals, Inc., Equity, 8/22/2007, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 3,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 22, 2007
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
944
|
|
|
|
944
|
|
944
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Savara, Inc., Equity, 8/11/2015, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 203,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 57,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 11, 2015
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
11,119
|
|
|
|
11,119
|
|
11,119
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Total Valo Health, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,660,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
680,410
|
|
|
|
680,410
|
|
680,410
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Total Verge Analytics, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,603,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 103,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
208,588
|
|
|
|
208,588
|
|
208,588
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Valo Health, LLC, Equity, 10/31/2022, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 920,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Oct. 31, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
170,102
|
|
|
|
170,102
|
|
170,102
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Valo Health, LLC, Equity, 12/11/2020, Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 3,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,740,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 11, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
510,308
|
|
|
|
510,308
|
|
510,308
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Verge Analytics, Inc., Equity, 7/2/2025, SAFE |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[57] |
$ 103,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[57] |
$ 103,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54],[57] |
Jul. 02, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Verge Analytics, Inc., Equity, 9/6/2023, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 06, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
208,588
|
|
|
|
208,588
|
|
208,588
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Viridian Therapeutics, Inc., Equity, 11/6/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[54] |
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[54] |
$ 665,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[54] |
Nov. 06, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[54] |
32,310
|
|
|
|
32,310
|
|
32,310
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, X4 Pharmaceuticals, Inc., Equity, 11/26/2019, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 2,945,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 151,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Nov. 26, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
52,202
|
|
|
|
52,202
|
|
52,202
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, uniQure B.V., Equity, 1/31/2019, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39],[54] |
$ 1,107,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39],[54] |
$ 827,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Jan. 31, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39],[54] |
34,208
|
|
|
|
34,208
|
|
34,208
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Electronics & Computer Hardware, Locus Robotics Corp., Equity, 11/17/2022, Preferred Series F |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 650,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 378,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Nov. 17, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
15,116
|
|
|
|
15,116
|
|
15,116
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Electronics & Computer Hardware, Skydio, Inc., Equity, 3/8/2022, Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 811,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 08, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
248,900
|
|
|
|
248,900
|
|
248,900
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Equity, SAFE |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
|
$ 1,900,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
1,900,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Financial Technologies, Hypercore Inc., Equity, 1/22/2026, Preferred Series A-II |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 378,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Jan. 22, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
231,938
|
|
|
|
231,938
|
|
231,938
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Financial Technologies, Oportun, Equity, 6/28/2013, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[54] |
$ 577,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[54] |
$ 394,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Jun. 28, 2013
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[54] |
48,365
|
|
|
|
48,365
|
|
48,365
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Financial Technologies, Worldremit Group Limited, Equity, 6/24/2024, Preferred Series X |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
$ 922,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 515,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[38],[39],[54] |
Jun. 24, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[38],[39] |
9,737
|
|
|
|
9,737
|
|
9,737
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Curana Health Holdings, LLC, Equity, 3/26/2026, Class C Non Voting Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 197,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 241,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 26, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
59,697
|
|
|
|
59,697
|
|
59,697
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Curana Health Holdings, LLC, Equity, 5/13/2024, Class B Voting Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 2,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,335,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
May 13, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
1,114,380
|
|
|
|
1,114,380
|
|
1,114,380
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Main Street Rural, Inc., Equity, 10/28/2024, Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,750,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,217,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Oct. 28, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
993
|
|
|
|
993
|
|
993
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, NH Holdings 2025 SPV, L.P., Equity, 6/21/2024, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 2,551,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 546,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 21, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
669,494
|
|
|
|
669,494
|
|
669,494
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Strive Health Holdings, LLC, Equity, 6/27/2025, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 599,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 962,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 27, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
82,043
|
|
|
|
82,043
|
|
82,043
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Total Curana Health Holdings, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 2,697,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,576,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
1,174,077
|
|
|
|
1,174,077
|
|
1,174,077
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, WellBe Senior Medical, LLC, Equity, 6/10/2024, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,600,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,086,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 10, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
181,163
|
|
|
|
181,163
|
|
181,163
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Technology & Digital Health, Click Therapeutics, Inc., Equity, 5/20/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[35] |
$ 1,662,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[35] |
$ 2,233,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[35],[54] |
May 20, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[35] |
560,000
|
|
|
|
560,000
|
|
560,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Technology & Digital Health, DNAnexus, Inc., Equity, 3/21/2014, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 97,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 15,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Mar. 21, 2014
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
51,948
|
|
|
|
51,948
|
|
51,948
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Technology & Digital Health, Verana Health, Inc., Equity, 7/8/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Jul. 08, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
23,814
|
|
|
|
23,814
|
|
23,814
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Information Services, Yipit, LLC, Equity, 12/30/2021, Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 3,825,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,759,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 30, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
41,021
|
|
|
|
41,021
|
|
41,021
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Medical Devices & Equipment, Coronado Aesthetics, LLC, Equity, 10/15/2021, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[44],[54] |
Oct. 15, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[44] |
180,000
|
|
|
|
180,000
|
|
180,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Medical Devices & Equipment, Coronado Aesthetics, LLC, Equity, 10/15/2021, Preferred Series A-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[44] |
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[44] |
$ 180,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[44],[54] |
Oct. 15, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[44] |
5,000,000
|
|
|
|
5,000,000
|
|
5,000,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Medical Devices & Equipment, Orchestra BioMed Holdings, Inc., Equity, 8/4/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 2,262,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 04, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
363,636
|
|
|
|
363,636
|
|
363,636
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Medical Devices & Equipment, Total Coronado Aesthetics, LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 180,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
5,180,000
|
|
|
|
5,180,000
|
|
5,180,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Semiconductors, Achronix Semiconductor Corporation, Equity, 6/26/2015, Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 7,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 181,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 26, 2015
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
497,767
|
|
|
|
497,767
|
|
497,767
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Semiconductors, Achronix Semiconductor Corporation, Equity, 7/1/2011, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 160,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 59,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jul. 01, 2011
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
277,995
|
|
|
|
277,995
|
|
277,995
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Semiconductors, Total Achronix Semiconductor Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 167,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 240,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
775,762
|
|
|
|
775,762
|
|
775,762
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Planet Labs PBC, Equity, 1/13/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[54] |
$ 1,527,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[54] |
$ 992,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[54] |
Jan. 13, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[54] |
60,496
|
|
|
|
60,496
|
|
60,496
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Stoke Space Technologies, Inc., Equity, 2/6/2026, Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,407,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,511,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Feb. 06, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
28,168
|
|
|
|
28,168
|
|
28,168
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Stoke Space Technologies, Inc., Equity, 8/19/2026, Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,406,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,365,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 19, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
11,779
|
|
|
|
11,779
|
|
11,779
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Stoke Space Technologies, Inc., Equity, 9/23/2025, Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,406,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,684,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 23, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
43,867
|
|
|
|
43,867
|
|
43,867
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Total Stoke Space Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 4,219,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 7,560,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
83,814
|
|
|
|
83,814
|
|
83,814
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Sustainable and Renewable Technology, Impossible Foods, Inc., Equity, 5/10/2019, Preferred Series E-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 89,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
May 10, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
188,611
|
|
|
|
188,611
|
|
188,611
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Sustainable and Renewable Technology, Modumetal, Inc., Equity, 6/1/2015, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 01, 2015
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
1,035
|
|
|
|
1,035
|
|
1,035
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Sustainable and Renewable Technology, Pivot Bio, Inc., Equity, 6/28/2021, Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 4,500,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 377,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 28, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
593,080
|
|
|
|
593,080
|
|
593,080
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Sustainable and Renewable Technology, SUNation Energy, Inc., Equity, 12/10/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 3,153,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 10, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
3
|
|
|
|
3
|
|
3
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, System Software, Docker, Inc., Equity, 11/29/2018, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 4,284,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Nov. 29, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
20,000
|
|
|
|
20,000
|
|
20,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, System Software, Lightbend, Inc., Equity, 12/4/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 265,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 04, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
38,461
|
|
|
|
38,461
|
|
38,461
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 632,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 162,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Oct. 25, 2016
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
108,710
|
|
|
|
|
|
108,710
|
|
108,710
|
|
| Investment, Identifier [Axis]: Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 10,250,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
10,250,000
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Fund, Cash & Cash Equivalents, GS Financial Square Government Fund, FGTXX/38141W273 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 68,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
68,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Cybersecurity and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[9],[20] |
|
|
385,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[9],[20] |
|
|
$ 364,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[9],[20],[50] |
|
|
Jul. 21, 2022
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[14],[20] |
|
|
$ 2,906,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[14],[20] |
|
|
$ 5,408,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[14],[20],[50] |
|
|
Nov. 16, 2020
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[14],[20] |
|
|
$ 1,349,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[14],[20] |
|
|
$ 1,291,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[14],[20],[50] |
|
|
Jun. 23, 2022
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments, Cybersecurity, Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, 7/21/2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
385,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 365,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[38],[39],[54] |
Jul. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments, Drug Discovery & Development, Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, 11/16/2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[38],[39] |
$ 3,070,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[38],[39] |
$ 4,781,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[28],[38],[39],[54] |
Nov. 16, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments, Drug Discovery & Development, Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, 6/23/2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[38],[39] |
$ 1,716,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[38],[39] |
$ 1,497,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[28],[38],[39],[54] |
Jun. 23, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments, Drug Discovery & Development, Forbion Ventures Fund VIII Coöperatief U.A., Investment Funds & Vehicles, 7/23/2026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[28],[38],[39] |
$ 158,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[38],[39] |
$ 159,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[28],[38],[39],[54] |
Jul. 23, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Annex Cloud, Warrant, Acquisition Date 6/5/2025, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Jun. 05, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
50,000
|
|
|
|
|
|
50,000
|
|
50,000
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 448,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 207,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Sep. 23, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
254,778
|
|
|
|
|
|
254,778
|
|
254,778
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 215,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 81,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Oct. 04, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
435,396
|
|
|
|
|
|
435,396
|
|
435,396
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Carbyne, Inc., Warrant, Acquisition Date 2/24/2025, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 24,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 460,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Feb. 24, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
11,408
|
|
|
|
|
|
11,408
|
|
11,408
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
$ 26,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
$ 75,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[20],[50] |
|
|
Sep. 21, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[20] |
|
|
102,898
|
|
|
|
|
|
102,898
|
|
102,898
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 461,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 864,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Mar. 11, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
770,838
|
|
|
|
|
|
770,838
|
|
770,838
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 545,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 41,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Aug. 02, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
727,047
|
|
|
|
|
|
727,047
|
|
727,047
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Distributed Creation Inc., Warrant, Acquisition Date 4/21/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 180,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 248,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Apr. 21, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
104,622
|
|
|
|
|
|
104,622
|
|
104,622
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 278,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 440,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Jun. 30, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
95,911
|
|
|
|
|
|
95,911
|
|
95,911
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Earnix, Inc., Warrant, Acquisition Date 6/6/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 220,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 283,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Jun. 06, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
20,762
|
|
|
|
|
|
20,762
|
|
20,762
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 96,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
May 10, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
75,917
|
|
|
|
|
|
75,917
|
|
75,917
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 325,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 110,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Jul. 29, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
84,995
|
|
|
|
|
|
84,995
|
|
84,995
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Funnel Holding AB (publ), Warrant, Acquisition Date 10/24/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
$ 46,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
$ 47,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[20],[50] |
|
|
Oct. 24, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[20] |
|
|
485,385
|
|
|
|
|
|
485,385
|
|
485,385
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 208,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 104,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Mar. 31, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
64,293
|
|
|
|
|
|
64,293
|
|
64,293
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[13],[20] |
|
|
$ 39,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[13],[20] |
|
|
$ 33,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[13],[20],[50] |
|
|
Jan. 23, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[13],[20] |
|
|
93,211
|
|
|
|
|
|
93,211
|
|
93,211
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Mango Technologies, Inc., Warrant, Acquisition Date 8/15/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 401,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 410,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Aug. 15, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
75,825
|
|
|
|
|
|
75,825
|
|
75,825
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 252,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 331,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Sep. 30, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
82,362
|
|
|
|
|
|
82,362
|
|
82,362
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Pindrop Security, Inc., Warrant, Acquisition Date 6/26/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8] |
|
|
$ 494,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8] |
|
|
$ 320,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[8],[50] |
|
|
Jun. 26, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[8] |
|
|
134,542
|
|
|
|
|
|
134,542
|
|
134,542
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 215,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 609,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Jun. 30, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
69,120
|
|
|
|
|
|
69,120
|
|
69,120
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[13] |
|
|
$ 96,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[13] |
|
|
$ 7,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[13],[50] |
|
|
Mar. 22, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[13] |
|
|
77,934
|
|
|
|
|
|
77,934
|
|
77,934
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
$ 174,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
$ 44,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[20],[50] |
|
|
Jun. 08, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[20] |
|
|
321,956
|
|
|
|
|
|
321,956
|
|
321,956
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Suzy, Inc., Warrant, Acquisition Date 8/24/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10] |
|
|
$ 367,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10] |
|
|
$ 182,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[8],[10],[50] |
|
|
Aug. 24, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[8],[10] |
|
|
292,936
|
|
|
|
|
|
292,936
|
|
292,936
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[22] |
|
|
$ 360,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[22] |
|
|
$ 255,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[22],[50] |
|
|
Mar. 22, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[22] |
|
|
509,753
|
|
|
|
|
|
509,753
|
|
509,753
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/27/2025, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[22] |
|
|
$ 136,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[22] |
|
|
$ 83,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[22],[50] |
|
|
Mar. 27, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[22] |
|
|
473,266
|
|
|
|
|
|
473,266
|
|
473,266
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Total Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 496,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 338,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
983,019
|
|
|
|
|
|
983,019
|
|
983,019
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Ushur, Inc., Warrant, Acquisition Date 6/5/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10] |
|
|
$ 265,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10] |
|
|
$ 183,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[8],[10],[50] |
|
|
Jun. 05, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[8],[10] |
|
|
1,603,911
|
|
|
|
|
|
1,603,911
|
|
1,603,911
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[13] |
|
|
$ 126,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[13] |
|
|
$ 4,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[13],[50] |
|
|
Mar. 31, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7],[13] |
|
|
98,428
|
|
|
|
|
|
98,428
|
|
98,428
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 1,275,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Jan. 21, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
152,048
|
|
|
|
|
|
152,048
|
|
152,048
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and ZeroEyes, Inc., Warrant, Acquisition Date 5/6/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[8],[10] |
|
|
$ 132,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[8],[10] |
|
|
$ 34,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[8],[10],[50] |
|
|
May 06, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[8],[10] |
|
|
26,422
|
|
|
|
|
|
26,422
|
|
26,422
|
|
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 36,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 31,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 21, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
75,567
|
|
|
|
|
|
75,567
|
|
75,567
|
|
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Antheia, Inc., Warrant, Acquisition Date 8/29/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 1,601,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 2,547,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Aug. 29, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
2,023,810
|
|
|
|
|
|
2,023,810
|
|
2,023,810
|
|
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[13] |
|
|
$ 461,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[13] |
|
|
$ 62,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[13],[50] |
|
|
Dec. 23, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[13] |
|
|
53,418
|
|
|
|
|
|
53,418
|
|
53,418
|
|
| Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[13] |
|
|
$ 242,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[13] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[13],[50] |
|
|
Jun. 28, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[13] |
|
|
486,097
|
|
|
|
|
|
486,097
|
|
486,097
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 228,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 03, 2014
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
1,662,441
|
|
|
|
|
|
1,662,441
|
|
1,662,441
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 17,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 713,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 27, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
686,270
|
|
|
|
|
|
686,270
|
|
686,270
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Altumint, Inc., Warrant, Acquisition Date 10/31/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 126,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 155,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Oct. 31, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
1,701
|
|
|
|
|
|
1,701
|
|
1,701
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and AppDirect, Inc., Warrant, Acquisition Date 9/22/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 228,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 188,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Sep. 22, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
87,938
|
|
|
|
|
|
87,938
|
|
87,938
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
$ 164,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 232,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Dec. 14, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20] |
|
|
174,163
|
|
|
|
|
|
174,163
|
|
174,163
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
$ 20,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 62,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Feb. 13, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20] |
|
|
109,257
|
|
|
|
|
|
109,257
|
|
109,257
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 20,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Oct. 29, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
529,661
|
|
|
|
|
|
529,661
|
|
529,661
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 116,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 11,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Mar. 12, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
11,806
|
|
|
|
|
|
11,806
|
|
11,806
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 39,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 7,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 29, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
127,032
|
|
|
|
|
|
127,032
|
|
127,032
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Peek Travel, Inc., Warrant, Acquisition Date 10/28/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 157,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 163,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Oct. 28, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
60,169
|
|
|
|
|
|
60,169
|
|
60,169
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
$ 60,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 24,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Oct. 03, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20] |
|
|
27,298
|
|
|
|
|
|
27,298
|
|
27,298
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 166,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 12,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Dec. 22, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
117,042
|
|
|
|
|
|
117,042
|
|
117,042
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 470,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Mar. 12, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
13,106
|
|
|
|
|
|
13,106
|
|
13,106
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[13],[22] |
|
|
$ 1,242,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[13],[22] |
|
|
$ 5,096,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[13],[22],[50] |
|
|
Jun. 12, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[13],[22] |
|
|
1,604,724
|
|
|
|
|
|
1,604,724
|
|
1,604,724
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 57,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Nov. 14, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
1,607,143
|
|
|
|
|
|
1,607,143
|
|
1,607,143
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 83,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Aug. 23, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
444,444
|
|
|
|
|
|
444,444
|
|
444,444
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 16,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Apr. 20, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
600,000
|
|
|
|
|
|
600,000
|
|
600,000
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 782,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 30, 2016
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
1,800,000
|
|
|
|
|
|
1,800,000
|
|
1,800,000
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 62,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Aug. 01, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
1,211,537
|
|
|
|
|
|
1,211,537
|
|
1,211,537
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 985,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 1,214,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
May 01, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
343,497
|
|
|
|
|
|
343,497
|
|
343,497
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Carwow LTD |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 184,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 294,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
283,420
|
|
|
|
|
|
283,420
|
|
283,420
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Skyword, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 140,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
2,051,587
|
|
|
|
|
|
2,051,587
|
|
2,051,587
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 860,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
3,611,537
|
|
|
|
|
|
3,611,537
|
|
3,611,537
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Akeyless Security Ltd. and Warrant, Acquisition Date 8/4/2025 and Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[9],[20] |
|
|
$ 68,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[9],[20] |
|
|
$ 47,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[9],[20],[50] |
|
|
Aug. 04, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7],[9],[20] |
|
|
87,917
|
|
|
|
|
|
87,917
|
|
87,917
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 284,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 401,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Nov. 18, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
29,691
|
|
|
|
|
|
29,691
|
|
29,691
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Coronet Cyber Security Ltd. and Warrant, Acquisition Date 9/26/2024 and Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 254,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 25,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Sep. 26, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
39,183
|
|
|
|
|
|
39,183
|
|
39,183
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Dragos, Inc. and Warrant, Acquisition Date 6/28/2023 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 1,575,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 970,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Jun. 28, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
57,528
|
|
|
|
|
|
57,528
|
|
57,528
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Morphisec Information Security 2014 Ltd. and Warrant, Acquisition Date 10/1/2024 and Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[9],[20] |
|
|
$ 104,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[9],[20] |
|
|
$ 58,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[9],[20],[50] |
|
|
Oct. 01, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7],[9],[20] |
|
|
200,115
|
|
|
|
|
|
200,115
|
|
200,115
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Semperis Technologies Inc. and Warrant, Acquisition Date 4/23/2024 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 446,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 455,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Apr. 23, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
193,264
|
|
|
|
|
|
193,264
|
|
193,264
|
|
| Investment, Identifier [Axis]: Warrant Investments and Defense Technologies and Saronic Technologies, Inc., Warrant, Acquisition Date 6/9/2025, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[10] |
|
|
$ 726,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[10] |
|
|
$ 1,094,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[10],[50] |
|
|
Jun. 09, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8],[10] |
|
|
109,757
|
|
|
|
|
|
109,757
|
|
109,757
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[13],[50] |
|
|
$ 1,290,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[13],[50] |
|
|
$ 5,765,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[13],[50] |
|
|
Sep. 25, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[13],[50] |
|
|
61,004
|
|
|
|
|
|
61,004
|
|
61,004
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Beren Therapeutics P.B.C., Warrant, Acquisition Date 10/8/2025, Series Preferred Series A+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 102,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 117,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Oct. 08, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
67,923
|
|
|
|
|
|
67,923
|
|
67,923
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20],[50] |
|
|
$ 278,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20],[50] |
|
|
$ 127,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Jun. 30, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20],[50] |
|
|
75,376
|
|
|
|
|
|
75,376
|
|
75,376
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 287,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 65,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Dec. 08, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
100,000
|
|
|
|
|
|
100,000
|
|
100,000
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 37,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Sep. 14, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
16,112
|
|
|
|
|
|
16,112
|
|
16,112
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 233,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 272,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Jun. 09, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
95,221
|
|
|
|
|
|
95,221
|
|
95,221
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[50] |
|
|
$ 228,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[50] |
|
|
$ 67,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Aug. 09, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8],[50] |
|
|
238,095
|
|
|
|
|
|
238,095
|
|
238,095
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[50] |
|
|
$ 88,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[50] |
|
|
$ 16,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[9],[50] |
|
|
Nov. 02, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8],[9],[50] |
|
|
14,342
|
|
|
|
|
|
14,342
|
|
14,342
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[50] |
|
|
$ 570,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[50] |
|
|
$ 4,669,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[50] |
|
|
May 09, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[50] |
|
|
13,229
|
|
|
|
|
|
13,229
|
|
13,229
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[9],[13],[22],[50] |
|
|
$ 848,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[9],[13],[22],[50] |
|
|
$ 180,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[9],[13],[22],[50] |
|
|
Sep. 17, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8],[9],[13],[22],[50] |
|
|
64,687
|
|
|
|
|
|
64,687
|
|
64,687
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 20,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 10,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Mar. 23, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
475,510
|
|
|
|
|
|
475,510
|
|
475,510
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 296,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
May 14, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
106,035
|
|
|
|
|
|
106,035
|
|
106,035
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and SynOx Therapeutics Limited, Warrant, Acquisition Date 4/18/2024, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
$ 83,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 84,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Apr. 18, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20] |
|
|
251,195
|
|
|
|
|
|
251,195
|
|
251,195
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 12/30/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[50] |
|
|
$ 721,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[50] |
|
|
$ 1,311,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[50] |
|
|
Dec. 30, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[50] |
|
|
117,168
|
|
|
|
|
|
117,168
|
|
117,168
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 256,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 61,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 15, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
102,216
|
|
|
|
|
|
102,216
|
|
102,216
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 510,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 8,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 18, 2019
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
46,424
|
|
|
|
|
|
46,424
|
|
46,424
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20],[50] |
|
|
$ 118,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20],[50] |
|
|
$ 170,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Dec. 22, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20],[50] |
|
|
43,689
|
|
|
|
|
|
43,689
|
|
43,689
|
|
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 101,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 30,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 15, 2017
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
49,078
|
|
|
|
|
|
49,078
|
|
49,078
|
|
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 34,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 61,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jun. 21, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
8,503
|
|
|
|
|
|
8,503
|
|
8,503
|
|
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 557,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 386,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Nov. 08, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
622,255
|
|
|
|
|
|
622,255
|
|
622,255
|
|
| Investment, Identifier [Axis]: Warrant Investments and Energy Technologies and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7] |
|
|
$ 52,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7] |
|
|
$ 45,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[50] |
|
|
Apr. 15, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7] |
|
|
18,472
|
|
|
|
|
|
18,472
|
|
18,472
|
|
| Investment, Identifier [Axis]: Warrant Investments and Energy Technologies and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[8] |
|
|
$ 507,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[8] |
|
|
$ 100,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[8],[50] |
|
|
Mar. 27, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7],[8] |
|
|
246,618
|
|
|
|
|
|
246,618
|
|
246,618
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[9],[20] |
|
|
$ 54,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[9],[20] |
|
|
$ 811,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[9],[20],[50] |
|
|
Apr. 10, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7],[9],[20] |
|
|
6,763
|
|
|
|
|
|
6,763
|
|
6,763
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Finix Payment, Inc., Warrant, Acquisition Date 12/17/2025, Series Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[10] |
|
|
$ 38,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[10] |
|
|
$ 38,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[10],[50] |
|
|
Dec. 17, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7],[10] |
|
|
525,583
|
|
|
|
|
|
525,583
|
|
525,583
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Total Worldremit Group Limited |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7] |
|
|
$ 155,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7] |
|
|
$ 55,000
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7] |
|
|
79,083
|
|
|
|
|
|
79,083
|
|
79,083
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[9],[20] |
|
|
$ 129,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[9],[20] |
|
|
$ 55,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[9],[20],[50] |
|
|
Feb. 11, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7],[9],[20] |
|
|
77,215
|
|
|
|
|
|
77,215
|
|
77,215
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7],[9],[20] |
|
|
$ 26,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7],[9],[20] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[9],[20],[50] |
|
|
Aug. 27, 2021
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7],[9],[20] |
|
|
1,868
|
|
|
|
|
|
1,868
|
|
1,868
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Belong Health, Inc., Warrant, Acquisition Date 11/13/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10] |
|
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10] |
|
|
$ 238,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[10],[50] |
|
|
Nov. 13, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[10] |
|
|
1,933,102
|
|
|
|
|
|
1,933,102
|
|
1,933,102
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC, Warrant, Acquisition Date 1/4/2024, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 156,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 718,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jan. 04, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
447,410
|
|
|
|
|
|
447,410
|
|
447,410
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Octave Health Group, Inc., Warrant, Acquisition Date 11/28/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10] |
|
|
$ 168,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10] |
|
|
$ 175,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[10],[50] |
|
|
Nov. 28, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[10] |
|
|
225,310
|
|
|
|
|
|
225,310
|
|
225,310
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc., Warrant, Acquisition Date 7/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 382,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 50,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jul. 03, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
194,830
|
|
|
|
|
|
194,830
|
|
194,830
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Acquisition Date 9/28/2023, Series Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8] |
|
|
$ 278,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8] |
|
|
$ 501,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[50] |
|
|
Sep. 28, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8] |
|
|
129,400
|
|
|
|
|
|
129,400
|
|
129,400
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Technology & Digital Health and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7] |
|
|
$ 739,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7] |
|
|
$ 220,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[50] |
|
|
Sep. 12, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7] |
|
|
612,166
|
|
|
|
|
|
612,166
|
|
612,166
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Technology & Digital Health and Imagen Technologies, Inc., Warrant, Acquisition Date 11/26/2025, Series Preferred Series C-3-VI |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[7],[10] |
|
|
$ 110,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[7],[10] |
|
|
$ 92,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[7],[10],[50] |
|
|
Nov. 26, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[7],[10] |
|
|
311,570
|
|
|
|
|
|
311,570
|
|
311,570
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Technology & Digital Health and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7] |
|
|
$ 229,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7] |
|
|
$ 70,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[50] |
|
|
Mar. 30, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7] |
|
|
63,202
|
|
|
|
|
|
63,202
|
|
63,202
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Technology & Digital Health and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[7] |
|
|
$ 121,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[7] |
|
|
$ 48,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[7],[50] |
|
|
Mar. 28, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[7] |
|
|
192,431
|
|
|
|
|
|
192,431
|
|
192,431
|
|
| Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Quid, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 356,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Aug. 22, 2017
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
60,000
|
|
|
|
|
|
60,000
|
|
60,000
|
|
| Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[9],[20] |
|
|
$ 57,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[9],[20] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[9],[20],[50] |
|
|
Jun. 29, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[9],[20] |
|
|
129,638
|
|
|
|
|
|
129,638
|
|
129,638
|
|
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 537,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 185,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 31, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
392,308
|
|
|
|
|
|
392,308
|
|
392,308
|
|
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 528,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 23, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
1,111,111
|
|
|
|
|
|
1,111,111
|
|
1,111,111
|
|
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and VulcanForms Inc., Warrant, Acquisition Date 1/30/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 37,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 64,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jan. 30, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
83,262
|
|
|
|
|
|
83,262
|
|
83,262
|
|
| Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 67,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 32,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Dec. 30, 2022
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
369,370
|
|
|
|
|
|
369,370
|
|
369,370
|
|
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Warrant, Acquisition Date 11/6/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[10],[50] |
|
|
$ 216,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[10],[50] |
|
|
$ 299,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[10],[50] |
|
|
Nov. 06, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8],[10],[50] |
|
|
167,831
|
|
|
|
|
|
167,831
|
|
167,831
|
|
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 276,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 75,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Sep. 08, 2023
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
51,635
|
|
|
|
|
|
51,635
|
|
51,635
|
|
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10],[13],[50] |
|
|
$ 363,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10],[13],[50] |
|
|
$ 385,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[10],[13],[50] |
|
|
Jan. 22, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[10],[13],[50] |
|
|
113,247
|
|
|
|
|
|
113,247
|
|
113,247
|
|
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[50] |
|
|
$ 61,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[50] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Mar. 31, 2017
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[50] |
|
|
15,712
|
|
|
|
|
|
15,712
|
|
15,712
|
|
| Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 1/11/2017, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 92,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 49,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Jan. 11, 2017
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
250,000
|
|
|
|
|
|
250,000
|
|
250,000
|
|
| Investment, Identifier [Axis]: Warrant Investments and Space Technologies and HawkEye 360, Inc. and Warrant and 12/18/2025 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 263,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 283,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Dec. 18, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
40,912
|
|
|
|
|
|
40,912
|
|
40,912
|
|
| Investment, Identifier [Axis]: Warrant Investments and Space Technologies and Loft Orbital Solutions Inc. and Warrant and 9/10/2025 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4] |
|
|
$ 185,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
|
|
$ 184,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[50] |
|
|
Sep. 10, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
|
|
22,688
|
|
|
|
|
|
22,688
|
|
22,688
|
|
| Investment, Identifier [Axis]: Warrant Investments and Space Technologies and Stoke Space Technologies, Inc., Warrant, Acquisition Date 6/16/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[8],[10] |
|
|
$ 990,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[8],[10] |
|
|
$ 2,301,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[8],[10],[50] |
|
|
Jun. 16, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[8],[10] |
|
|
99,497
|
|
|
|
|
|
99,497
|
|
99,497
|
|
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Tidal Vision Products, Inc., Warrant, Acquisition Date 10/10/2025, Series Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[10] |
|
|
$ 232,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[10] |
|
|
$ 174,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[10],[50] |
|
|
Oct. 10, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[10] |
|
|
48,491
|
|
|
|
|
|
48,491
|
|
48,491
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and CloudBolt Software, Inc. and Warrant, Acquisition Date 9/30/2020 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 117,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Sep. 30, 2020
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
211,342
|
|
|
|
|
|
211,342
|
|
211,342
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and Cloudian, Inc. and Warrant, Acquisition Date 11/6/2018 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 71,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Nov. 06, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
477,454
|
|
|
|
|
|
477,454
|
|
477,454
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and Harness, Inc. and Warrant, Acquisition Date 3/12/2024 and Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 534,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 1,446,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Mar. 12, 2024
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
193,618
|
|
|
|
|
|
193,618
|
|
193,618
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and Lightbend, Inc. and Warrant, Acquisition Date 2/14/2018 and Preferred Series LB-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5] |
|
|
$ 131,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5] |
|
|
$ 38,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[50] |
|
|
Feb. 14, 2018
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5] |
|
|
86,984
|
|
|
|
|
|
86,984
|
|
86,984
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and Scylla DB Ltd. and Warrant, Acquisition Date 7/24/2025 and Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[4],[5],[9],[20] |
|
|
$ 52,000
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[5],[9],[20] |
|
|
$ 59,000
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[5],[9],[20],[50] |
|
|
Jul. 24, 2025
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[5],[9],[20] |
|
|
159,684
|
|
|
|
|
|
159,684
|
|
159,684
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Annex Cloud, Warrant, 6/5/2025, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[33] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[33] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[33],[54] |
Jun. 05, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[33] |
185,185
|
|
|
|
185,185
|
|
185,185
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Automation Anywhere, Inc., Warrant, 9/23/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 448,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 144,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 23, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
254,778
|
|
|
|
254,778
|
|
254,778
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Brain Corporation, Warrant, 10/4/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 215,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 67,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Oct. 04, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
435,396
|
|
|
|
435,396
|
|
435,396
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Cutover, Inc., Warrant, 9/21/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 26,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 35,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Sep. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
102,898
|
|
|
|
102,898
|
|
102,898
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Dashlane, Inc., Warrant, 3/11/2019, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 461,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 810,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 11, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
770,838
|
|
|
|
770,838
|
|
770,838
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Demandbase, Inc., Warrant, 8/2/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 545,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 19,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 02, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
727,047
|
|
|
|
727,047
|
|
727,047
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, DevRev, Inc., Warrant, 6/8/2026, Preferred Series A |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 47,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 78,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 08, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
314,825
|
|
|
|
314,825
|
|
314,825
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Distributed Creation Inc., Warrant, 4/21/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 180,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 242,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Apr. 21, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
104,622
|
|
|
|
104,622
|
|
104,622
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Earnix, Inc., Warrant, 6/6/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 220,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 334,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 06, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
20,762
|
|
|
|
20,762
|
|
20,762
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, First Insight, Inc., Warrant, 5/10/2018, Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 96,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
May 10, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
75,917
|
|
|
|
75,917
|
|
75,917
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Fulfil Solutions, Inc., Warrant, 7/29/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 325,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 94,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jul. 29, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
84,995
|
|
|
|
84,995
|
|
84,995
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Funnel Holding AB (publ), Warrant, 10/24/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 51,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 47,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Oct. 24, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
554,725
|
|
|
|
554,725
|
|
554,725
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Kore.ai, Inc., Warrant, 3/31/2023, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 208,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 46,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 31, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
64,293
|
|
|
|
64,293
|
|
64,293
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Leapwork ApS, Warrant, 1/23/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 39,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 12,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Jan. 23, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
93,211
|
|
|
|
93,211
|
|
93,211
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Mango Technologies, Inc., Warrant, 8/15/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[40] |
$ 377,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[40] |
$ 284,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[40],[54] |
Aug. 15, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[40] |
71,298
|
|
|
|
71,298
|
|
71,298
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Mixpanel, Inc., Warrant, 9/30/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 252,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 30, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
82,362
|
|
|
|
82,362
|
|
82,362
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Pindrop Security, Inc., Warrant, 6/26/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 494,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 370,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Jun. 26, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
134,542
|
|
|
|
134,542
|
|
134,542
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Sisense Ltd., Warrant, 6/8/2023, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 174,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 2,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Jun. 08, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
321,956
|
|
|
|
321,956
|
|
321,956
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Suzy, Inc., Warrant, 8/24/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41] |
$ 367,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[41],[54] |
Aug. 24, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[41] |
292,936
|
|
|
|
292,936
|
|
292,936
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Tipalti Solutions Ltd., Warrant, 3/22/2023, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[42] |
$ 360,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[42] |
$ 187,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[42],[54] |
Mar. 22, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[42] |
509,753
|
|
|
|
509,753
|
|
509,753
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Tipalti Solutions Ltd., Warrant, 3/27/2025, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[42] |
$ 136,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
$ 35,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[42],[54] |
Mar. 27, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[42] |
473,266
|
|
|
|
473,266
|
|
473,266
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Total Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 496,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 222,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
983,019
|
|
|
|
983,019
|
|
983,019
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Ushur, Inc., Warrant, 6/5/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41] |
$ 265,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41] |
$ 71,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[41],[54] |
Jun. 05, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[41] |
1,603,911
|
|
|
|
1,603,911
|
|
1,603,911
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Veem, Inc., Warrant, 3/31/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 126,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 31, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
98,428
|
|
|
|
98,428
|
|
98,428
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, VideoAmp, Inc., Warrant, 1/21/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 1,275,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Jan. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
152,048
|
|
|
|
152,048
|
|
152,048
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, ZeroEyes, Inc., Warrant, 5/6/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41] |
$ 140,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41] |
$ 29,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[41],[54] |
May 06, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[41] |
33,750
|
|
|
|
33,750
|
|
33,750
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, micro1 Inc., Warrant, 5/20/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
$ 369,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 441,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[41],[54] |
May 20, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[41] |
37,299
|
|
|
|
37,299
|
|
37,299
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Biotechnology Tools, Alamar Biosciences, Inc., Warrant, 6/21/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 36,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 637,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
31,251
|
|
|
|
31,251
|
|
31,251
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Biotechnology Tools, Antheia, Inc., Warrant, 8/29/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 1,601,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 3,402,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 29, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
2,023,810
|
|
|
|
2,023,810
|
|
2,023,810
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Communications & Networking, Aryaka Networks, Inc., Warrant, 6/28/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[40] |
$ 242,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[40] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[40],[54] |
Jun. 28, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[40] |
486,097
|
|
|
|
486,097
|
|
486,097
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Communications & Networking, Tarana Wireless, Inc.., Warrant, 3/20/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
$ 43,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 19,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[41],[54] |
Mar. 20, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[41] |
827,622
|
|
|
|
827,622
|
|
827,622
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Products, Gadget Guard, LLC, Warrant, 6/3/2014, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 228,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 03, 2014
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
1,662,441
|
|
|
|
1,662,441
|
|
1,662,441
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Products, Whoop, Inc., Warrant, 6/27/2018, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 17,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,024,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 27, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
686,270
|
|
|
|
686,270
|
|
686,270
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Altumint, Inc., Warrant, 10/31/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 127,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 24,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Oct. 31, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
1,701
|
|
|
|
1,701
|
|
1,701
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, AppDirect, Inc., Warrant, 9/22/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 254,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 82,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 22, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
104,173
|
|
|
|
104,173
|
|
104,173
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Carwow LTD, Warrant, 12/14/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 164,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 134,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Dec. 14, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
174,163
|
|
|
|
174,163
|
|
174,163
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Carwow LTD, Warrant, 2/13/2024, Preferred Series D-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 20,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 34,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Feb. 13, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
109,257
|
|
|
|
109,257
|
|
109,257
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Houzz, Inc., Warrant, 10/29/2019, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 20,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Oct. 29, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
529,661
|
|
|
|
529,661
|
|
529,661
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Landing Holdings Inc., Warrant, 3/12/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 116,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Mar. 12, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
11,806
|
|
|
|
11,806
|
|
11,806
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Lendio, Inc., Warrant, 3/29/2019, Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 39,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 29, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
127,032
|
|
|
|
127,032
|
|
127,032
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Peek Travel, Inc., Warrant, 10/28/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 157,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 79,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Oct. 28, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
60,169
|
|
|
|
60,169
|
|
60,169
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Perk Group Inc., Warrant, 5/13/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 207,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 207,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
May 13, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
17,372
|
|
|
|
17,372
|
|
17,372
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Plentific Ltd, Warrant, 10/3/2023, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 60,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 35,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Oct. 03, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
27,298
|
|
|
|
27,298
|
|
27,298
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Provi, Warrant, 12/22/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 166,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 3,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Dec. 22, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
117,042
|
|
|
|
117,042
|
|
117,042
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Rhino Labs, Inc., Warrant, 3/12/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 470,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Mar. 12, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
13,106
|
|
|
|
13,106
|
|
13,106
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, SeatGeek, Inc., Warrant, 6/12/2019, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[40] |
$ 1,242,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[40] |
$ 5,505,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[40],[54] |
Jun. 12, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[40] |
1,604,724
|
|
|
|
1,604,724
|
|
1,604,724
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Skyword, Inc., Warrant, 11/14/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 57,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 5,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Nov. 14, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
1,607,143
|
|
|
|
1,607,143
|
|
1,607,143
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Skyword, Inc., Warrant, 8/23/2019, Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 83,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
444,444
|
|
|
|
444,444
|
|
444,444
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Snagajob.com, Inc., Warrant, 4/20/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 16,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Apr. 20, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
600,000
|
|
|
|
600,000
|
|
600,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Snagajob.com, Inc., Warrant, 8/1/2018, Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 62,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 01, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
1,211,537
|
|
|
|
1,211,537
|
|
1,211,537
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Thumbtack, Inc., Warrant, 5/1/2018, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 985,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 1,013,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
May 01, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
343,497
|
|
|
|
343,497
|
|
343,497
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Total Carwow LTD |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 184,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 168,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
283,420
|
|
|
|
283,420
|
|
283,420
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Total Skyword, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 140,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 5,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
2,051,587
|
|
|
|
2,051,587
|
|
2,051,587
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Total Snagajob.com, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 78,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
1,811,537
|
|
|
|
1,811,537
|
|
1,811,537
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Akeyless Security Ltd., Warrant, 8/4/2025, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
$ 103,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 80,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[38],[39],[54] |
Aug. 04, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[38],[39] |
131,876
|
|
|
|
131,876
|
|
131,876
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Bitsight Technologies, Inc., Warrant, 11/18/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 284,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 470,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Nov. 18, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
29,691
|
|
|
|
29,691
|
|
29,691
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Coronet Cyber Security Ltd., Warrant, 9/26/2024, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 254,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 3,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Sep. 26, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
39,183
|
|
|
|
39,183
|
|
39,183
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Morphisec Information Security 2014 Ltd., Warrant, 10/1/2024, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
$ 104,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 56,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[38],[39],[54] |
Oct. 01, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[38],[39] |
200,115
|
|
|
|
200,115
|
|
200,115
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Semperis Technologies Inc., Warrant, 4/23/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 446,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 985,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Apr. 23, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
193,264
|
|
|
|
193,264
|
|
193,264
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Allen Control Systems Inc., Warrant, 9/16/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 297,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 294,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 16, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
18,042
|
|
|
|
18,042
|
|
18,042
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Hermeus Corporation, Warrant, 3/20/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 577,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 920,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 20, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
55,973
|
|
|
|
55,973
|
|
55,973
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Saronic Technologies, Inc., Warrant, 6/15/2026, Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[42] |
$ 1,283,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[42] |
$ 763,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[42],[54] |
Jun. 15, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[42] |
70,546
|
|
|
|
70,546
|
|
70,546
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Saronic Technologies, Inc., Warrant, 6/9/2025, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41],[42] |
$ 726,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41],[42] |
$ 1,837,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[41],[42],[54] |
Jun. 09, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[41],[42] |
109,757
|
|
|
|
109,757
|
|
109,757
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Total Saronic Technologies, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 2,009,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 2,600,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
180,303
|
|
|
|
180,303
|
|
180,303
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Axsome Therapeutics, Inc., Warrant, 1/9/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[54] |
$ 410,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[54] |
$ 1,748,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[54] |
Jan. 09, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[54] |
20,608
|
|
|
|
20,608
|
|
20,608
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Beren Therapeutics P.B.C., Warrant, 10/8/2025, Preferred Series A+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
$ 246,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 323,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[41],[54] |
Oct. 08, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[41] |
135,847
|
|
|
|
135,847
|
|
135,847
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, COMPASS Pathways plc, Warrant, 6/30/2023, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39],[54] |
$ 278,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39],[54] |
$ 348,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Jun. 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39],[54] |
75,376
|
|
|
|
75,376
|
|
75,376
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Cellarity, LLC (p.k.a. Cellarity, Inc.), Warrant, 12/8/2021, Preferred Series B Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 287,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 86,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Dec. 08, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
100,000
|
|
|
|
100,000
|
|
100,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Century Therapeutics, Inc., Warrant, 9/14/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 37,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 14, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
16,112
|
|
|
|
16,112
|
|
16,112
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Heron Therapeutics, Inc., Warrant, 8/9/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[54] |
$ 228,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
$ 2,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Aug. 09, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[54] |
238,095
|
|
|
|
238,095
|
|
238,095
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Kura Oncology, Inc., Warrant, 11/2/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[38],[54] |
$ 88,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[38],[54] |
$ 19,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[38],[54] |
Nov. 02, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[38],[54] |
14,342
|
|
|
|
14,342
|
|
14,342
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Lexicon Pharmaceuticals, Inc., Warrant, 5/4/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[40],[41],[54] |
$ 447,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[40],[41],[54] |
$ 529,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[40],[41],[54] |
May 04, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[40],[41],[54] |
501,571
|
|
|
|
501,571
|
|
501,571
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Madrigal Pharmaceuticals, Inc., Warrant, 5/9/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[54] |
$ 570,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[54] |
$ 3,906,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[54] |
May 09, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[54] |
13,229
|
|
|
|
13,229
|
|
13,229
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Phathom Pharmaceuticals, Inc., Warrant, 9/17/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[38],[42],[54] |
$ 848,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[38],[42],[54] |
$ 25,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[38],[42],[54] |
Sep. 17, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[38],[42],[54] |
64,687
|
|
|
|
64,687
|
|
64,687
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Redshift Bioanalytics, Inc., Warrant, 3/23/2022, Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 20,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 20,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Mar. 23, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
475,510
|
|
|
|
475,510
|
|
475,510
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Rocket Pharmaceuticals, Inc., Warrant, 9/30/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[41],[54] |
$ 412,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[41],[54] |
$ 411,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[41],[54] |
Sep. 30, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[41],[54] |
307,274
|
|
|
|
307,274
|
|
307,274
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Scynexis, Inc., Warrant, 5/14/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 296,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
May 14, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
13,253
|
|
|
|
13,253
|
|
13,253
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, SynOx Therapeutics Limited, Warrant, 4/18/2024, Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 199,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 160,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Apr. 18, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
558,230
|
|
|
|
558,230
|
|
558,230
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Valo Health, LLC, Warrant, 6/15/2020, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 256,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 87,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 15, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
102,216
|
|
|
|
102,216
|
|
102,216
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, X4 Pharmaceuticals, Inc., Warrant, 3/18/2019, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 510,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 2,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 18, 2019
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
46,424
|
|
|
|
46,424
|
|
46,424
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, enGene Therapeutics Inc. (p.k.a. enGene, Inc.), Warrant, 12/22/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39],[54] |
$ 218,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39],[54] |
$ 30,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Dec. 22, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39],[54] |
72,284
|
|
|
|
72,284
|
|
72,284
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Electronics & Computer Hardware, 908 Devices, Inc., Warrant, 3/15/2017, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 101,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 200,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 15, 2017
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
49,078
|
|
|
|
49,078
|
|
49,078
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Electronics & Computer Hardware, Locus Robotics Corp., Warrant, 6/21/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 34,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 76,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jun. 21, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
8,503
|
|
|
|
8,503
|
|
8,503
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Electronics & Computer Hardware, Skydio, Inc., Warrant, 11/8/2021, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 557,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 651,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Nov. 08, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
622,255
|
|
|
|
622,255
|
|
622,255
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Energy Technologies, Ampion, PBC, Warrant, 4/15/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 52,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Apr. 15, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
18,472
|
|
|
|
18,472
|
|
18,472
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Energy Technologies, Antares Nuclear, Inc., Warrant, 9/3/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 486,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 441,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Sep. 03, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
12,861
|
|
|
|
12,861
|
|
12,861
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Energy Technologies, Electric Hydrogen Co., Warrant, 3/27/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[35] |
$ 507,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[35] |
$ 97,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[35],[54] |
Mar. 27, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[35] |
246,618
|
|
|
|
246,618
|
|
246,618
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Cloudpay, Inc., Warrant, 4/10/2018, Preferred Series B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
$ 54,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 706,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[38],[39],[54] |
Apr. 10, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[38],[39] |
6,763
|
|
|
|
6,763
|
|
6,763
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Finix Payments, Inc., Warrant, 12/17/2025, Preferred Series C |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[41] |
$ 122,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[41] |
$ 171,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[41],[54] |
Dec. 17, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[41] |
1,839,547
|
|
|
|
1,839,547
|
|
1,839,547
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Total Worldremit Group Limited |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 155,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 12,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
79,083
|
|
|
|
79,083
|
|
79,083
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Worldremit Group Limited, Warrant, 2/11/2021, Preferred Series D |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
$ 129,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 12,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[38],[39],[54] |
Feb. 11, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[38],[39] |
77,215
|
|
|
|
77,215
|
|
77,215
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Worldremit Group Limited, Warrant, 8/27/2021, Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[38],[39] |
$ 26,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[38],[39] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[38],[39],[54] |
Aug. 27, 2021
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[38],[39] |
1,868
|
|
|
|
1,868
|
|
1,868
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Belong Health, Inc., Warrant, 11/13/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 141,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[41],[54] |
Nov. 13, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[41] |
1,933,102
|
|
|
|
1,933,102
|
|
1,933,102
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Connections Health Holdings, LLC, Warrant, 5/27/2026, Class B Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
$ 94,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 133,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[41],[54] |
May 27, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[41] |
68,029
|
|
|
|
68,029
|
|
68,029
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Curana Health Holdings, LLC, Warrant, 1/4/2024, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 156,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 548,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jan. 04, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
447,410
|
|
|
|
447,410
|
|
447,410
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Octave Health Group, Inc. , Warrant, 11/28/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
$ 168,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 176,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[41],[54] |
Nov. 28, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[41] |
225,310
|
|
|
|
225,310
|
|
225,310
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Strive Health Holdings, LLC, Warrant, 9/28/2023, Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35] |
$ 278,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35] |
$ 738,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[54] |
Sep. 28, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35] |
129,400
|
|
|
|
129,400
|
|
129,400
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, The Recovery Company, Inc. (p.k.a. Recover Together, Inc.), Warrant, 7/3/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 382,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 18,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jul. 03, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
194,830
|
|
|
|
194,830
|
|
194,830
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, CollectiveHealth, Inc., Warrant, 1/26/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 21,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 12,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Jan. 26, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
577,252
|
|
|
|
577,252
|
|
577,252
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, Elation Health, Inc., Warrant, 9/12/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 739,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 187,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Sep. 12, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
612,166
|
|
|
|
612,166
|
|
612,166
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, Imagen Technologies, Inc., Warrant, 11/26/2025, Preferred Series C-3-VI |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6],[41] |
$ 110,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6],[41] |
$ 380,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[41],[54] |
Nov. 26, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6],[41] |
311,570
|
|
|
|
311,570
|
|
311,570
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, Modern Life, Inc., Warrant, 3/30/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 229,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 138,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Mar. 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
63,202
|
|
|
|
63,202
|
|
63,202
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, Vida Health, Inc., Warrant, 3/28/2022, Preferred Series E |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[6] |
$ 120,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[6] |
$ 110,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[6],[54] |
Mar. 28, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[6] |
192,431
|
|
|
|
192,431
|
|
192,431
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Information Services, NetBase Quid, Inc., Warrant, 8/22/2017, Preferred Series 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 356,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Aug. 22, 2017
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
60,000
|
|
|
|
60,000
|
|
60,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Manufacturing Technology, Bright Machines, Inc., Warrant, 3/31/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 537,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 258,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 31, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
392,308
|
|
|
|
392,308
|
|
392,308
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Manufacturing Technology, MacroFab, Inc., Warrant, 3/23/2022, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 528,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 23, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
1,111,111
|
|
|
|
1,111,111
|
|
1,111,111
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Manufacturing Technology, VulcanForms Inc., Warrant, 1/30/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 74,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 340,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jan. 30, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
99,923
|
|
|
|
99,923
|
|
99,923
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Media/Content/Info, Fever Labs, Inc., Warrant, 12/30/2022, Preferred Series E-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 67,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 44,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 30, 2022
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
369,370
|
|
|
|
369,370
|
|
369,370
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Cognito Therapeutics Group, Inc., Warrant, 1/23/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
$ 149,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 177,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[41],[54] |
Jan. 23, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[41] |
76,529
|
|
|
|
76,529
|
|
76,529
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Orchestra BioMed Holdings, Inc., Warrant, 11/6/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41],[54] |
$ 216,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41],[54] |
$ 470,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[41],[54] |
Nov. 06, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[41],[54] |
167,831
|
|
|
|
167,831
|
|
167,831
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Senseonics Holdings, Inc., Warrant, 5/6/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[40],[54] |
$ 110,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[40],[54] |
$ 287,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[40],[54] |
May 06, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[40],[54] |
61,793
|
|
|
|
61,793
|
|
61,793
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Senseonics Holdings, Inc., Warrant, 9/8/2023, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[40],[54] |
$ 277,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[40],[54] |
$ 168,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[40],[54] |
Sep. 08, 2023
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[40],[54] |
51,635
|
|
|
|
51,635
|
|
51,635
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Sight Sciences, Inc., Warrant, 1/22/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[40],[41],[54] |
$ 363,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[40],[41],[54] |
$ 468,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[40],[41],[54] |
Jan. 22, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[40],[41],[54] |
113,247
|
|
|
|
113,247
|
|
113,247
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Tela Bio, Inc., Warrant, 3/31/2017, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 61,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
15,712
|
|
|
|
15,712
|
|
15,712
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Total Senseonics Holdings, Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 387,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 455,000
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
113,428
|
|
|
|
113,428
|
|
113,428
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Semiconductors, Achronix Semiconductor Corporation, Warrant, 1/11/2017, Preferred Series D-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 92,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 89,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Jan. 11, 2017
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
250,000
|
|
|
|
250,000
|
|
250,000
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Space Technologies, HawkEye 360, Inc., Warrant, 12/18/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[54] |
$ 227,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
$ 230,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Dec. 18, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[54] |
40,912
|
|
|
|
40,912
|
|
40,912
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Space Technologies, LeoLabs, Inc., Warrant, 4/8/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 118,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 117,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Apr. 08, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
106,289
|
|
|
|
106,289
|
|
106,289
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Space Technologies, Loft Orbital Solutions Inc.., Warrant, 9/10/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 185,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 208,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 10, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
22,688
|
|
|
|
22,688
|
|
22,688
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Space Technologies, Stoke Space Technologies, Inc., Warrant, 6/16/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[35],[41] |
$ 990,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[41] |
$ 7,372,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[35],[41],[54] |
Jun. 16, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[35],[41] |
99,497
|
|
|
|
99,497
|
|
99,497
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Sustainable and Renewable Technology, Tidal Vision Products, Inc., Warrant, 10/10/2025, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[41] |
$ 304,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
$ 202,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[41],[54] |
Oct. 10, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[41] |
72,736
|
|
|
|
72,736
|
|
72,736
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, CloudBolt Software, Inc., Warrant, 9/30/2020, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 117,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Sep. 30, 2020
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
211,342
|
|
|
|
211,342
|
|
211,342
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Cloudian, Inc., Warrant, 11/6/2018, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 71,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Nov. 06, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
477,454
|
|
|
|
477,454
|
|
477,454
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, ControlUp Technologies Ltd., Warrant, 1/2/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 33,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 40,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Jan. 02, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
62,045
|
|
|
|
62,045
|
|
62,045
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Harness, Inc., Warrant, 3/12/2024, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 534,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 856,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 12, 2024
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
193,618
|
|
|
|
193,618
|
|
193,618
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Lightbend, Inc., Warrant, 2/14/2018, Preferred Series LB-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 131,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Feb. 14, 2018
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
86,984
|
|
|
|
86,984
|
|
86,984
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Neo4j, Inc., Warrant, 3/31/2026, Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3] |
$ 42,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 87,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[54] |
Mar. 31, 2026
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
|
18,395
|
|
|
|
18,395
|
|
18,395
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Scylla DB Ltd., Warrant, 7/24/2025, Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Investment Holdings [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investment cost |
[3],[38],[39] |
$ 52,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[39] |
$ 34,000
|
|
|
|
|
|
|
|
|
|
|
|
| Investments owned acquisition date |
[38],[39],[54] |
Jul. 24, 2025
|
|
|
|
|
|
|
|
|
|
|
|
| Shares (in shares) | shares |
[38],[39] |
159,684
|
|
|
|
159,684
|
|
159,684
|
|
|
|
|
|
|
|